IKKB
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A0MZ66 | S444 | Sugiyama | SHTN1 KIAA1598 | RPVNQTARPKTKPESSKGCEsAVDELKGILGtLNKSTSSRs |
| A0MZ66 | S464 | Sugiyama | SHTN1 KIAA1598 | sAVDELKGILGtLNKSTSSRsLKsLDPENsEtELERILRRR |
| A0MZ66 | S467 | Sugiyama | SHTN1 KIAA1598 | DELKGILGtLNKSTSSRsLKsLDPENsEtELERILRRRKVt |
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NMY6 | S161 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | QEINRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAE |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| A6NMY6 | T163 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| A8K0Z3 | S105 | Sugiyama | WASHC1 FAM39E WASH1 | AIKVFSSAKYPAPGRLQEyGsIFTGAQDPGLQRRPRHRIQS |
| C4AMC7 | S105 | Sugiyama | WASH3P FAM39DP | AIKVFSSAKYPAPERLQEyGsIFTGAQDPGLQRRPRHRIQS |
| O00116 | S174 | Sugiyama | AGPS AAG5 | DtPPSVVNEDFLHDLKETNIsysQEADDRVFRAHGHCLHEI |
| O00161 | S23 | Sugiyama | SNAP23 | NLssEEIQQRAHQITDEsLEstRRILGLAIEsQDAGIKtIt |
| O00161 | S95 | EPSD|PSP | SNAP23 | ELNKCCGLCVCPCNRTKNFEsGKAYKttWGDGGENsPCNVV |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00233 | S46 | Sugiyama | PSMD9 | LMRRKEEIEAQIKANyDVLEsQKGIGMNEPLVDCEGyPRSD |
| O00299 | S221 | Sugiyama | CLIC1 G6 NCC27 | EAFRGVHRYLsNAyAREEFAstCPDDEEIELAyEQVAKALK |
| O00410 | S974 | Sugiyama | IPO5 KPNB3 RANBP5 | VIQSADSKTKENVNAtENCIsAVGKIMKFKPDCVNVEEVLP |
| O00483 | S66 | Sugiyama | NDUFA4 | DRNNPEPWNKLGPNDQYKFysVNVDysKLKKERPDF_____ |
| O00571 | S71 | Sugiyama | DDX3X DBX DDX3 | GFyDKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGsG |
| O14545 | S320 | Sugiyama | TRAFD1 FLN29 | YPEELLIDHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQN |
| O14545 | S409 | Sugiyama | TRAFD1 FLN29 | CDQRPATATNHVTEGIPRLDsQPQEtsPELPRRRVRHQGDL |
| O14618 | S197 | Sugiyama | CCS | GRAIFRMEDEQLKVWDVIGRsLIIDEGEDDLGRGGHPLSKI |
| O14744 | S463 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | NELSPECLDGAQHFLKDDGVsIPGEYTsFLAPISSSKLYNE |
| O14744 | S470 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | LDGAQHFLKDDGVsIPGEYTsFLAPISSSKLYNEVRACREK |
| O14893 | S131 | Sugiyama | GEMIN2 SIP1 | STVRQNVNKHRSHWKsQQLDsNVTMPKSEDEEGWKKFCLGE |
| O14910 | S135 | Sugiyama | LIN7A MALS1 VELI1 | DEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGDQL |
| O14920 | S177 | ELM|PSP | IKBKB IKKB | EQRLIHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQ |
| O14920 | S181 | ELM|PSP | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O14920 | S507 | Sugiyama | IKBKB IKKB | KTSIQIDLEKYSEQTEFGITsDKLLLAWREMEQAVELCGRE |
| O14920 | S634 | Sugiyama | IKBKB IKKB | KTVVCKQKALELLPKVEEVVsLMNEDEKTVVRLQEKRQKEL |
| O14920 | S670 | GPS6|SIGNOR|ELM|EPSD | IKBKB IKKB | RQKELWNLLKIACSKVRGPVsGsPDsMNAsRLsQPGQLMsQ |
| O14920 | S672 | GPS6|SIGNOR|ELM|EPSD | IKBKB IKKB | KELWNLLKIACSKVRGPVsGsPDsMNAsRLsQPGQLMsQPs |
| O14920 | S675 | SIGNOR|ELM|EPSD | IKBKB IKKB | WNLLKIACSKVRGPVsGsPDsMNAsRLsQPGQLMsQPstAs |
| O14920 | S679 | SIGNOR|EPSD | IKBKB IKKB | KIACSKVRGPVsGsPDsMNAsRLsQPGQLMsQPstAsNsLP |
| O14920 | S682 | SIGNOR|ELM|EPSD | IKBKB IKKB | CSKVRGPVsGsPDsMNAsRLsQPGQLMsQPstAsNsLPEPA |
| O14920 | S689 | SIGNOR|ELM|EPSD | IKBKB IKKB | VsGsPDsMNAsRLsQPGQLMsQPstAsNsLPEPAKKsEELV |
| O14920 | S692 | SIGNOR|ELM|EPSD | IKBKB IKKB | sPDsMNAsRLsQPGQLMsQPstAsNsLPEPAKKsEELVAEA |
| O14920 | S695 | SIGNOR|ELM|EPSD | IKBKB IKKB | sMNAsRLsQPGQLMsQPstAsNsLPEPAKKsEELVAEAHNL |
| O14920 | S697 | SIGNOR|ELM|EPSD | IKBKB IKKB | NAsRLsQPGQLMsQPstAsNsLPEPAKKsEELVAEAHNLCT |
| O14920 | S705 | SIGNOR|ELM|EPSD | IKBKB IKKB | GQLMsQPstAsNsLPEPAKKsEELVAEAHNLCTLLENAIQD |
| O14920 | S733 | SIGNOR|ELM|EPSD | IKBKB IKKB | HNLCTLLENAIQDTVREQDQsFTALDWsWLQTEEEEHsCLE |
| O14920 | S740 | SIGNOR|ELM|EPSD | IKBKB IKKB | ENAIQDTVREQDQsFTALDWsWLQTEEEEHsCLEQAs____ |
| O14920 | S750 | SIGNOR|ELM|EPSD | IKBKB IKKB | QDQsFTALDWsWLQTEEEEHsCLEQAs______________ |
| O14920 | S756 | SIGNOR|EPSD | IKBKB IKKB | ALDWsWLQTEEEEHsCLEQAs____________________ |
| O14950 | T129 | Sugiyama | MYL12B MRLC2 MYLC2B | CFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPID |
| O14976 | S1185 | Sugiyama | GAK DNAJC26 | RAPSFAQKPKVsENDFEDLLsNQGFSSRSDKKGPKTIAEMR |
| O14980 | S450 | Sugiyama | XPO1 CRM1 | VLVVENDQGEVVREFMKDTDsINLyKNMRETLVyLTHLDyV |
| O15020 | S1417 | Sugiyama | SPTBN2 KIAA0302 SCA5 | SWLESLQAQLHSDDYGKDLTsVNILLKKQQMLEWEMAVREK |
| O15119 | S723 | Sugiyama | TBX3 | sMsLsPKLCAEKEAATsELQsIQRLVSGLEAKPDRsRSASP |
| O15143 | S323 | Sugiyama | ARPC1B ARC41 | QNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCS |
| O15305 | S230 | Sugiyama | PMM2 | KTMPGGNDHEIFTDPRTMGysVTAPEDTRRICELLFS____ |
| O15350 | S471 | PSP | TP73 P73 | GMLNNHGHAVPANGEMSSSHsAQSMVSGSHCTPPPPYHADP |
| O15355 | S245 | Sugiyama | PPM1G PPM1C | GQVGEPGIPtGEAGPsCssAsDKLPRVAKSKFFEDSEDESD |
| O15523 | S71 | Sugiyama | DDX3Y DBY | GFHDKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSGS |
| O43164 | S196 | Sugiyama | PJA2 KIAA0438 RNF131 | EDNDHLQLSAEVVEGSRYQEsLGNtVFELENREAEAYtGLs |
| O43164 | S253 | Sugiyama | PJA2 KIAA0438 RNF131 | LDsVPLVKssAGDTEFVHQNsQEIQRSSQDEMVSTKQQNNT |
| O43172 | S298 | Sugiyama | PRPF4 PRP4 | AIVFHPKSTVSLDPKDVNLAsCAADGSVKLWSLDSDEPVAD |
| O43175 | S251 | Sugiyama | PHGDH PGDH3 | VVNCARGGIVDEGALLRALQsGQCAGAALDVFTEEPPRDRA |
| O43324 | S100 | Sugiyama | EEF1E1 AIMP3 P18 | TQVDGHSSKNDIHTLLKDLNsyLEDKVYLTGYNFTLADILL |
| O43524 | S644 | GPS6|SIGNOR|ELM|EPSD|PSP | FOXO3 FKHRL1 FOXO3A | MEsIIRSELMDADGLDFNFDsLISTQNVVGLNVGNFTGAKQ |
| O43707 | S507 | Sugiyama | ACTN4 | DsHNVNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAID |
| O43707 | S511 | Sugiyama | ACTN4 | VNtRCQKICDQWDALGsLtHsRREALEKTEKQLEAIDQLHL |
| O43715 | S32 | Sugiyama | TRIAP1 15E1.1 HSPC132 | KREYDQCFNRWFAEKFLKGDssGDPCTDLFKRYQQCVQKAI |
| O43765 | S197 | Sugiyama | SGTA SGT SGT1 | EAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTGGVG |
| O43813 | S16 | Sugiyama | LANCL1 GPR69A | _____MAQRAFPNPyADyNKsLAEGyFDAAGRLTPEFSQRL |
| O43815 | S369 | Sugiyama | STRN | PNRSKLQDMLANLRDVDELPsLQPsVGsPsRPsssRLPEHE |
| O43815 | S373 | Sugiyama | STRN | KLQDMLANLRDVDELPsLQPsVGsPsRPsssRLPEHEINRA |
| O43852 | S125 | Sugiyama | CALU | IyEDVERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDD |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60220 | S57 | Sugiyama | TIMM8A DDP DDP1 TIM8A | HQMTELCWEKCMDKPGPKLDsRAEACFVNCVERFIDTSQFI |
| O60343 | S757 | Sugiyama | TBC1D4 AS160 KIAA0603 | ASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRISWRQRIF |
| O60566 | S509 | Sugiyama | BUB1B BUBR1 MAD3L SSK1 | IPGMTLSSSVCQVNCCARETsLAENIWQEQPHSKGPsVPFS |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60664 | S225 | Sugiyama | PLIN3 M6PRBP1 TIP47 | PLTDAELARIAtsLDGFDVAsVQQQRQEQSyFVRLGsLSER |
| O60664 | T216 | Sugiyama | PLIN3 M6PRBP1 TIP47 | sEEWADNHLPLTDAELARIAtsLDGFDVAsVQQQRQEQSyF |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60749 | S265 | Sugiyama | SNX2 TRG9 | RTVKHPTLLQDPDLRQFLEssELPRAVNTQALsGAGILRMV |
| O60763 | S751 | Sugiyama | USO1 VDP | EIGRLREEIEELKRNQELLQsQLTEKDSMIENMKSSQtSGT |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75083 | S11 | Sugiyama | WDR1 | __________MPYEIKKVFAsLPQVERGVSKIIGGDPKGNN |
| O75116 | S930 | Sugiyama | ROCK2 KIAA0619 | SLAAQLEITLTKADSEQLARsIAEEQysDLEKEKIMKELEI |
| O75116 | S970 | Sugiyama | ROCK2 KIAA0619 | IKEMMARHKQELTEKDAtIAsLEETNRtLtSDVANLANEKE |
| O75122 | S1027 | Sugiyama | CLASP2 KIAA0627 | sMPtHssPRsRDyNPyNysDsIsPFNKsALKEAMFDDDADQ |
| O75208 | S95 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | ssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPAHG |
| O75330 | S344 | Sugiyama | HMMR IHABP RHAMM | KFILEQQEREKLQQKELQIDsLLQQEKELSSSLHQKLCSFQ |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75369 | S2487 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | FKAKVTGQRLVsPGsANEtssILVEsVTRsstETCysAIPK |
| O75369 | S2492 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | TGQRLVsPGsANEtssILVEsVTRsstETCysAIPKASSDA |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O75534 | S598 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | KVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQGM |
| O75569 | S18 | Sugiyama | PRKRA PACT RAX HSD-14 HSD14 | ___MSQSRHRAEAPPLEREDsGtFsLGKMITAKPGKTPIQV |
| O75569 | T20 | Sugiyama | PRKRA PACT RAX HSD-14 HSD14 | _MSQSRHRAEAPPLEREDsGtFsLGKMITAKPGKTPIQVLH |
| O75643 | S42 | Sugiyama | SNRNP200 ASCC3L1 BRR2 HELIC2 KIAA0788 | QADRsLIDRTRRDEPTGEVLsLVGKLEGTRMGDKAQRTKPQ |
| O75821 | S28 | Sugiyama | EIF3G EIF3S4 | sKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPELL |
| O75821 | T27 | Sugiyama | EIF3G EIF3S4 | DsKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPEL |
| O76070 | S73 | Sugiyama | SNCG BCSG1 PERSYN PRSN | TsVAEKTKEQANAVSEAVVssVNTVATKTVEEAENIAVtsG |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95260 | S169 | Sugiyama | ATE1 | ESLESEGKNSKKEEPQELLQsQDFVGEKLGsGEPSHSVKVH |
| O95292 | S156 | Sugiyama | VAPB UNQ484/PRO983 | EINKIIstTAsKtEtPIVSKsLsssLDDtEVKKVMEECKRL |
| O95292 | S160 | Sugiyama | VAPB UNQ484/PRO983 | IIstTAsKtEtPIVSKsLsssLDDtEVKKVMEECKRLQGEV |
| O95425 | S227 | Sugiyama | SVIL | RGQELsATRQAHDLsPAAEsssTFsFSGRDssFtEVPRsPK |
| O95425 | S231 | Sugiyama | SVIL | LsATRQAHDLsPAAEsssTFsFSGRDssFtEVPRsPKHAHS |
| O95757 | S40 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sGGIETIANEySDRCtPACIsLGSRTRAIGNAAKSQIVTNV |
| O95757 | S517 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | VIEKQNLEGDHsDAPMETEtsFKNENKDNMDKMQVDQEEGH |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95816 | S31 | Sugiyama | BAG2 | NEGRFCRsssMADRsSRLLEsLDQLELRVEALREAATAVEQ |
| O95817 | S467 | Sugiyama | BAG3 BIS | TDKKYLMIEEYLTKELLALDsVDPEGRADVRQARRDGVRKV |
| O95861 | S57 | Sugiyama | BPNT1 | IVEKTCATDLQTKADRLAQMsICSsLARKFPKLTIIGEEDL |
| O95861 | S61 | Sugiyama | BPNT1 | TCATDLQTKADRLAQMsICSsLARKFPKLTIIGEEDLPSEE |
| O95881 | S136 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | LFLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQE |
| O95999 | S134 | GPS6|SIGNOR|EPSD|PSP | BCL10 CIPER CLAP | LKGLKCSSCEPFPDGAtNNLsRsNsDEsNFsEKLRASTVMY |
| O95999 | S136 | GPS6|SIGNOR|PSP | BCL10 CIPER CLAP | GLKCSSCEPFPDGAtNNLsRsNsDEsNFsEKLRASTVMYHP |
| O95999 | S138 | GPS6|SIGNOR|PSP | BCL10 CIPER CLAP | KCSSCEPFPDGAtNNLsRsNsDEsNFsEKLRASTVMYHPEG |
| O95999 | S141 | GPS6|SIGNOR|PSP | BCL10 CIPER CLAP | SCEPFPDGAtNNLsRsNsDEsNFsEKLRASTVMYHPEGESS |
| O95999 | S144 | GPS6|SIGNOR|PSP | BCL10 CIPER CLAP | PFPDGAtNNLsRsNsDEsNFsEKLRASTVMYHPEGESSTTP |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00441 | S103 | Sugiyama | SOD1 | GDLGNVtADKDGVADVsIEDsVIsLsGDHCIIGRTLVVHEK |
| P00441 | S106 | Sugiyama | SOD1 | GNVtADKDGVADVsIEDsVIsLsGDHCIIGRTLVVHEKADD |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00558 | S390 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | IIGGGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPG |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P01100 | S308 | EPSD|PSP | FOS G0S7 | SVPDMDLSGSFYAADWEPLHsGSLGMGPMATELEPLCtPVV |
| P01106 | S82 | PSP | MYC BHLHE39 | EDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsLRGDND |
| P01106 | S86 | PSP | MYC BHLHE39 | KKFELLPtPPLsPsRRsGLCsPSyVAVTPFsLRGDNDGGGG |
| P02786 | S137 | Sugiyama | TFRC | PAARRLyWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREA |
| P02786 | S616 | Sugiyama | TFRC | QFVIKLTHDVELNLDYERYNsQLLsFVRDLNQYRADIKEMG |
| P02786 | S620 | Sugiyama | TFRC | KLTHDVELNLDYERYNsQLLsFVRDLNQYRADIKEMGLSLQ |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S354 | Sugiyama | ALDOA ALDA | ANsLACQGKytPsGQAGAAAsEsLFVsNHAy__________ |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | Y364 | Sugiyama | ALDOA ALDA | tPsGQAGAAAsEsLFVsNHAy____________________ |
| P04083 | S170 | Sugiyama | ANXA1 ANX1 LPC1 | RDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsE |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T153 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | MGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04632 | T85 | Sugiyama | CAPNS1 CAPN4 CAPNS | VIsAISEAAAQYNPEPPPPRtHysNIEANEsEEVRQFRRLF |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T174 | Sugiyama | HSPB1 HSP27 HSP28 | SSsLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGP |
| P05023 | S217 | Sugiyama | ATP1A1 | DRIPADLRIIsANGCKVDNssLtGESEPQtRsPDFtNENPL |
| P05023 | S757 | Sugiyama | ATP1A1 | AGSDVSKQAADMILLDDNFAsIVTGVEEGRLIFDNLKKSIA |
| P05198 | S129 | Sugiyama | EIF2S1 EIF2A | YSILRHVAEVLEYTKDEQLEsLFQRTAWVFDDKyKRPGyGA |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05387 | S44 | Sugiyama | RPLP2 D11S2243E RPP2 | KKILDsVGIEADDDRLNKVIsELNGKNIEDVIAQGIGKLAs |
| P05387 | S64 | Sugiyama | RPLP2 D11S2243E RPP2 | sELNGKNIEDVIAQGIGKLAsVPAGGAVAVsAAPGsAAPAA |
| P05455 | S225 | Sugiyama | SSB | LRAKQEQEAKQKLEEDAEMKsLEEKIGCLLKFSGDLDDQTC |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05556 | S509 | Sugiyama | ITGB1 FNRB MDF2 MSK12 | CRCNEGRVGRHCECstDEVNsEDMDAYCRKENSSEICSNNG |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S247 | Sugiyama | KRT8 CYK8 | LYEEEIRELQSQISDTSVVLsMDNSRsLDMDsIIAEVKAQy |
| P05787 | S253 | Sugiyama | KRT8 CYK8 | RELQSQISDTSVVLsMDNSRsLDMDsIIAEVKAQyEDIANR |
| P05787 | S280 | Sugiyama | KRT8 CYK8 | IAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDL |
| P05787 | S404 | Sugiyama | KRT8 CYK8 | LDIEIATYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06493 | S53 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | KKIRLEsEEEGVPstAIREIsLLKELRHPNIVSLQDVLMQD |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | S79 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GKGVSKAVEHINKtIAPALVsKKLNVtEQEKIDKLMIEMDG |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P06748 | S43 | Sugiyama | NPM1 NPM | LKADKDyHFKVDNDENEHQLsLRTVsLGAGAKDELHIVEAE |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | S44 | Sugiyama | LDHB | ITVVGVGQVGMACAISILGKsLADELALVDVLEDKLKGEMM |
| P07203 | S197 | Sugiyama | GPX1 | RRYSRRFQTIDIEPDIEALLsQGPSCA______________ |
| P07203 | S95 | Sugiyama | GPX1 | GFPCNQFGHQENAKNEEILNsLKyVRPGGGFEPNFMLFEKC |
| P07205 | S390 | Sugiyama | PGK2 PGKB | VIGGGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPG |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07355 | S161 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | QEINRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAE |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07355 | T163 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07737 | S92 | Sugiyama | PFN1 | sVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtKtDKtLVL |
| P07814 | S1473 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | CEDWIKKtTARDQDLEPGAPsMGAKSLCIPFKPLCELQPGA |
| P07814 | T746 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | NETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S164 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGT |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S169 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILH |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S468 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQ |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S543 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKKQEE |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | S72 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ssDALDKIRyEsLtDPsKLDsGKELHINLIPNKQDRtLtIV |
| P07900 | T540 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yMIEPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKK |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P07919 | S61 | Sugiyama | UQCRH | EKCVKARERLELCDERVssRsHtEEDCtEELFDFLHARDHC |
| P07942 | S656 | Sugiyama | LAMB1 | RIPTSSRCGNTIPDDDNQVVsLsPGSRYVVLPRPVCFEKGT |
| P08174 | S106 | Sugiyama | CD55 CR DAF | QWSDIEEFCNRSCEVPtRLNsAsLKQPYITQNyFPVGtVVE |
| P08174 | S68 | Sugiyama | CD55 CR DAF | ALEGRTsFPEDtVItyKCEEsFVKIPGEKDsVICLKGSQWS |
| P08174 | T62 | Sugiyama | CD55 CR DAF | VPNAQPALEGRTsFPEDtVItyKCEEsFVKIPGEKDsVICL |
| P08174 | Y63 | Sugiyama | CD55 CR DAF | PNAQPALEGRTsFPEDtVItyKCEEsFVKIPGEKDsVICLK |
| P08195 | S134 | Sugiyama | SLC3A2 MDU1 | ELNELEPEKQPMNAAsGAAMsLAGAEKNGLVKIKVAEDEAE |
| P08195 | S292 | Sugiyama | SLC3A2 MDU1 | VAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNY |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08195 | S521 | Sugiyama | SLC3A2 MDU1 | GAVSANMTVKGQsEDPGsLLsLFRRLsDQRsKERSLLHGDF |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08236 | S46 | Sugiyama | GUSB | GMLYPQESPSRECKELDGLWsFRADFSDNRRRGFEEQWYRR |
| P08238 | S159 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGT |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S164 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILH |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S474 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKEQV |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S532 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yMtEPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | S67 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AsDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERtLtLV |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09496 | S236 | Sugiyama | CLTA | RLCDFNPKSSKQAKDVSRMRsVLIsLKQAPLVH________ |
| P09496 | S240 | Sugiyama | CLTA | FNPKSSKQAKDVSRMRsVLIsLKQAPLVH____________ |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0C0S5 | S99 | Sugiyama | H2AZ1 H2AFZ H2AZ | VKRITPRHLQLAIRGDEELDsLIKATIAGGGVIPHIHKSLI |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10398 | S157 | Sugiyama | ARAF ARAF1 PKS PKS2 | SSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRPLN |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S187 | Sugiyama | HSPD1 HSP60 | EIAQVAtIsANGDKEIGNIIsDAMKKVGRKGVITVKDGKtL |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P11047 | S942 | Sugiyama | LAMC1 LAMB2 | GFYNLQSGQGCERCDCHALGstNGQCDIRTGQCECQPGITG |
| P11142 | S362 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | RIPKIQKLLQDFFNGKELNKsINPDEAVAyGAAVQAAILsG |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | S544 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KYKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKIND |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11279 | S141 | Sugiyama | LAMP1 | NLSDTHLFPNASSKEIKtVEsITDIRADIDKKYRCVSGTQV |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P12004 | S152 | Sugiyama | PCNA | EySCVVKMPSGEFARICRDLsHIGDAVVIsCAKDGVKFSAs |
| P12004 | S161 | Sugiyama | PCNA | SGEFARICRDLsHIGDAVVIsCAKDGVKFSAsGELGNGNIK |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12268 | S508 | Sugiyama | IMPDH2 IMPD2 | LKFEKRtssAQVEGGVHsLHsyEKRLF______________ |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P12429 | S21 | Sugiyama | ANXA3 ANX3 | MASIWVGHRGTVRDyPDFsPsVDAEAIQKAIRGIGTDEKML |
| P12814 | S797 | Sugiyama | ACTN1 | SLGYDIGNDPQGEAEFARIMsIVDPNRLGVVTFQAFIDFMS |
| P13010 | S318 | Sugiyama | XRCC5 G22P2 | NDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSEGK |
| P13073 | S72 | Sugiyama | COX4I1 COX4 | VKHLSASQKALKEKEKASWssLsMDEKVELYRIKFKEsFAE |
| P13473 | S155 | Sugiyama | LAMP2 | LTVDELLAIRIPLNDLFRCNsLSTLEKNDVVQHYWDVLVQA |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13637 | S207 | Sugiyama | ATP1A3 | DRVPADLRIISAHGCKVDNssLtGESEPQTRSPDCTHDNPL |
| P13637 | S747 | Sugiyama | ATP1A3 | AGSDVSKQAADMILLDDNFAsIVTGVEEGRLIFDNLKKSIA |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13667 | S383 | Sugiyama | PDIA4 ERP70 ERP72 | FQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHRKVS |
| P13667 | S495 | Sugiyama | PDIA4 ERP70 ERP72 | NAAILDEsGKKFAMEPEEFDsDtLREFVtAFKKGKLKPVIK |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13798 | S8 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | _____________MERQVLLsEPEEAAALyRGLSRQPALsA |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13861 | T104 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVIHPKTD |
| P13861 | Y105 | Sugiyama | PRKAR2A PKR2 PRKAR2 | DLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVIHPKTDE |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14314 | T479 | Sugiyama | PRKCSH G19P1 | KFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPSR |
| P14618 | S100 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGPEIR |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14854 | S68 | Sugiyama | COX6B1 COX6B | GGDIsVCEWyQRVYQsLCPtsWVTDWDEQRAEGTFPGKI__ |
| P14854 | T67 | Sugiyama | COX6B1 COX6B | KGGDIsVCEWyQRVYQsLCPtsWVTDWDEQRAEGTFPGKI_ |
| P14866 | S473 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | VSKQPAIMPGQSyGLEDGsCsyKDFSESRNNRFstPEQAAK |
| P14868 | S32 | Sugiyama | DARS1 DARS PIG40 | EKPREIMDAAEDyAKERyGIssMIQsQEKPDRVLVRVRDLt |
| P14868 | S33 | Sugiyama | DARS1 DARS PIG40 | KPREIMDAAEDyAKERyGIssMIQsQEKPDRVLVRVRDLtI |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15336 | S62 | Sugiyama | ATF2 CREB2 CREBP1 | LAVHKHKHEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P16070 | S71 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLCKAFNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRI |
| P16070 | T76 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | FNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSI |
| P16083 | S80 | Sugiyama | NQO2 NMOR2 | LSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIF |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17301 | S797 | Sugiyama | ITGA2 CD49B | TAKVFSIPFHKDCGEDGLCIsDLVLDVRQIPAAQEQPFIVS |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17812 | S587 | Sugiyama | CTPS1 CTPS | ysDRsGsssPDsEItELKFPsINHD________________ |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18084 | S507 | Sugiyama | ITGB5 | CECSPGYLGTRCECQDGENQsVyQNLCREAEGKPLCSGRGD |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18615 | S138 | Sugiyama | NELFE RD RDBP | DDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEGPGA |
| P18615 | S139 | Sugiyama | NELFE RD RDBP | DLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEGPGAG |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18754 | S90 | Sugiyama | RCC1 CHC1 | VQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsVEGSEM |
| P19105 | T128 | Sugiyama | MYL12A MLCB MRLC3 RLC | CFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPID |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | Y463 | Sugiyama | NCL | EKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsG |
| P19438 | S381 | EPSD|PSP | TNFRSF1A TNFAR TNFR1 | AVVENVPPLRWKEFVRRLGLsDHEIDRLELQNGRCLREAQy |
| P19784 | S344 | Sugiyama | CSNK2A2 CK2A2 | yFyPVVKEQsQPCADNAVLssGLtAAR______________ |
| P19838 | S80 | PSP | NFKB1 | VCEGPSHGGLPGASSEKNKKsYPQVKICNYVGPAKVIVQLV |
| P19838 | S923 | GPS6|SIGNOR|ELM|EPSD|PSP | NFKB1 | sLPLsPAstRQQIDELRDSDsVCDsGVEtsFRKLsFtEsLt |
| P19838 | S927 | GPS6|SIGNOR|ELM|EPSD|PSP | NFKB1 | sPAstRQQIDELRDSDsVCDsGVEtsFRKLsFtEsLtSGAS |
| P19838 | S932 | GPS6|SIGNOR|EPSD|PSP | NFKB1 | RQQIDELRDSDsVCDsGVEtsFRKLsFtEsLtSGASLLTLN |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20648 | S228 | Sugiyama | ATP4A | DRVPADIRILAAQGCKVDNssLtGESEPQTRSPECTHESPL |
| P20749 | S122 | SIGNOR | BCL3 BCL4 D19S37 | PLVNLPTPLYPMMCPMEHPLsADIAMATRADEDGDTPLHIA |
| P20749 | S454 | SIGNOR|EPSD|PSP | BCL3 BCL4 D19S37 | FAGVLRGPGRPVPPSPAPGGs____________________ |
| P20810 | S297 | Sugiyama | CAST | KKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEVDE |
| P20810 | S311 | Sugiyama | CAST | LEALsAsLGTRQAEPELDLRsIKEVDEAKAKEEKLEKCGED |
| P20810 | S337 | Sugiyama | CAST | EAKAKEEKLEKCGEDDEtIPsEyRLKPATDKDGKPLLPEPE |
| P21127 | S277 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | APAQKPAQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSA |
| P21333 | S1522 | Sugiyama | FLNA FLN FLN1 | NADGTQTVNyVPSREGPysIsVLyGDEEVPRsPFKVKVLPT |
| P21580 | S381 | PSP | TNFAIP3 OTUD7C | EQGRREGHAQNPMEPSVPQLsLMDVKCETPNCPFFMSVNTQ |
| P22314 | S56 | Sugiyama | UBA1 A1S9T UBE1 | VPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVL |
| P22692 | S255 | Sugiyama | IGFBP4 IBP4 | VKLPGGLEPKGELDCHQLADsFRE_________________ |
| P23381 | S213 | Sugiyama | WARS1 IFI53 WARS WRS | IQMTDDEKYLWKDLtLDQAysyAVENAKDIIACGFDINKTF |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23396 | S209 | EPSD|PSP | RPS3 OK/SW-cl.26 | MLPWDPTGKIGPKKPLPDHVsIVEPKDEILPttPIsEQKGG |
| P23434 | S150 | Sugiyama | GCSH | NPGLVNKSCyEDGWLIKMtLsNPsELDELMsEEAyEKYIKS |
| P23434 | S153 | Sugiyama | GCSH | LVNKSCyEDGWLIKMtLsNPsELDELMsEEAyEKYIKSIEE |
| P23434 | S160 | Sugiyama | GCSH | EDGWLIKMtLsNPsELDELMsEEAyEKYIKSIEE_______ |
| P23434 | T148 | Sugiyama | GCSH | AENPGLVNKSCyEDGWLIKMtLsNPsELDELMsEEAyEKYI |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23528 | S160 | Sugiyama | CFL1 CFL | yEEVKDRCTLAEKLGGsAVIsLEGKPL______________ |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23921 | S780 | Sugiyama | RRM1 RR1 | KEKVSKEEEEKERNtAAMVCsLENRDECLMCGS________ |
| P23921 | T555 | Sugiyama | RRM1 RR1 | IyyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTP |
| P24534 | S164 | Sugiyama | EEF1B2 EEF1B EF1B | LDVKPWDDEtDMAKLEECVRsIQADGLVWGssKLVPVGyGI |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P24844 | T129 | Sugiyama | MYL9 MLC2 MRLC1 MYRL2 | CFDEEASGFIHEDHLRELLttMGDRFtDEEVDEMyREAPID |
| P24941 | S53 | Sugiyama | CDK2 CDKN2 | KKIRLDtETEGVPstAIREIsLLKELNHPNIVKLLDVIHTE |
| P25205 | S34 | Sugiyama | MCM3 | EAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVNDL |
| P25205 | S781 | Sugiyama | MCM3 | QSIGMNRLTESINRDSEEPFsSVEIQAALSKMQDDNQVMVS |
| P25208 | S95 | Sugiyama | NFYB HAP3 | TGKIAKDAKECVQECVSEFIsFITsEASERCHQEKRKTING |
| P25208 | S99 | Sugiyama | NFYB HAP3 | AKDAKECVQECVSEFIsFITsEASERCHQEKRKTINGEDIL |
| P25445 | S333 | Sugiyama | FAS APT1 FAS1 TNFRSF6 | IILKDITSDSENSNFRNEIQsLV__________________ |
| P25705 | S53 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | ARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETGR |
| P25705 | S65 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | KtGtAEMssILEERILGADtsVDLEETGRVLsIGDGIARVH |
| P25705 | S76 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | EERILGADtsVDLEETGRVLsIGDGIARVHGLRNVQAEEMV |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25788 | Y239 | Sugiyama | PSMA3 HC8 PSC8 | ELTNGRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM____ |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25963 | S32 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P25963 | S36 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NFKBIA IKBA MAD3 NFKBI | PRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEIRLEP |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P26639 | S702 | Sugiyama | TARS1 TARS | ISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAEEE |
| P26640 | S613 | Sugiyama | VARS1 G7A VARS VARS2 | TPAHDQNDyEVGQRHGLEAIsIMDsRGALINVPPPFLGLPR |
| P27348 | S37 | Sugiyama | YWHAQ | ERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKNVVGGRRS |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27695 | S129 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | QELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDE |
| P27695 | S135 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | SHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDEEHDQEG |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S193 | Sugiyama | CALR CRTC | tLIVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIKDPDA |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S439 | Sugiyama | MAP4 | AQANDIISSTEISSAEKVALssETEVALARDMtLPPETNVI |
| P27816 | T162 | Sugiyama | MAP4 | KMYHDDDLADLVFPssAtADtsIFAGQNDPLKDSYGMsPCN |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P27824 | S554 | Sugiyama | CANX | EKDKGDEEEEGEEKLEEKQKsDAEEDGGtVsQEEEDRKPKA |
| P28062 | S261 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | YSGGVVNMYHMKEDGWVKVEsTDVSDLLHQyREANQ_____ |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28066 | S180 | Sugiyama | PSMA5 | GtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLI |
| P28838 | S54 | Sugiyama | LAP3 LAPEP PEPS | KGLVLGIYSKEKEDDVPQFTsAGENFDKLLAGKLRETLNIS |
| P29144 | S176 | Sugiyama | TPP2 | FDVANNGSsQANKLIKEELQsQVELLNsFEKKYSDPGPVYD |
| P29144 | S183 | Sugiyama | TPP2 | SsQANKLIKEELQsQVELLNsFEKKYSDPGPVYDCLVWHDG |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29401 | S439 | Sugiyama | TKT | VSIGEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVE |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S86 | Sugiyama | EEF1D EF1D | GPGAssGtsGDHGELVVRIAsLEVENQsLRGVVQELQQAIs |
| P29692 | S93 | Sugiyama | EEF1D EF1D | tsGDHGELVVRIAsLEVENQsLRGVVQELQQAIsKLEARLN |
| P30041 | T221 | Sugiyama | PRDX6 AOP2 KIAA0106 | LFPKGVFtKELPSGKKYLRYtPQP_________________ |
| P30044 | S168 | Sugiyama | PRDX5 ACR1 SBBI10 | RLLADPTGAFGKEtDLLLDDsLVsIFGNRRLKRFsMVVQDG |
| P30044 | S171 | Sugiyama | PRDX5 ACR1 SBBI10 | ADPTGAFGKEtDLLLDDsLVsIFGNRRLKRFsMVVQDGIVK |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30084 | S107 | Sugiyama | ECHS1 | LTGGDKAFAAGADIKEMQNLsFQDCySSKFLKHWDHLTQVK |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | T69 | Sugiyama | PEBP1 PBP PEBP | RPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWHHFLV |
| P30101 | S474 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yFsPANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEK |
| P30101 | S478 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKK |
| P30533 | S230 | Sugiyama | LRPAP1 A2MRAP | SDIKGSVLHSRHTELKEKLRsINQGLDRLRRVsHQGystEA |
| P30740 | S118 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | YNFLPEFLVSTQKtyGADLAsVDFQHASEDARKTINQWVKG |
| P30740 | S72 | Sugiyama | SERPINB1 ELANH2 MNEI PI2 | AQLSKTFHFNTVEEVHSRFQsLNADINKRGASYILKLANRL |
| P31153 | S247 | Sugiyama | MAT2A AMS2 MATA2 | IKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLtGRKII |
| P31327 | S1021 | Sugiyama | CPS1 | RTLRQLGKKTVVVNCNPETVstDFDECDKLyFEELSLERIL |
| P31327 | S468 | Sugiyama | CPS1 | AVKAMKEENVKTVLMNPNIAsVQTNEVGLKQADTVYFLPIT |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P31327 | S863 | Sugiyama | CPS1 | LSEPSsTRIyAIAKAIDDNMsLDEIEKLTYIDKWFLYKMRD |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31942 | S298 | Sugiyama | HNRNPH3 HNRPH3 | GGsGMGGYGRDGMDNQGGyGsVGRMGMGNNysGGyGtPDGL |
| P31943 | S161 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | ITLPVDFQGRStGEAFVQFAsQEIAEKALKKHKERIGHRyI |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31943 | S285 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | NyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDI |
| P31943 | T286 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDIy |
| P31946 | S132 | SIGNOR|Sugiyama | YWHAB | TQPESKVFyLKMKGDYFRyLsEVAsGDNKQTtVsNsQQAyQ |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | S16 | Sugiyama | STIP1 | _____MEQVNELKEKGNKALsVGNIDDALQCysEAIKLDPH |
| P31948 | S28 | Sugiyama | STIP1 | KEKGNKALsVGNIDDALQCysEAIKLDPHNHVLysNRsAAy |
| P32929 | S56 | Sugiyama | CTH | AVVPPISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVA |
| P33176 | S527 | Sugiyama | KIF5B KNS KNS1 | QEVEDKTKEyELLSDELNQKsATLAsIDAELQKLKEMTNHQ |
| P33176 | S532 | Sugiyama | KIF5B KNS KNS1 | KTKEyELLSDELNQKsATLAsIDAELQKLKEMTNHQKKRAA |
| P33176 | S718 | Sugiyama | KIF5B KNS KNS1 | KQAVEQQIQSHRETHQKQIssLRDEVEAKAKLITDLQDQNQ |
| P33240 | S336 | Sugiyama | CSTF2 | PtPRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQGPPM |
| P33240 | S37 | Sugiyama | CSTF2 | SVFVGNIPYEATEEQLKDIFsEVGPVVsFRLVYDRETGKPK |
| P33240 | S44 | Sugiyama | CSTF2 | PYEATEEQLKDIFsEVGPVVsFRLVYDRETGKPKGYGFCEY |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33316 | S164 | Sugiyama | DUT | YTIPPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDV |
| P33991 | S464 | Sugiyama | MCM4 CDC21 | KRVELLKELSRKPDIYERLAsALAPsIYEHEDIKKGILLQL |
| P33991 | S469 | Sugiyama | MCM4 CDC21 | LKELSRKPDIYERLAsALAPsIYEHEDIKKGILLQLFGGTR |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34932 | S40 | Sugiyama | HSPA4 APG2 HSPH2 | AGGIETIANEysDRCtPACIsFGPKNRSIGAAAKSQVISNA |
| P35221 | S690 | Sugiyama | CTNNA1 | RAIMAQLPQEQKAKIAEQVAsFQEEKSKLDAEVSKWDDSGN |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P35568 | S268 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | NMHETILEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHH |
| P35568 | S270 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | HETILEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHHLN |
| P35568 | S272 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | TILEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHHLNNP |
| P35568 | S274 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | LEAMRAMSDEFRPRsKsQsssNCSNPISVPLRRHHLNNPPP |
| P35568 | S307 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | HHLNNPPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVR |
| P35568 | S312 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | IRS1 | PPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVRAssDG |
| P35568 | S341 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | PGsFRVRAssDGEGtMsRPAsVDGsPVsPstNRTHAHRHRG |
| P35568 | S345 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | RVRAssDGEGtMsRPAsVDGsPVsPstNRTHAHRHRGsARL |
| P35568 | S527 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | AGDEAASAADLDNRFRKRtHsAGtsPTITHQKTPSQSSVAs |
| P35568 | S531 | SIGNOR|ELM|iPTMNet|EPSD | IRS1 | AASAADLDNRFRKRtHsAGtsPTITHQKTPSQSSVAsIEEy |
| P35579 | S1154 | Sugiyama | MYH9 | KRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKK |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35606 | S204 | Sugiyama | COPB2 | HEKGVNCIDyysGGDKPyLIsGADDRLVKIWDYQNKTCVQT |
| P35606 | S350 | Sugiyama | COPB2 | MGDAEIKDGERLPLAVKDMGsCEIyPQtIQHNPNGRFVVVC |
| P35613 | S277 | Sugiyama | BSG UNQ6505/PRO21383 | KITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPG |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35637 | S340 | Sugiyama | FUS TLS | PMINLyTDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFs |
| P35998 | S89 | Sugiyama | PSMC2 MSS1 | DTGLAPPALWDLAADKQTLQsEQPLQVARCTKIINADSEDP |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38606 | S384 | Sugiyama | ATP6V1A ATP6A1 ATP6V1A1 VPP2 | RLAEMPADSGYPAyLGARLAsFYERAGRVKCLGNPEREGSV |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S549 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | IVHVSAKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39687 | S117 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | GNKIKDLstIEPLKKLENLKsLDLFNCEVtNLNDyRENVFK |
| P40763 | S181 | Sugiyama | STAT3 APRF | KMKVVENLQDDFDFNyKTLKsQGDMQDLNGNNQsVTRQKMQ |
| P40855 | S147 | Sugiyama | PEX19 HK33 PXF OK/SW-cl.22 | SCLKETLSGLAKNATDLQNssMsEEELTKAMEGLGMDEGDG |
| P40926 | S317 | Sugiyama | MDH2 | KGIEKNLGIGKVssFEEKMIsDAIPELKASIKKGEDFVKTL |
| P41236 | S24 | Sugiyama | PPP1R2 IPP2 | STAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSKKs |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42224 | T749 | PSP | STAT1 | EEFDEVSRIVGsVEFDSMMNtV___________________ |
| P42771 | S8 | SIGNOR|EPSD|PSP | CDKN2A CDKN2 MTS1 | _____________MEPAAGssMEPSADWLATAAARGRVEEV |
| P42858 | S13 | PSP | HTT HD IT15 | ________MAtLEKLMKAFEsLKsFQQQQQQQQQQQQQQQQ |
| P42858 | S16 | PSP | HTT HD IT15 | _____MAtLEKLMKAFEsLKsFQQQQQQQQQQQQQQQQQQQ |
| P42858 | T3 | PSP | HTT HD IT15 | __________________MAtLEKLMKAFEsLKsFQQQQQQ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43121 | S93 | Sugiyama | MCAM MUC18 | IFRVRQGQGQSEPGEYEQRLsLQDRGAtLALtQVtPQDERI |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43246 | S558 | Sugiyama | MSH2 | NFsTVDIQKNGVKFTNSKLtsLNEEYTKNKTEYEEAQDAIV |
| P43246 | T557 | Sugiyama | MSH2 | KNFsTVDIQKNGVKFTNSKLtsLNEEYTKNKTEYEEAQDAI |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P45974 | S787 | Sugiyama | USP5 ISOT | DAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQLFAFI |
| P46013 | S1686 | Sugiyama | MKI67 | PTGDGKSMKAFMEsPKQILDsAAsLtGsKRQLRTPKGKsEV |
| P46013 | S1689 | Sugiyama | MKI67 | DGKSMKAFMEsPKQILDsAAsLtGsKRQLRTPKGKsEVPED |
| P46013 | S1970 | Sugiyama | MKI67 | ALEDLAGFKELFQtPGHtEEsMtDDKITEVsCKsPQPDPVK |
| P46013 | T1972 | Sugiyama | MKI67 | EDLAGFKELFQtPGHtEEsMtDDKITEVsCKsPQPDPVKtP |
| P46060 | S50 | Sugiyama | RANGAP1 KIAA1835 SD | LKLNTAEDAKDVIKEIEDFDsLEALRLEGNtVGVEAARVIA |
| P46109 | S8 | Sugiyama | CRKL | _____________MSSARFDssDRsAWyMGPVsRQEAQtRL |
| P46109 | S9 | Sugiyama | CRKL | ____________MSSARFDssDRsAWyMGPVsRQEAQtRLQ |
| P46736 | S252 | Sugiyama | BRCC3 BRCC36 C6.1A CXorf53 | AVELPKILCQEEQDAYRRIHsLTHLDsVtKIHNGSVFTKNL |
| P46736 | S258 | Sugiyama | BRCC3 BRCC36 C6.1A CXorf53 | ILCQEEQDAYRRIHsLTHLDsVtKIHNGSVFTKNLCSQMSA |
| P46940 | S373 | Sugiyama | IQGAP1 KIAA0051 | DKQQKRQsGQTDPLQKEELQsGVDAANSAAQQyQRRLAAVA |
| P46940 | S730 | Sugiyama | IQGAP1 KIAA0051 | PPNFVQNSMQLSREEIQsSIsGVTAAYNREQLWLANEGLIT |
| P47756 | S204 | Sugiyama | CAPZB | sGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKI |
| P47897 | S219 | Sugiyama | QARS1 QARS | TDRRTAKDVVENGETADQTLsLMEQLRGEALKFHKPGENYK |
| P48739 | S165 | Sugiyama | PITPNB | DRSQVEPADyKADEDPALFQsVKtKRGPLGPNWKKELANsP |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49321 | S662 | Sugiyama | NASP | LKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsstsGF |
| P49327 | S1129 | Sugiyama | FASN FAS | QQVPILEKFCFtPHTEEGCLsERAALQEELQLCKGLVQALQ |
| P49327 | S1747 | Sugiyama | FASN FAS | sFEQHVLWHTGGKGVDLVLNsLAEEKLQASVRCLATHGRFL |
| P49327 | S2465 | Sugiyama | FASN FAS | LLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHRTLL |
| P49588 | S249 | Sugiyama | AARS1 AARS | ILKPLPKKsIDtGMGLERLVsVLQNKMSNYDTDLFVPYFEA |
| P49589 | S305 | Sugiyama | CARS1 CARS | KLVPEAVGDQKALQEGEGDLsIsADRLsEKRSPNDFALWKA |
| P49736 | S170 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | KRRQVERAtEDGEEDEEMIEsIENLEDLKGHSVREWVsMAG |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | S401 | Sugiyama | GDI2 RABGDIB | VsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIY |
| P50416 | S612 | Sugiyama | CPT1A CPT1 | SMTRLFREGRTETVRSCTTEsCDFVRAMVDPAQTVEQRLKL |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50897 | S262 | Sugiyama | PPT1 CLN1 PPT | EWFGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVF |
| P50990 | S162 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | ILPNLVCCsAKNLRDIDEVssLLRTSIMSKQyGNEVFLAKL |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P50991 | T201 | Sugiyama | CCT4 CCTD SRB | SLLsPMSVNAVMKVIDPAtAtsVDLRDIKIVKKLGGTIDDC |
| P50993 | S215 | Sugiyama | ATP1A2 KIAA0778 | DRVPADLRIISSHGCKVDNssLtGESEPQTRSPEFTHENPL |
| P50993 | S754 | Sugiyama | ATP1A2 KIAA0778 | SGSDVSKQAADMILLDDNFAsIVTGVEEGRLIFDNLKKSIA |
| P51858 | S239 | Sugiyama | HDGF HMG1L2 | DEEEEAtKEDAEAPGIRDHEsL___________________ |
| P52272 | S365 | Sugiyama | HNRNPM HNRPM NAGR1 | KMGGMEGPFGGGMENMGRFGsGMNMGRINEILsNALKRGEI |
| P52597 | S285 | Sugiyama | HNRNPF HNRPF | syCLsGMyDHRYGDsEFtVQsTTGHCVHMRGLPYKAtENDI |
| P52789 | S893 | Sugiyama | HK2 | KVMHETVKDLAPKCDVsFLQsEDGSGKGAALITAVACRIRE |
| P52907 | S215 | Sugiyama | CAPZA1 | QVHYYEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENA |
| P52907 | S219 | Sugiyama | CAPZA1 | YEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENAENEy |
| P52907 | T217 | Sugiyama | CAPZA1 | HYYEDGNVQLVSHKDVQDsLtVsNEAQtAKEFIKIIENAEN |
| P52948 | S679 | Sugiyama | NUP98 ADAR2 | ytNPIAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRN |
| P52948 | S683 | Sugiyama | NUP98 ADAR2 | IAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEG |
| P53634 | S452 | Sugiyama | CTSC CPPI | GWGENGyFRIRRGtDECAIEsIAVAAtPIPKL_________ |
| P53634 | T445 | Sugiyama | CTSC CPPI | VKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAtPIPKL__ |
| P53634 | T458 | Sugiyama | CTSC CPPI | yFRIRRGtDECAIEsIAVAAtPIPKL_______________ |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54105 | S193 | Sugiyama | CLNS1A CLCI ICLN | GLSHLTAEGQATLERLEGMLsQsVssQYNMAGVRtEDsIRD |
| P54105 | S195 | Sugiyama | CLNS1A CLCI ICLN | SHLTAEGQATLERLEGMLsQsVssQYNMAGVRtEDsIRDyE |
| P54136 | S21 | Sugiyama | RARS1 RARS | MDVLVSECSARLLQQEEEIKsLTAEIDRLKNCGCLGAsPNL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55036 | S39 | Sugiyama | PSMD4 MCB1 | GDFLPTRLQAQQDAVNIVCHsKTRSNPENNVGLITLANDCE |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P55072 | S37 | Sugiyama | VCP HEL-220 HEL-S-70 | LKQKNRPNRLIVDEAINEDNsVVsLSQPKMDELQLFRGDTV |
| P55072 | S40 | Sugiyama | VCP HEL-220 HEL-S-70 | KNRPNRLIVDEAINEDNsVVsLSQPKMDELQLFRGDTVLLK |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55795 | S161 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | MTLPVDFQGRStGEAFVQFAsQEIAEKALKKHKERIGHRyI |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P55795 | S281 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | GRDLNyCFsGMsDHRyGDGGssFQstTGHCVHMRGLPYRAT |
| P55795 | T286 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | yCFsGMsDHRyGDGGssFQstTGHCVHMRGLPYRATENDIY |
| P56192 | S812 | Sugiyama | MARS1 MARS | GHQIGTVSPLFQKLENDQIEsLRQRFGGGQAKtsPKPAVVE |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P60174 | S106 | Sugiyama | TPI1 TPI | DCGAtWVVLGHsERRHVFGEsDELIGQKVAHALAEGLGVIA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | S394 | Sugiyama | EIF4A1 DDX2A EIF4A | NMVTEEDKRTLRDIEtFyNtsIEEMPLNVADLI________ |
| P60842 | T393 | Sugiyama | EIF4A1 DDX2A EIF4A | INMVTEEDKRTLRDIEtFyNtsIEEMPLNVADLI_______ |
| P61024 | S39 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | yRHVMLPKDIAKLVPKTHLMsEsEWRNLGVQQsQGWVHyMI |
| P61024 | S41 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | HVMLPKDIAKLVPKTHLMsEsEWRNLGVQQsQGWVHyMIHE |
| P61158 | S406 | Sugiyama | ACTR3 ARP3 | STPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs________ |
| P61204 | S147 | Sugiyama | ARF3 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P61247 | S203 | Sugiyama | RPS3A FTE1 MFTL | EVVNKLIPDsIGKDIEKACQsIyPLHDVFVRKVKMLKKPKF |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61769 | S48 | Sugiyama | B2M CDABP0092 HDCMA22P | QVysRHPAENGKSNFLNCYVsGFHPsDIEVDLLKNGERIEK |
| P61769 | S53 | Sugiyama | B2M CDABP0092 HDCMA22P | HPAENGKSNFLNCYVsGFHPsDIEVDLLKNGERIEKVEHsD |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61923 | S161 | Sugiyama | COPZ1 COPZ CGI-120 HSPC181 | QVVHRVALRGEDVPLTEQtVsQVLQsAKEQIKWSLLR____ |
| P61923 | S166 | Sugiyama | COPZ1 COPZ CGI-120 HSPC181 | VALRGEDVPLTEQtVsQVLQsAKEQIKWSLLR_________ |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | S77 | Sugiyama | HNRNPK HNRPK | VIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIETI |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T210 | Sugiyama | YWHAG | PEQACHLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNL |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62304 | S89 | Sugiyama | SNRPE | KSRKQLGRIMLKGDNITLLQsVsN_________________ |
| P62633 | S121 | Sugiyama | CNBP RNF163 ZNF9 | CGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRCG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62820 | S114 | Sugiyama | RAB1A RAB1 | TDQESFNNVKQWLQEIDRYAsENVNKLLVGNKCDLTTKKVV |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62857 | S61 | Sugiyama | RPS28 | sIIRNVKGPVREGDVLtLLEsEREARRLR____________ |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62942 | S68 | Sugiyama | FKBP1A FKBP1 FKBP12 | KFMLGKQEVIRGWEEGVAQMsVGQRAKLTISPDYAYGATGH |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63151 | S79 | Sugiyama | PPP2R2A | QENKIQSHSRGEyNVystFQsHEPEFDyLKSLEIEEKINKI |
| P63151 | Y74 | Sugiyama | PPP2R2A | IFQQEQENKIQSHSRGEyNVystFQsHEPEFDyLKSLEIEE |
| P63167 | S21 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAH |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63220 | S31 | Sugiyama | RPS21 | LYVPRKCSASNRIIGAKDHAsIQMNVAEVDKVTGRFNGQFK |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63241 | S75 | Sugiyama | EIF5A | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQ |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84077 | S147 | Sugiyama | ARF1 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P84095 | S44 | Sugiyama | RHOG ARHG | TTNAFPKEyIPTVFDNySAQsAVDGRTVNLNLWDTAGQEEY |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q00005 | S75 | Sugiyama | PPP2R2B | QESKNQVHRRGEyNVystFQsHEPEFDyLKSLEIEEKINKI |
| Q00005 | Y70 | Sugiyama | PPP2R2B | IFQREQESKNQVHRRGEyNVystFQsHEPEFDyLKSLEIEE |
| Q00526 | S53 | Sugiyama | CDK3 CDKN3 | KKIRLDLEMEGVPSTAIREIsLLKELKHPNIVRLLDVVHNE |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q00839 | S59 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01082 | S1414 | Sugiyama | SPTBN1 SPTB2 | KWLHGLESQIQSDDyGKDLTsVNILLKKQQMLENQMEVRKK |
| Q01082 | S781 | Sugiyama | SPTBN1 SPTB2 | LDILKIVssSDVGHDEystQsLVKKHKDVAEEIANYRPTLD |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01201 | S472 | EPSD|PSP | RELB | GPFLPPSALLPDPDFFSGTVsLPGLEPPGGPDLLDDGFAYD |
| Q01518 | S338 | Sugiyama | CAP1 CAP | EPAVLELEGKKWRVENQENVsNLVIEDTELKQVAYIYKCVN |
| Q01581 | S516 | Sugiyama | HMGCS1 HMGCS | PAKKVPRLPAtAAEPEAAVIsNGEH________________ |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02818 | S193 | Sugiyama | NUCB1 NUC | HEEFKRyEMLKEHERRRyLEsLGEEQRKEAERKLEEQQRRH |
| Q02818 | S320 | Sugiyama | NUCB1 NUC | VMKNVDTNQDRLVtLEEFLAstQRKEFGDTGEGWETVEMHP |
| Q02818 | T313 | Sugiyama | NUCB1 NUC | RLRMREHVMKNVDTNQDRLVtLEEFLAstQRKEFGDTGEGW |
| Q02818 | T321 | Sugiyama | NUCB1 NUC | MKNVDTNQDRLVtLEEFLAstQRKEFGDTGEGWETVEMHPA |
| Q02952 | S1251 | Sugiyama | AKAP12 AKAP250 | EETKEQSKMEDtLEHTDKEVsVEtVsILsKTEGtQEADQyA |
| Q02952 | S1256 | Sugiyama | AKAP12 AKAP250 | QSKMEDtLEHTDKEVsVEtVsILsKTEGtQEADQyADEKTK |
| Q02952 | S1259 | Sugiyama | AKAP12 AKAP250 | MEDtLEHTDKEVsVEtVsILsKTEGtQEADQyADEKTKDVP |
| Q02952 | S1367 | Sugiyama | AKAP12 AKAP250 | EAEPTHVNEEKLEHETAVTVsEEVSKQLLQtVNVPIIDGAK |
| Q02952 | S1674 | Sugiyama | AKAP12 AKAP250 | QQLEEVVLPSEEEGGGAGTKsVPEDDGHALLAERIEKsLVE |
| Q02952 | T1254 | Sugiyama | AKAP12 AKAP250 | KEQSKMEDtLEHTDKEVsVEtVsILsKTEGtQEADQyADEK |
| Q04206 | S131 | EPSD|PSP | RELA NFKB3 | HSFQNLGIQCVKKRDLEQAIsQRIQtNNNPFQVPIEEQRGD |
| Q04206 | S261 | EPSD|PSP | RELA NFKB3 | QADVHRQVAIVFRtPPYADPsLQAPVRVsMQLRRPsDRELs |
| Q04206 | S311 | EPSD|PSP | RELA NFKB3 | DTDDRHRIEEKRKRtYEtFKsIMKKsPFSGPTDPRPPPRRI |
| Q04206 | S42 | EPSD|PSP | RELA NFKB3 | EIIEQPKQRGMRFRYKCEGRsAGsIPGERSTDTTKTHPTIK |
| Q04206 | S45 | EPSD|PSP | RELA NFKB3 | EQPKQRGMRFRYKCEGRsAGsIPGERSTDTTKTHPTIKING |
| Q04206 | S468 | GPS6|SIGNOR|EPSD|PSP | RELA NFKB3 | EDLGALLGNSTDPAVFTDLAsVDNsEFQQLLNQGIPVAPHT |
| Q04206 | S536 | GPS6|SIGNOR|ELM|EPSD|PSP | RELA NFKB3 | APLGAPGLPNGLLsGDEDFSsIADMDFsALLSQISS_____ |
| Q04695 | S277 | Sugiyama | KRT17 | RDQYEKMAEKNRKDAEDWFFsKTEELNREVATNsELVQSGK |
| Q04864 | S516 | GPS6 | REL | VNMMTTSsDSMGETDNPRLLsMNLENPsCNsVLDPRDLRQL |
| Q04864 | S526 | GPS6 | REL | MGETDNPRLLsMNLENPsCNsVLDPRDLRQLHQMSSSSMSA |
| Q04864 | S557 | EPSD|PSP | REL | HQMSSSSMSAGANSNTTVFVsQSDAFEGSDFSCADNSMINE |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q04917 | T210 | Sugiyama | YWHAH YWHA1 | PEQACLLAKQAFDDAIAELDtLNEDsyKDstLIMQLLRDNL |
| Q05682 | S131 | Sugiyama | CALD1 CAD CDM | LQEALERQKEFDPtItDAsLsLPsRRMQNDTAENETTEKEE |
| Q05682 | S134 | Sugiyama | CALD1 CAD CDM | ALERQKEFDPtItDAsLsLPsRRMQNDTAENETTEKEEKsE |
| Q05682 | T126 | Sugiyama | CALD1 CAD CDM | RRQKRLQEALERQKEFDPtItDAsLsLPsRRMQNDTAENET |
| Q05682 | T86 | Sugiyama | CALD1 CAD CDM | VEVNAQNsVPDEEAKTTtTNtQVEGDDEAAFLERLARREER |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | S126 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | SDPKRtIAQDyGVLKADEGIsFRGLFIIDDKGILRQItVND |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07021 | S205 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | DCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYT |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07021 | S87 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | CGCGCGSLHTDGDKAFVDFLsDEIKEERKIQKHKTLPKMsG |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07157 | S1360 | Sugiyama | TJP1 ZO1 | IVRSNHyDPEEDEEyyRKQLsyFDRRsFENKPPAHIAASHL |
| Q08209 | S498 | Sugiyama | PPP3CA CALNA CNA | RINERMPPRRDAMPsDANLNsINKALTSETNGTDSNGSNSS |
| Q08378 | S924 | Sugiyama | GOLGA3 | LHREVAQVRQHMADLEGHLQsAQKERDEMETHLQSLQFDKE |
| Q08752 | S119 | Sugiyama | PPID CYP40 CYPD | yGEKFEDENFHyKHDREGLLsMANAGRNTNGSQFFITTVPT |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q09161 | S33 | Sugiyama | NCBP1 CBP80 NCBP | GQPHKRRKtsDANEtEDHLEsLICKVGEKSACSLESNLEGL |
| Q09666 | S298 | Sugiyama | AHNAK PM227 | VDIsssLGGRAVEVQGPsLEsGDHGKIKFPTMKVPKFGVST |
| Q12778 | S319 | PSP | FOXO1 FKHR FOXO1A | PGsHsNDDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLG |
| Q12792 | S55 | Sugiyama | TWF1 PTK9 | EQLVIGSYSQPSDSWDKDyDsFVLPLLEDKQPCYILFRLDS |
| Q12802 | S906 | Sugiyama | AKAP13 BRX HT31 LBC | IKGNTDSSLQSVGKATLALDsVLTEEGKLLVVSESSAAQEQ |
| Q12906 | T38 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | HssVyPTQEELEAVQNMVsHtERALKAVsDWIDEQEKGssE |
| Q12931 | S477 | Sugiyama | TRAP1 HSP75 HSPC5 | EQEVKEDIAKLLRYESSALPsGQLtsLsEyASRMRAGtRNI |
| Q12931 | S482 | Sugiyama | TRAP1 HSP75 HSPC5 | EDIAKLLRYESSALPsGQLtsLsEyASRMRAGtRNIyyLCA |
| Q12931 | T481 | Sugiyama | TRAP1 HSP75 HSPC5 | KEDIAKLLRYESSALPsGQLtsLsEyASRMRAGtRNIyyLC |
| Q13136 | S666 | Sugiyama | PPFIA1 LIP1 | IQEEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPA |
| Q13148 | S92 | SIGNOR | TARDBP TDP43 | VYVVNYPKDNKRKMDEtDAssAVKVKRAVQKTSDLIVLGLP |
| Q13148 | T8 | SIGNOR | TARDBP TDP43 | _____________MsEyIRVtEDENDEPIEIPSEDDGtVLL |
| Q13155 | S51 | Sugiyama | AIMP2 JTV1 PRO0992 | HGRSyGPAPGAGHVQEEsNLsLQALESRQDDILKRLYELKA |
| Q13177 | S152 | Sugiyama | PAK2 | sNtVKQKyLsFtPPEKDGFPsGtPALNAKGtEAPAVVtEEE |
| Q13263 | S479 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERLDLDLtA |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13283 | T255 | Sugiyama | G3BP1 G3BP | PADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPHVV |
| Q13347 | S177 | Sugiyama | EIF3I EIF3S2 TRIP1 | LGECIIAGHESGELNQYSAKsGEVLVNVKEHSRQINDIQLs |
| Q13347 | S197 | Sugiyama | EIF3I EIF3S2 TRIP1 | sGEVLVNVKEHSRQINDIQLsRDMtMFVtASKDNTAKLFDs |
| Q13409 | S219 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | NDSKAPPHELTEEEKQQILHsEEFLsFFDHSTRIVERALSE |
| Q13409 | S224 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | PPHELTEEEKQQILHsEEFLsFFDHSTRIVERALSEQINIF |
| Q13439 | S1187 | Sugiyama | GOLGA4 | DKRKVSELTSKLKTTDEEFQsLKsSHEKSNKSLEDKSLEFK |
| Q13439 | S1190 | Sugiyama | GOLGA4 | KVSELTSKLKTTDEEFQsLKsSHEKSNKSLEDKSLEFKKLS |
| Q13464 | S633 | Sugiyama | ROCK1 | ERRDRGHDSEMIGDLQARITsLQEEVKHLKHNLEKVEGERK |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13526 | S105 | Sugiyama | PIN1 | ALELINGyIQKIKSGEEDFEsLAsQFSDCSsAKARGDLGAF |
| Q13561 | S391 | Sugiyama | DCTN2 DCTN50 | LTQVQTTMRENLATVEGNFAsIDERMKKLGK__________ |
| Q13564 | S198 | Sugiyama | NAE1 APPBP1 HPP1 | NALEDLRLDKPFPELREHFQsyDLDHMEKKDHSHTPWIVII |
| Q13568 | S446 | EPSD|PSP | IRF5 | LLEMFSGELsWsADsIRLQIsNPDLKDRMVEQFKELHHIWQ |
| Q13601 | S284 | Sugiyama | KRR1 HRB2 | KEYtPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKA |
| Q13733 | S763 | Sugiyama | ATP1A4 ATP1AL2 | SGSDVSKQAADMILLDDNFAsIVTGVEEGRLIFDNLKKSIM |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14152 | S513 | Sugiyama | EIF3A EIF3S10 KIAA0139 | FGsDLNyAtREDAPIGPHLQsMPSEQIRNQLTAMSSVLAKA |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14160 | S1225 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | GVIANPFAAGIGHRNsLEsIssIDRELsPEGPGKEKELPGQ |
| Q14160 | S1226 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | VIANPFAAGIGHRNsLEsIssIDRELsPEGPGKEKELPGQT |
| Q14160 | S761 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | sIAGGKGstPYKGDDEGIFIsRVsEEGPAARAGVRVGDKLL |
| Q14160 | S917 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | IAEGGAAHRAGTLQVGDRVLsINGVDVTEARHDHAVSLLtA |
| Q14164 | S172 | GPS6|EPSD | IKBKE IKKE IKKI KIAA0151 | IyKLtDFGAARELDDDEKFVsVyGtEEyLHPDMYERAVLRK |
| Q14192 | S13 | Sugiyama | FHL2 DRAL SLIM3 | ________MTERFDCHHCNEsLFGKKYILREESPYCVVCFE |
| Q14192 | S238 | Sugiyama | FHL2 DRAL SLIM3 | AKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKCsLsL |
| Q14192 | S257 | Sugiyama | FHL2 DRAL SLIM3 | IsFEERQWHNDCFNCKKCsLsLVGRGFLTERDDILCPDCGK |
| Q14204 | S1313 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | DREKCAKAKEALELtDtGLLsGSEERVQVALEELQDLKGVW |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14247 | S331 | Sugiyama | CTTN EMS1 | GVQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIR |
| Q14247 | S432 | Sugiyama | CTTN EMS1 | EERLPssPVyEDAAsFKAELsyRGPVsGtEPEPVysMEAAD |
| Q14247 | S447 | Sugiyama | CTTN EMS1 | FKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYATE |
| Q14247 | Y433 | Sugiyama | CTTN EMS1 | ERLPssPVyEDAAsFKAELsyRGPVsGtEPEPVysMEAADy |
| Q14247 | Y446 | Sugiyama | CTTN EMS1 | sFKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYAT |
| Q14257 | S207 | Sugiyama | RCN2 ERC55 | TEFVIQEALEEHDKNGDGFVsLEEFLGDyRWDPTANEDPEW |
| Q14257 | T301 | Sugiyama | RCN2 ERC55 | KKLsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL____ |
| Q14320 | S292 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | ARGKsGPLFNFDVHDDVRLLsDATVEKDESHAGKVVLRSWY |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14444 | S200 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | EEELSLLDEFyKLVDPERDMsLRLNEQYEHASIHLWDLLEG |
| Q14444 | S307 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | SEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEVVNSL |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14498 | S341 | Sugiyama | RBM39 HCC1 RNPC2 | MKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRLQLMA |
| Q14566 | S324 | Sugiyama | MCM6 | APTNPRFGGKELRDEEQtAEsIKNQMTVKEWEKVFEMsQDK |
| Q14568 | S164 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGT |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S169 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | TVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILH |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14653 | S396 | EPSD|PSP | IRF3 | VEMARVGGAssLENtVDLHIsNsHPLsLtsDQYKAYLQDLV |
| Q14653 | S398 | EPSD|PSP | IRF3 | MARVGGAssLENtVDLHIsNsHPLsLtsDQYKAYLQDLVEG |
| Q14653 | S402 | EPSD|PSP | IRF3 | GGAssLENtVDLHIsNsHPLsLtsDQYKAYLQDLVEGMDFQ |
| Q14653 | S405 | EPSD|PSP | IRF3 | ssLENtVDLHIsNsHPLsLtsDQYKAYLQDLVEGMDFQGPG |
| Q14653 | T404 | EPSD|PSP | IRF3 | AssLENtVDLHIsNsHPLsLtsDQYKAYLQDLVEGMDFQGP |
| Q14671 | S183 | Sugiyama | PUM1 KIAA0099 PUMH1 | PKGIFLGDQWRDsAWGTsDHsVsQPIMVQRRPGQsFHVNsE |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14790 | S16 | Sugiyama | CASP8 MCH5 | _____MDFSRNLyDIGEQLDsEDLAsLKFLsLDYIPQRKQE |
| Q14790 | S21 | Sugiyama | CASP8 MCH5 | MDFSRNLyDIGEQLDsEDLAsLKFLsLDYIPQRKQEPIKDA |
| Q14847 | S146 | Sugiyama | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14980 | S1788 | Sugiyama | NUMA1 NMP22 NUMA | EsLEsLyFtPIPARsQAPLEssLDsLGDVFLDsGRKtRSAR |
| Q14980 | S1792 | Sugiyama | NUMA1 NMP22 NUMA | sLyFtPIPARsQAPLEssLDsLGDVFLDsGRKtRSARRRtt |
| Q14C86 | S569 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | PVDENKLHGKPDKTLRFSLCsDNLEGIsEGPSNRSNSVSSL |
| Q15054 | S269 | Sugiyama | POLD3 KIAA0039 | VNLDSEQAVKEEKIVEQPTVsVTEPKLATPAGLKKSSKKAE |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | S13 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | ________MADFDtyDDRAyssFGGGRGsRGsAGGHGsRSQ |
| Q15056 | S14 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | _______MADFDtyDDRAyssFGGGRGsRGsAGGHGsRSQK |
| Q15056 | S94 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | RDKDTDKFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVD |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15084 | S169 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFYAPW |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15293 | T101 | Sugiyama | RCN1 RCN | KERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNVA |
| Q15393 | S1184 | Sugiyama | SF3B3 KIAA0017 SAP130 | RSyyFPVKNVIDGDLCEQFNsMEPNKQKNVSEELDRtPPEV |
| Q15398 | S446 | Sugiyama | DLGAP5 DLG7 KIAA0008 | PHHGVPYFRNILQSETEKLTsHCFEWDRKLELDIPDDAKDL |
| Q15398 | S777 | Sugiyama | DLGAP5 DLG7 KIAA0008 | sItSQDVLMssPEKNTAsQNsILEEGEtKIsQsELFDNKsL |
| Q15545 | S338 | Sugiyama | TAF7 TAF2F TAFII55 | FQAVLDELKQKEDREKEQLSsLQEELEsLLEK_________ |
| Q15545 | S345 | Sugiyama | TAF7 TAF2F TAFII55 | LKQKEDREKEQLSsLQEELEsLLEK________________ |
| Q15643 | S1001 | Sugiyama | TRIP11 CEV14 | EERQDIQTDNSDIFQETKVQsLNIENGSEKHDLSKAETERL |
| Q15643 | S406 | Sugiyama | TRIP11 CEV14 | EVFRLQQALSDAENEIMRLSsLNQDNsLAEDNLKLKMRIEV |
| Q15648 | S932 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | GGDNGETKFKGNNQADTVDFsIIsVAGKALAPADLMEHHsG |
| Q15648 | S935 | Sugiyama | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | NGETKFKGNNQADTVDFsIIsVAGKALAPADLMEHHsGsQG |
| Q15653 | S19 | iPTMNet|EPSD | NFKBIB IKBB TRIP9 | __MAGVACLGKAADADEWCDsGLGsLGPDAAAPGGPGLGAE |
| Q15653 | S23 | iPTMNet|EPSD | NFKBIB IKBB TRIP9 | GVACLGKAADADEWCDsGLGsLGPDAAAPGGPGLGAELGPG |
| Q15785 | S55 | Sugiyama | TOMM34 URCC3 | ALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCIKDCT |
| Q16204 | S328 | Sugiyama | CCDC6 D10S170 TST1 | LQREMERREALCRQLsEsEssLEMDDERYFNEMsAQGLRPR |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16626 | S163 | Sugiyama | MEA1 MEA | RTMAGVSLPAPGVPAWAREIsDAQWEDVVQKALQARQAsPA |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | S456 | Sugiyama | KYNU | APVPLyNsFHDVyKFTNLLtsILDsAETKN___________ |
| Q16719 | S460 | Sugiyama | KYNU | LyNsFHDVyKFTNLLtsILDsAETKN_______________ |
| Q16875 | S269 | SIGNOR|EPSD|PSP | PFKFB3 | IYLCRHGENEHNLQGRIGGDsGLSSRGKKFASALSKFVEEQ |
| Q16881 | S329 | Sugiyama | TXNRD1 GRIM12 KDRF | IAtGERPRyLGIPGDKEyCIsSDDLFsLPyCPGKTLVVGAS |
| Q16881 | S335 | Sugiyama | TXNRD1 GRIM12 KDRF | PRyLGIPGDKEyCIsSDDLFsLPyCPGKTLVVGASYVALEC |
| Q2TAA2 | S241 | Sugiyama | IAH1 | SSLPLLLPYWRDVAEAKPELsLLGDGDH_____________ |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q53EL6 | S46 | Sugiyama | PDCD4 H731 | GDEENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKN |
| Q53EL6 | S49 | Sugiyama | PDCD4 H731 | ENAGTEEIKNEINGNWIsAssINEARINAKAKRRLRKNssR |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S405 | Sugiyama | HSP90AB3P HSP90BC | YMTEPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | S67 | Sugiyama | HSP90AB3P HSP90BC | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNPQERTLALV |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S67 | Sugiyama | HSP90AB2P HSP90BB | ASDALDKIRyEsLtDPsKLDsGKELKIDIIPNTQEHTLTLV |
| Q58FG1 | S251 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | EPIDEYCVQQLKEFEGKtLVsVTKEDLELPEDEEEKKKQEE |
| Q58FG1 | T248 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | YTIEPIDEYCVQQLKEFEGKtLVsVTKEDLELPEDEEEKKK |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5JSH3 | S197 | Sugiyama | WDR44 RPH11 | NKEAVEVKGGGDVLEPVssDsLstKDFAAVEEVAPAKPPRH |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5UIP0 | S1663 | Sugiyama | RIF1 | PDDLPNVCEEKNETSKyAEysFtsLPVPESNLRTRNAIKRL |
| Q5UIP0 | S1666 | Sugiyama | RIF1 | LPNVCEEKNETSKyAEysFtsLPVPESNLRTRNAIKRLHKR |
| Q5VT52 | S1070 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETLGy |
| Q5VW32 | S273 | Sugiyama | BROX BROFTI C1orf58 | AYCYHGETLLASDKCGEAIRsLQEAEKLYAKAEALCKEYGE |
| Q66LE6 | S85 | Sugiyama | PPP2R2D KIAA1541 | QENKSRPHSRGEyNVystFQsHEPEFDyLKSLEIEEKINKI |
| Q66LE6 | Y80 | Sugiyama | PPP2R2D KIAA1541 | IFQREQENKSRPHSRGEyNVystFQsHEPEFDyLKSLEIEE |
| Q68CZ2 | S430 | Sugiyama | TNS3 TEM6 TENS1 TPP | APGTRRGLSAQEKAELDQLLsGFGLEDPGssLKEMTDARSK |
| Q6FI81 | S305 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CAsCPyLGMPAFKPGEKVLLsDsNLHDA_____________ |
| Q6IBS0 | S140 | Sugiyama | TWF2 PTK9L MSTP011 | ELFGTVKDDLSFAGyQKHLssCAAPAPLtsAERELQQIRIN |
| Q6IS14 | S75 | Sugiyama | EIF5AL1 | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDFQLIGIQ |
| Q6NVY1 | S242 | Sugiyama | HIBCH | LAMLEEDLLALKsPSKENIAsVLENyHtESKIDRDKSFILE |
| Q6P2E9 | S107 | PSP | EDC4 HEDLS | SSTCIGILAKEVEIVASSDSsISSKARGSNKVKIQPVAKYD |
| Q6P2E9 | S405 | PSP | EDC4 HEDLS | TVSWTCLQTIRFSPDIFSSVsVPPSLKVCLDLSAEYLILSD |
| Q6P2E9 | S583 | PSP | EDC4 HEDLS | HGsQPDLRRIVELPAPADFLsLssEtKPKLMtPDAFMTPSA |
| Q6P2E9 | S855 | PSP | EDC4 HEDLS | REtCStLAEsPRNGLQEKHKsLAFHRPPYHLLQQRDsQDAs |
| Q6P996 | S724 | Sugiyama | PDXDC1 KIAA0251 | QKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQItL |
| Q6P996 | T720 | Sugiyama | PDXDC1 KIAA0251 | RLPGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPE |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PKG0 | S824 | Sugiyama | LARP1 KIAA0731 LARP | VKEGRTLDAKMPRKRKtRHssNPPLEsHVGWVMDSREHRPR |
| Q6PKG0 | S830 | Sugiyama | LARP1 KIAA0731 LARP | LDAKMPRKRKtRHssNPPLEsHVGWVMDSREHRPRtAsIss |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6ULP2 | S328 | Sugiyama | AFTPH AFTH | RGFSVEKQGLPTLQQDEFLQsGVQsKAWSLVDSADNSEAIR |
| Q6ULP2 | S332 | Sugiyama | AFTPH AFTH | VEKQGLPTLQQDEFLQsGVQsKAWSLVDSADNSEAIRREQC |
| Q6UX04 | S203 | Sugiyama | CWC27 SDCCAG10 UNQ438/PRO871 | KKEKPEEEVKKLKPKGTKNFsLLsFGEEAEEEEEEVNRVSQ |
| Q6UX04 | S206 | Sugiyama | CWC27 SDCCAG10 UNQ438/PRO871 | KPEEEVKKLKPKGTKNFsLLsFGEEAEEEEEEVNRVSQSMK |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q6VEQ5 | S105 | Sugiyama | WASH2P FAM39B | AIKVFSSAKYPAPERLQEyGsIFTGAQDPGLQRRPRHRIQS |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71RC2 | S394 | Sugiyama | LARP4 PP13296 | RVKPQFRssGGsEHstEGsVsLGDGQLNRYSSRNFPAERHN |
| Q71RC2 | S75 | Sugiyama | LARP4 PP13296 | EGNAELSEDICKEYEVMySssCETTRNTTGIEESTDGMILG |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71UI9 | S99 | Sugiyama | H2AZ2 H2AFV H2AV | VKRITPRHLQLAIRGDEELDsLIKATIAGGGVIPHIHKSLI |
| Q7KZF4 | S126 | Sugiyama | SND1 TDRD11 | GREyGMIyLGKDTNGENIAEsLVAEGLAtRREGMRANNPEQ |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7LBC6 | S1259 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | EAGSLRSVLNKEsHsPFGLDsFNstAKVsPLtPKLFNSLLL |
| Q7LBC6 | S1262 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | SLRSVLNKEsHsPFGLDsFNstAKVsPLtPKLFNSLLLGPT |
| Q7RTV0 | S53 | Sugiyama | PHF5A | CDSyVRPCTLVRICDECNyGsyQGRCVICGGPGVSDAyyCK |
| Q7Z2W4 | S640 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | QYGEEKDKRKNsNVDssyLEsLyQSCPRGVVPFQAGSRNYE |
| Q7Z3K3 | S28 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | MECEEEELEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQP |
| Q7Z3K3 | S35 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | LEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQPVSAPVPI |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z434 | S442 | PSP | MAVS IPS1 KIAA1271 VISA | GVLASQVDsPFsGCFEDLAIsASTSLGMGPCHGPEENEYKs |
| Q7Z460 | S548 | Sugiyama | CLASP1 KIAA0622 MAST1 | LESSyQKALQSHLKNSDsIVsLPQsDRsssssQEsLNRPLs |
| Q7Z4H3 | S170 | Sugiyama | HDDC2 C6orf74 NS5ATP2 CGI-130 | QASEYEDLEHKPGRLQDFYDsTAGKFNHPEIVQLVsELEAE |
| Q7Z6Z7 | S1368 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | ATEYLLTHPPPIMGGVVRDLsMsEEDQMMRAIAMsLGQDIP |
| Q86UE4 | S306 | Sugiyama | MTDH AEG1 LYRIC | WNEKSVKLssQIsAGEEKWNsVsPAsAGKRKtEPSAWsQDt |
| Q86UK7 | S895 | Sugiyama | ZNF598 | AHGDASSHQALHAARDDDFPsLQAIARIIT___________ |
| Q86UP2 | S906 | Sugiyama | KTN1 CG1 KIAA0004 | KEKDLANTGKWLQDLQEENEsLKAHVQEVAQHNLKEASSAS |
| Q86VP6 | S1226 | Sugiyama | CAND1 KIAA0829 TIP120 TIP120A | PELAAIFESIQKDssstNLEsMDts________________ |
| Q86VS8 | S232 | Sugiyama | HOOK3 | EKSSLLAENQVLMERLNQsDsIEDPNsPAGRRHLQLQTQLE |
| Q86VS8 | S298 | Sugiyama | HOOK3 | EISELRQQNDELTtLADEAQsLKDEIDVLRHSSDKVSKLEG |
| Q86VS8 | T291 | Sugiyama | HOOK3 | RCEELEKEISELRQQNDELTtLADEAQsLKDEIDVLRHSSD |
| Q86WR0 | S204 | Sugiyama | CCDC25 | RSYssLMKVENMSSNQDGNDsDEFM________________ |
| Q8IW35 | S500 | Sugiyama | CEP97 LRRIQ2 | GLLPCPEPTIISAILKDDNHsLtFFPESTEQKQSDIKKPEN |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8IZ69 | S480 | Sugiyama | TRMT2A | VELCPEAVEDARVNAQDNELsNVEFHCGRAEDLVPTLVSRL |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N1F7 | S112 | Sugiyama | NUP93 KIAA0095 | PVKDTDIQGFLKNEKDNALLsAIEESRKRtFGMAEEYHRES |
| Q8N3F0 | S58 | EPSD|PSP | MTURN C7orf41 | GVSFYVLCPDNGCGDNFHVWsESEDCLPFLQLAQDYISSCG |
| Q8N5N7 | S68 | Sugiyama | MRPL50 | PILVCPPLRSRAYTPPEDLQsRLEsYVKEVFGSSLPSNWQD |
| Q8N5N7 | S72 | Sugiyama | MRPL50 | CPPLRSRAYTPPEDLQsRLEsYVKEVFGSSLPSNWQDISLE |
| Q8N6T3 | S174 | Sugiyama | ARFGAP1 ARF1GAP | QsVtAssDKAFEDWLNDDLGsyQGAQGNRyVGFGNtPPPQK |
| Q8NBS9 | S285 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | LLWFRDGKKVDQYKGKRDLEsLREyVEsQLQRTETGATETV |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TCG1 | S705 | Sugiyama | CIP2A KIAA1524 | KNEELSVLLKAQQVESERAQsDIEHLFQHNRKLESVAEEHE |
| Q8TCG1 | S904 | Sugiyama | CIP2A KIAA1524 | MIAMIHSLSGGKINPETVNLsI___________________ |
| Q8TD19 | S13 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | ________MsVLGEYERHCDsINSDFGSEsGGCGDssPGPS |
| Q8TEW0 | S720 | Sugiyama | PARD3 PAR3 PAR3A | ELPIETALDDRERRIsHsLysGIEGLDEsPsRNAALsRIMG |
| Q8TEW0 | Y719 | Sugiyama | PARD3 PAR3 PAR3A | PELPIETALDDRERRIsHsLysGIEGLDEsPsRNAALsRIM |
| Q8WU90 | S231 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | LPPGFVLKKDKKKEEKEDEIsLEDLIERERSALGPNVTKIT |
| Q8WUD4 | S152 | Sugiyama | CCDC12 | QRAIAELIRERLKGQEDsLAsAVDAATEQKtCDsD______ |
| Q8WVC0 | S75 | Sugiyama | LEO1 RDL | QPSNKELFGDDsEDEGAsHHsGSDNHSERSDNRsEAsERSD |
| Q8WVM8 | S340 | Sugiyama | SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23 | tPVDKFWQKHKGSPFPEVAEsVQQELEsYRAQEDEVKRLKS |
| Q8WVM8 | S347 | Sugiyama | SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23 | QKHKGSPFPEVAEsVQQELEsYRAQEDEVKRLKSIMGLEGE |
| Q8WWI1 | S1182 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | SSNIESKEINGIHDEsNAFEsKASEsISLKNLKRRsQFFEQ |
| Q8WWM7 | S276 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | MFKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRELRA |
| Q8WWM7 | Y270 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | GWDPNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFR |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92574 | S487 | SIGNOR|EPSD|PSP | TSC1 KIAA0243 TSC | AsEEDsIEKDKEEAAIsRELsEITTAEAEPVVPRGGFDsPF |
| Q92574 | S511 | SIGNOR|EPSD|PSP | TSC1 KIAA0243 TSC | TAEAEPVVPRGGFDsPFyRDsLPGsQRKtHsAAsssQGASV |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92621 | S1857 | Sugiyama | NUP205 C7orf14 KIAA0225 | VSKLQNVEQLPPDEIKELCQsVMPAGVDKISTAQKYVLARR |
| Q92688 | S117 | Sugiyama | ANP32B APRIL PHAPI2 | GNKLKDIstLEPLKKLECLKsLDLFNCEVtNLNDyREsVFK |
| Q92796 | S615 | Sugiyama | DLG3 KIAA1232 | GLSDDYYGAKNLKGQEDAILsYEPVTRQEIHYARPVIILGP |
| Q92804 | S289 | Sugiyama | TAF15 RBP56 TAF2N | PMINLYTDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKEFH |
| Q92888 | S409 | Sugiyama | ARHGEF1 | ELEPEEPPGWRELVPPDtLHsLPKSQVKRQEVISELLVTEA |
| Q92905 | S201 | SIGNOR|PSP | COPS5 CSN5 JAB1 | VNLGAFRTYPKGYKPPDEGPsEyQtIPLNKIEDFGVHCKQY |
| Q92905 | T205 | SIGNOR|PSP | COPS5 CSN5 JAB1 | AFRTYPKGYKPPDEGPsEyQtIPLNKIEDFGVHCKQYYALE |
| Q92917 | S59 | Sugiyama | GPKOW GPATC5 GPATCH5 T54 | AGPsPEEKDFLKTVEGRELQsVKPQEAPKELVIPLIQNGHR |
| Q92945 | S193 | Sugiyama | KHSRP FUBP2 | DSGCKVQIsPDsGGLPERsVsLtGAPEsVQKAKMMLDDIVS |
| Q92945 | S200 | Sugiyama | KHSRP FUBP2 | IsPDsGGLPERsVsLtGAPEsVQKAKMMLDDIVSRGRGGPP |
| Q93052 | S313 | Sugiyama | LPP | QGRyyEGyyAAGPGyGGRNDsDPtyGQQGHPNtWKREPGyt |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q969G3 | S317 | Sugiyama | SMARCE1 BAF57 | RKRQEEREKEAAEQAERsQssIVPEEEQAANKGEEKKDDEN |
| Q96AC1 | S666 | Sugiyama | FERMT2 KIND2 MIG2 PLEKHC1 | VHEFIGGYIFLSTRAKDQNEsLDEEMFyKLTSGWV______ |
| Q96AE4 | S52 | Sugiyama | FUBP1 | KDALQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQ |
| Q96AE4 | S55 | Sugiyama | FUBP1 | LQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDA |
| Q96AE4 | T51 | Sugiyama | FUBP1 | FKDALQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGD |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96BF3 | S220 | SIGNOR|PSP | TMIGD2 CD28H IGPR1 UNQ3059/PRO9879 | RGAPKKSEDCSGEGKDQRGQsIySTSFPQPAPRQPHLAsRP |
| Q96CV9 | S513 | EPSD|PSP | OPTN FIP2 GLC1E HIP7 HYPL NRP | ALQLAVLLKENDAFEDGGRQsLMEMQsRHGARtsDsDQQAy |
| Q96GA3 | S34 | Sugiyama | LTV1 C6orf93 | KAVsFHLVHRSQRDPLAADEsAPQRVLLPTQKIDNEERRAE |
| Q96GM8 | S420 | Sugiyama | TOE1 | KNDLEMGIKAARPEIADRATsEVPGsQAsPNPVPGDGLHRA |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96P70 | S890 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | GINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWTN |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q96T51 | S352 | Sugiyama | RUFY1 RABIP4 ZFYVE12 | LEKTNSKLQEELSAATDRICsLQEEQQQLREQNELIRERSE |
| Q99436 | T273 | Sugiyama | PSMB7 Z | AVLTEKITPLEIEVLEEtVQtMDts________________ |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q99584 | S62 | Sugiyama | S100A13 | VTQQLPHLLKDVGSLDEKMKsLDVNQDSELKFNEyWRLIGE |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99614 | S281 | Sugiyama | TTC1 TPR1 | PFGLstENFQIKQDsstGsysINFVQNPNNNR_________ |
| Q99614 | S90 | Sugiyama | TTC1 TPR1 | FEEEPGADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQ |
| Q99704 | S439 | SIGNOR|EPSD|PSP | DOK1 | PLLAPKPQGPAFPEPGtAtGsGIKsHNsALysQVQKSGAsG |
| Q99704 | S443 | SIGNOR|EPSD|PSP | DOK1 | PKPQGPAFPEPGtAtGsGIKsHNsALysQVQKSGAsGsWDC |
| Q99704 | S446 | SIGNOR|EPSD|PSP | DOK1 | QGPAFPEPGtAtGsGIKsHNsALysQVQKSGAsGsWDCGLS |
| Q99704 | S450 | SIGNOR|EPSD|PSP | DOK1 | FPEPGtAtGsGIKsHNsALysQVQKSGAsGsWDCGLSRVGT |
| Q99816 | S229 | Sugiyama | TSG101 | PVTTVGPSRDGtIsEDTIRAsLIsAVSDKLRWRMKEEMDRA |
| Q99816 | S232 | Sugiyama | TSG101 | TVGPSRDGtIsEDTIRAsLIsAVSDKLRWRMKEEMDRAQAE |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99933 | S338 | Sugiyama | BAG1 HAP | FLAECDTVEQNICQETERLQsTNFALAE_____________ |
| Q9BQA1 | S185 | Sugiyama | WDR77 MEP50 WD45 HKMT1069 Nbla10071 | AHAAQVTCVAAsPHKDSVFLsCSEDNRILLWDTRCPKPASQ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQS8 | S659 | Sugiyama | FYCO1 ZFYVE7 | LQALQADyQALQQRESAIQGsLASLEAEQAsIRHLGDQMEA |
| Q9BQS8 | S669 | Sugiyama | FYCO1 ZFYVE7 | LQQRESAIQGsLASLEAEQAsIRHLGDQMEASLLAVRKAKE |
| Q9BR61 | S271 | Sugiyama | ACBD6 | PTLRDQDGCLPEEVTGCKTVsLVLQRHTTGKA_________ |
| Q9BR76 | S391 | Sugiyama | CORO1B | EAALEAEEWVSGRDADPILIsLREAYVPSKQRDLKISRRNV |
| Q9BRA2 | S41 | Sugiyama | TXNDC17 TXNL5 | QHNGKTIFAyFTGSKDAGGKsWCPDCVQAEPVVREGLKHIS |
| Q9BRA2 | S8 | Sugiyama | TXNDC17 TXNL5 | _____________MARYEEVsVSGFEEFHRAVEQHNGKTIF |
| Q9BRK5 | S158 | Sugiyama | SDF4 CAB45 PSEC0034 | AMEEsKTHFRAVDPDGDGHVsWDEyKVKFLASKGHSEKEVA |
| Q9BRS2 | S130 | Sugiyama | RIOK1 RIO1 | DKVLRKFENKINLDKLNVtDsVINKVTEKSRQKEADMYRIK |
| Q9BTE6 | S174 | Sugiyama | AARSD1 | IEQSVNEKIRDRLPVNVRELsLDDPEVEQVsGRGLPDDHAG |
| Q9BTE6 | S184 | Sugiyama | AARSD1 | DRLPVNVRELsLDDPEVEQVsGRGLPDDHAGPIRVVNIEGV |
| Q9BTT0 | S48 | Sugiyama | ANP32E | LCVNGEIEGLNDTFKELEFLsMANVELSsLARLPSLNKLRK |
| Q9BTT0 | S56 | Sugiyama | ANP32E | GLNDTFKELEFLsMANVELSsLARLPSLNKLRKLELSDNII |
| Q9BUF5 | T72 | Sugiyama | TUBB6 | NESssQKYVPRAALVDLEPGtMDsVRSGPFGQLFRPDNFIF |
| Q9BV40 | S18 | Sugiyama | VAMP8 | ___MEEAsEGGGNDRVRNLQsEVEGVKNIMTQNVERILARG |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVS4 | S548 | Sugiyama | RIOK2 RIO2 | IFTKQRRENMQNIKssLEAAsFWGE________________ |
| Q9BXH1 | S10 | EPSD|PSP | BBC3 PUMA | ___________MARARQEGSsPEPVEGLARDGPRPFPLGRL |
| Q9BXH1 | S106 | PSP | BBC3 PUMA | RGPRPDGPQPsLSLAEQHLEsPVPSAPGALAGGPTQAAPGV |
| Q9BXH1 | S96 | PSP | BBC3 PUMA | RWPGGPRSRPRGPRPDGPQPsLSLAEQHLEsPVPSAPGALA |
| Q9BXP5 | S67 | Sugiyama | SRRT ARS2 ASR2 | RERRsRGEYRDYDRNRRERFsPPRHELsPPQKRMRRDWDEH |
| Q9BY32 | S53 | Sugiyama | ITPA C20orf37 My049 OK/SW-cl.9 | CTLVAQKIDLPEyQGEPDEIsIQKCQEAVRQVQGPVLVEDT |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9BZI7 | T180 | Sugiyama | UPF3B RENT3B UPF3X | yRKFLEsyAtDNEKMTstPEtLLEEIEAKNRELIAKKTTPL |
| Q9C0C2 | S1004 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sGFsPEEAQQQDEEFEKKIPsVEDsLGEGsRDAGRPGERGs |
| Q9C0C2 | S1008 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | PEEAQQQDEEFEKKIPsVEDsLGEGsRDAGRPGERGsGGLF |
| Q9C0C2 | S1051 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | stAHVPDGALGQRDQssWQNsDAsQEVGGHQERQQAGAQGP |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C2 | S806 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | STREWASRCGIGQEEMEAsSsQDQSKVSAPGVLTAQDRVVG |
| Q9C0C2 | S893 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LGtyssRDVsLGDWEFGKRDsLGAyAsQDANEQGQDLGKRD |
| Q9C0C2 | S899 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | RDVsLGDWEFGKRDsLGAyAsQDANEQGQDLGKRDHHGRys |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9GZV4 | S75 | Sugiyama | EIF5A2 | KVHLVGIDIFTGKKyEDICPstHNMDVPNIKRNDYQLICIQ |
| Q9GZZ9 | S24 | Sugiyama | UBA5 UBE1DC1 | SVERLQQRVQELERELAQERsLQVPRSGDGGGGRVRIEKMs |
| Q9H0L4 | S344 | Sugiyama | CSTF2T KIAA0689 | LPPRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQGPPM |
| Q9H0U4 | S111 | Sugiyama | RAB1B | TDQESYANVKQWLQEIDRYAsENVNKLLVGNKSDLTTKKVV |
| Q9H1A4 | S355 | Sugiyama | ANAPC1 TSG24 | PsLHsRsPsISNMAALsRAHsPALGVHsFsGVQRFNIssHN |
| Q9H1A4 | S362 | Sugiyama | ANAPC1 TSG24 | PsISNMAALsRAHsPALGVHsFsGVQRFNIssHNQsPKRHS |
| Q9H2G2 | S362 | Sugiyama | SLK KIAA0204 STK2 | DLsIAssEEDKLsQNACILEsVSEKtERSNsEDKLNSKILN |
| Q9H2U2 | S309 | Sugiyama | PPA2 HSPC124 | NCTNVQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVW |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H2U2 | S315 | Sugiyama | PPA2 HSPC124 | ISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK_ |
| Q9H2U2 | T303 | Sugiyama | PPA2 HSPC124 | CNGGAINCTNVQISDSPFRCtQEEARsLVEsVsssPNKEsN |
| Q9H3D4 | S43 | EPSD|PSP | TP63 KET P63 P73H P73L TP73L | VETPAHFSWKESYYRSTMSQsTQtNEFLsPEVFQHIWDFLE |
| Q9H3D4 | S51 | EPSD|PSP | TP63 KET P63 P73H P73L TP73L | WKESYYRSTMSQsTQtNEFLsPEVFQHIWDFLEQPICsVQP |
| Q9H3Q1 | S315 | Sugiyama | CDC42EP4 BORG4 CEP4 | sARSMGSHTTRDSSsLssCtsGILEERsPAFRGPDRARAAV |
| Q9H3Q1 | T314 | Sugiyama | CDC42EP4 BORG4 CEP4 | GsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPDRARAA |
| Q9H4F8 | S65 | Sugiyama | SMOC1 | LHCSRTQPKPICASDGRSYEsMCEYQRAKCRDPTLGVVHRG |
| Q9H765 | S31 | SIGNOR|PSP | ASB8 PP14212 | SIQSKYsLSERLIRTIAAIRsFPHDNVEDLIRGGADVNCTH |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9HAP6 | S120 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | DEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGDQL |
| Q9HAU0 | S837 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | AEVDEsNGEEKsEPVsEIEtsVVKGSHFPVGVVPPRAKsPt |
| Q9HCC0 | S523 | Sugiyama | MCCC2 MCCB | AALKEPIIKKFEEEGNPyySsARVWDDGIIDPADTRLVLGL |
| Q9NP61 | S457 | Sugiyama | ARFGAP3 ARFGAP1 | sQADYETRARLERLsAsssIssADLFEEPRKQPAGNysLSS |
| Q9NP61 | S458 | Sugiyama | ARFGAP3 ARFGAP1 | QADYETRARLERLsAsssIssADLFEEPRKQPAGNysLSSV |
| Q9NP74 | S194 | Sugiyama | PALMD C1orf11 PALML | yAMEIKVEKDLKTGESTVLSsIPLPsDDFKGTGIKVYDDGQ |
| Q9NP74 | S199 | Sugiyama | PALMD C1orf11 PALML | KVEKDLKTGESTVLSsIPLPsDDFKGTGIKVYDDGQKSVYA |
| Q9NPQ8 | S452 | Sugiyama | RIC8A | EGQysEDEDtDtDEyKEAKAsINPVTGRVEEKPPNPMEGMT |
| Q9NQA3 | S87 | Sugiyama | WASH6P CXYorf1 FAM39A | AIKVFSSAKYPAPERLQEyGsIFTGAQDPGLQRRPRHRIQS |
| Q9NQC3 | S1079 | Sugiyama | RTN4 KIAA0886 NOGO My043 SP1507 | GVIQAIQKSDEGHPFRAYLEsEVAIsEELVQKYSNsALGHV |
| Q9NQC3 | S1084 | Sugiyama | RTN4 KIAA0886 NOGO My043 SP1507 | IQKSDEGHPFRAYLEsEVAIsEELVQKYSNsALGHVNCTIK |
| Q9NQC7 | S418 | SIGNOR|EPSD|PSP | CYLD CYLD1 KIAA0849 HSPC057 | ssPPLQPPPVNSLTTENRFHsLPFsLtKMPNTNGsIGHsPL |
| Q9NQC7 | S422 | SIGNOR|EPSD|PSP | CYLD CYLD1 KIAA0849 HSPC057 | LQPPPVNSLTTENRFHsLPFsLtKMPNTNGsIGHsPLsLsA |
| Q9NQC7 | S432 | SIGNOR|EPSD|PSP | CYLD CYLD1 KIAA0849 HSPC057 | TENRFHsLPFsLtKMPNTNGsIGHsPLsLsAQsVMEELNTA |
| Q9NQC7 | S436 | SIGNOR|EPSD|PSP | CYLD CYLD1 KIAA0849 HSPC057 | FHsLPFsLtKMPNTNGsIGHsPLsLsAQsVMEELNTAPVQE |
| Q9NQC7 | S439 | SIGNOR|EPSD|PSP | CYLD CYLD1 KIAA0849 HSPC057 | LPFsLtKMPNTNGsIGHsPLsLsAQsVMEELNTAPVQESPP |
| Q9NQC7 | S441 | SIGNOR|EPSD|PSP | CYLD CYLD1 KIAA0849 HSPC057 | FsLtKMPNTNGsIGHsPLsLsAQsVMEELNTAPVQESPPLA |
| Q9NQC7 | S444 | SIGNOR|EPSD|PSP | CYLD CYLD1 KIAA0849 HSPC057 | tKMPNTNGsIGHsPLsLsAQsVMEELNTAPVQESPPLAMPP |
| Q9NQC7 | S568 | PSP | CYLD CYLD1 KIAA0849 HSPC057 | LQPVsNQIERCNsLAFGGYLsEVVEENTPPKMEKEGLEIMI |
| Q9NQG5 | S203 | Sugiyama | RPRD1B C20orf77 CREPT | ALQDLENAASGDATVRQKIAsLPQEVQDVsLLEKITDKEAA |
| Q9NQG5 | S212 | Sugiyama | RPRD1B C20orf77 CREPT | SGDATVRQKIAsLPQEVQDVsLLEKITDKEAAERLSKTVDE |
| Q9NQP4 | S125 | Sugiyama | PFDN4 PFD4 | VEsIQRVLADLKVQLYAKFGsNINLEADEs___________ |
| Q9NQW7 | S109 | Sugiyama | XPNPEP1 XPNPEPL XPNPEPL1 | NWTLMKMGLKDTPTQEDWLVsVLPEGSRVGVDPLIIPTDYW |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NR45 | S248 | Sugiyama | NANS SAS | VALGAKVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRL |
| Q9NR45 | S251 | Sugiyama | NANS SAS | GAKVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRLVER |
| Q9NR45 | S253 | Sugiyama | NANS SAS | KVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRLVERAL |
| Q9NRR5 | S270 | Sugiyama | UBQLN4 C1orf6 CIP75 UBIN | ELARNPAMMQEMMRNQDRALsNLEsIPGGYNALRRMYTDIQ |
| Q9NRR5 | S274 | Sugiyama | UBQLN4 C1orf6 CIP75 UBIN | NPAMMQEMMRNQDRALsNLEsIPGGYNALRRMYTDIQEPMF |
| Q9NTI5 | S1257 | Sugiyama | PDS5B APRIN AS3 KIAA0979 | LVQEQKPKGSQRSRKRGHtAsEsDEQQWPEEKRLKEDILEN |
| Q9NTJ3 | S964 | Sugiyama | SMC4 CAPC SMC4L1 | TEKEIKDTEKEVDDLTAELKsLEDKAAEVVKNTNAAEEsLP |
| Q9NUP9 | S120 | Sugiyama | LIN7C MALS3 VELI3 | EEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGDQL |
| Q9NUU7 | S89 | Sugiyama | DDX19A DDX19L | LVDNtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQGVYAM |
| Q9NY33 | S190 | Sugiyama | DPP3 | TYFSGNCTMEDAKLAQDFLDsQNLsAyNtRLFKEVDGEGKP |
| Q9NYL9 | S25 | Sugiyama | TMOD3 | FRKDLEKyKDLDEDELLGNLsEtELKQLETVLDDLDPENAL |
| Q9NZN5 | S1308 | Sugiyama | ARHGEF12 KIAA0382 LARG | sQGPQtDSVIQNSENIKAyHsGEGHMPFRTGTGDIAtCYsP |
| Q9NZN5 | Y1306 | Sugiyama | ARHGEF12 KIAA0382 LARG | tAsQGPQtDSVIQNSENIKAyHsGEGHMPFRTGTGDIAtCY |
| Q9P0K7 | S798 | Sugiyama | RAI14 KIAA1334 NORPEG | AMTDAMVPRSSYEKLQSsLEsEVSVLASKLKESVKEKEKVH |
| Q9P2E9 | S655 | Sugiyama | RRBP1 KIAA1398 | GEPGPPDADGPLyLPYKTLVstVGsMVFNEGEAQRLIEILS |
| Q9P2E9 | S659 | Sugiyama | RRBP1 KIAA1398 | PPDADGPLyLPYKTLVstVGsMVFNEGEAQRLIEILSEKAG |
| Q9P2E9 | S997 | Sugiyama | RRBP1 KIAA1398 | AsQAEADQQQTRLKELESQVsGLEKEAIELREAVEQQKVKN |
| Q9P2J5 | S391 | Sugiyama | LARS1 KIAA1352 LARS | VIYVLPMLTIKEDKGtGVVTsVPsDsPDDIAALRDLKKKQA |
| Q9P2J5 | T386 | Sugiyama | LARS1 KIAA1352 LARS | LTSYKVIYVLPMLTIKEDKGtGVVTsVPsDsPDDIAALRDL |
| Q9UBC2 | S377 | Sugiyama | EPS15L1 EPS15R | DMVPPsERGtPGPDssGsLGsGEFTGVKELDDISQEIAQLQ |
| Q9UBC2 | S479 | Sugiyama | EPS15L1 EPS15R | LRDMLSDVRQKCQDETQMISsLKTQIQSQESDLKsQEDDLN |
| Q9UBC2 | S518 | Sugiyama | EPS15L1 EPS15R | LNRAKSELNRLQQEETQLEQsIQAGRVQLETIIKSLKSTQD |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UBQ5 | S209 | Sugiyama | EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 | ICSQEESIKPKNIVEKIDFDsVSsIMAssQ___________ |
| Q9UBQ5 | S212 | Sugiyama | EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 | QEESIKPKNIVEKIDFDsVSsIMAssQ______________ |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UBT2 | S493 | Sugiyama | UBA2 SAE2 UBLE1B HRIHFB2115 | FAMVAPDVQIEDGKGTILISsEEGETEANNHKKLsEFGIRN |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | S335 | Sugiyama | NDRG3 | YIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGt |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UHD2 | S172 | GPS6 | TBK1 NAK | VyKLtDFGAARELEDDEQFVsLyGtEEyLHPDMYERAVLRK |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UKY7 | S96 | Sugiyama | CDV3 H41 | KAVTKDEDEWKELEQKEVDysGLRVQAMQIssEKEEDDNEK |
| Q9ULV4 | S389 | Sugiyama | CORO1C CRN2 CRNN4 | EAALEAEEWFEGKNADPILIsLKHGYIPGKNRDLKVVKKNI |
| Q9UMR2 | S90 | Sugiyama | DDX19B DBP5 DDX19 TDBP | LVDNtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQGVYAM |
| Q9UMX0 | S260 | Sugiyama | UBQLN1 DA41 PLIC1 | ELARNPAMMQEMMRNQDRALsNLEsIPGGYNALRRMYTDIQ |
| Q9UMX0 | S264 | Sugiyama | UBQLN1 DA41 PLIC1 | NPAMMQEMMRNQDRALsNLEsIPGGYNALRRMYTDIQEPML |
| Q9UNE7 | S216 | Sugiyama | STUB1 CHIP PP1131 | QQACIEAKHDKyMADMDELFsQVDEKRKKRDIPDyLCGKIS |
| Q9UNZ2 | S176 | Sugiyama | NSFL1C UBXN2C | RLGAAPEEEsAyVAGEKRQHssQDVHVVLKLWKsGFsLDNG |
| Q9UPN3 | S2769 | Sugiyama | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | EAIEKRLISPELANMIQIDSsEFSDHRAQIEKQEGIEVCAL |
| Q9UPQ0 | S204 | Sugiyama | LIMCH1 KIAA1102 | DsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRG |
| Q9UPQ0 | S207 | Sugiyama | LIMCH1 KIAA1102 | RsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRGssD |
| Q9UPQ0 | S217 | Sugiyama | LIMCH1 KIAA1102 | GRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsDsEsDL |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UPQ0 | T215 | Sugiyama | LIMCH1 KIAA1102 | RHGRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsDsEs |
| Q9UQ35 | S1102 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | EsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFs |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1318 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | VPsMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGP |
| Q9UQ35 | S1320 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLG |
| Q9UQ35 | S1326 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | GGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtG |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S876 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tsPQANEQsVtPQRRsCFEssPDPELKsRtPsRHsCsGssP |
| Q9UQ88 | S265 | Sugiyama | CDK11A CDC2L2 CDC2L3 PITSLREB | APAQKPAQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSA |
| Q9Y262 | S249 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | NVLHSLVDKSNINRQLEVytsGGDPEsVAGEyGRHSLYKML |
| Q9Y266 | S298 | Sugiyama | NUDC | DLDsEtRsMVEKMMYDQRQKsMGLPtsDEQKKQEILKKFMD |
| Q9Y266 | T283 | Sugiyama | NUDC | EINtKKINPENsKLsDLDsEtRsMVEKMMYDQRQKsMGLPt |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S127 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | RVVGRNGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDE |
| Q9Y2B0 | S139 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | DLQGIRIDsDISGtLKFACEsIVEEyEDELIEFFsREADNV |
| Q9Y2B0 | S153 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | LKFACEsIVEEyEDELIEFFsREADNVKDKLCSKRtDLCDH |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | S74 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | GsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGE |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y2L5 | S279 | Sugiyama | TRAPPC8 KIAA1012 | sYEDGPCtItsNKNsDNNLLsLDGLDNEVKDGLPNNFRAHP |
| Q9Y2T3 | S263 | Sugiyama | GDA KIAA1258 | ENRDEVEAVKNLYPSYKNYTsVYDKNNLLTNKTVMAHGCYL |
| Q9Y2V2 | S30 | Sugiyama | CARHSP1 | QPPtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRt |
| Q9Y2V2 | S32 | Sugiyama | CARHSP1 | PtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRtFs |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3F4 | S230 | Sugiyama | STRAP MAWD UNRIP | SAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLyKy |
| Q9Y3F4 | S260 | Sugiyama | STRAP MAWD UNRIP | AGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFSPDGELy |
| Q9Y446 | S180 | Sugiyama | PKP3 | RPVsFHERGGVGsRADyDtLsLRsLRLGPGGLDDRysLVsE |
| Q9Y446 | S183 | Sugiyama | PKP3 | sFHERGGVGsRADyDtLsLRsLRLGPGGLDDRysLVsEQLE |
| Q9Y450 | S67 | Sugiyama | HBS1L HBS1 KIAA1038 | KPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDH |
| Q9Y490 | S1898 | Sugiyama | TLN1 KIAA1027 TLN | sPEELGPLANQLTsDyGRLAsEAKPAAVAAENEEIGsHIKH |
| Q9Y4G8 | S1254 | EPSD|PSP | RAPGEF2 KIAA0313 NRAPGEP PDZGEF1 | GDRASLDAADsGRGsWTSCssGsHDNIQTIQHQRSWETLPF |
| Q9Y4H2 | S304 | ELM | IRS2 | HETILEAMKALKELFEFRPRsKsQssGssATHPISVPGARR |
| Q9Y4H2 | S306 | ELM | IRS2 | TILEAMKALKELFEFRPRsKsQssGssATHPISVPGARRHH |
| Q9Y4H2 | S384 | ELM | IRS2 | AsEGDGGAAAGAAAAGARPVsVAGsPLsPGPVRAPLsRSHt |
| Q9Y4H2 | S388 | ELM | IRS2 | DGGAAAGAAAAGARPVsVAGsPLsPGPVRAPLsRSHtLsGG |
| Q9Y4H2 | S577 | ELM | IRS2 | RRVsGDAAQDLDRGLRKRtYsLtTPARQRPVPQPssAsLDE |
| Q9Y4L1 | S461 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | VVYPILVEFTREVEEEPGIHsLKHNKRVLFSRMGPYPQRKV |
| Q9Y4X5 | S517 | Sugiyama | ARIH1 ARI MOP6 UBCH7BP HUSSY-27 | DLENATEVLSGYLERDIsQDsLQDIKQKVQDKYRYCESRRR |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5X1 | S116 | Sugiyama | SNX9 SH3PX1 SH3PXD3A | SNNHQVGSGNDPWSAWSASKsGNWESsEGWGAQPEGAGAQR |
| Q9Y5X1 | S122 | Sugiyama | SNX9 SH3PX1 SH3PXD3A | GSGNDPWSAWSASKsGNWESsEGWGAQPEGAGAQRNTNTPN |
| Q9Y696 | S27 | Sugiyama | CLIC4 | LNGLKEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWL |
| Q9Y696 | S31 | Sugiyama | CLIC4 | KEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWLKGVV |
| Q9Y6G9 | S381 | Sugiyama | DYNC1LI1 DNCLI1 | FVHEKEIMAEDDQVFLMKLQsLLAKQPPtAAGRPVDAsPRV |
| Q9Y6K9 | S31 | GPS6|SIGNOR|ELM|EPSD|PSP | IKBKG FIP3 NEMO | CEMVQPsGGPAADQDVLGEEsPLGKPAMLHLPsEQGAPETL |
| Q9Y6K9 | S376 | GPS6|SIGNOR|ELM|EPSD|PSP | IKBKG FIP3 NEMO | MRKRHVEVSQAPLPPAPAyLssPLALPsQRRsPPEEPPDFC |
| Q9Y6K9 | S43 | GPS6|SIGNOR|ELM|EPSD|PSP | IKBKG FIP3 NEMO | DQDVLGEEsPLGKPAMLHLPsEQGAPETLQRCLEENQELRD |
| Q9Y6K9 | S68 | SIGNOR|EPSD|PSP | IKBKG FIP3 NEMO | PETLQRCLEENQELRDAIRQsNQILRERCEELLHFQAsQRE |
| Q9Y6K9 | S85 | SIGNOR|EPSD|PSP | IKBKG FIP3 NEMO | IRQsNQILRERCEELLHFQAsQREEKEFLMCKFQEARKLVE |
| Q9Y6Q9 | S857 | iPTMNet|EPSD | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | LGLKSSQSVQSIRPPYNRAVsLDsPVsVGssPPVKNISAFP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.183465e-11 | 10.378 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.991266e-10 | 9.524 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.427457e-09 | 8.845 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.599957e-08 | 7.180 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.160075e-07 | 6.936 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.334761e-07 | 6.875 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.949430e-07 | 6.710 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.749856e-07 | 6.561 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.034888e-07 | 6.394 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.307085e-07 | 6.275 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.756181e-07 | 6.240 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.936130e-07 | 6.159 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.160116e-07 | 6.088 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.829065e-07 | 6.054 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.037239e-06 | 5.984 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.066192e-06 | 5.685 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.241190e-06 | 5.489 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.387422e-06 | 5.470 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.130424e-06 | 5.384 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.158056e-06 | 5.145 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.084304e-05 | 4.965 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.175726e-05 | 4.930 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.420314e-05 | 4.848 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.402263e-05 | 4.853 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.402263e-05 | 4.853 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.614712e-05 | 4.792 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.093068e-05 | 4.679 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.228981e-05 | 4.652 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.551648e-05 | 4.593 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.963466e-05 | 4.528 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.671010e-05 | 4.435 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.058041e-05 | 4.392 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.103258e-05 | 4.387 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.901562e-05 | 4.310 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.901562e-05 | 4.310 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.975486e-05 | 4.303 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.698400e-05 | 4.244 | 1 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.535838e-05 | 4.185 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.480262e-05 | 4.072 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.471594e-05 | 4.072 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.184697e-05 | 4.087 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.989174e-05 | 4.097 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.044664e-04 | 3.981 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.091389e-04 | 3.962 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.079540e-04 | 3.967 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.099968e-04 | 3.959 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.115712e-04 | 3.952 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.224622e-04 | 3.912 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.283734e-04 | 3.892 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.298079e-04 | 3.887 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.398191e-04 | 3.854 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.414410e-04 | 3.849 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.592874e-04 | 3.798 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.715309e-04 | 3.766 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.715309e-04 | 3.766 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.771053e-04 | 3.752 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.990169e-04 | 3.701 | 1 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.131324e-04 | 3.671 | 1 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.131324e-04 | 3.671 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.189819e-04 | 3.660 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.410164e-04 | 3.618 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.410164e-04 | 3.618 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.410164e-04 | 3.618 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.410164e-04 | 3.618 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.383371e-04 | 3.623 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.416450e-04 | 3.617 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.652992e-04 | 3.576 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.873230e-04 | 3.542 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.940307e-04 | 3.532 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.125382e-04 | 3.505 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.082966e-04 | 3.511 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.129597e-04 | 3.505 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.116118e-04 | 3.386 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.425047e-04 | 3.354 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.801680e-04 | 3.319 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.138229e-04 | 3.289 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.350677e-04 | 3.272 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.068378e-04 | 3.217 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.599578e-04 | 3.180 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.655211e-04 | 3.177 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.655211e-04 | 3.177 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.908222e-04 | 3.050 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.908222e-04 | 3.050 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.908222e-04 | 3.050 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.908222e-04 | 3.050 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.908222e-04 | 3.050 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.908222e-04 | 3.050 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.908222e-04 | 3.050 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.908222e-04 | 3.050 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.908222e-04 | 3.050 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.908222e-04 | 3.050 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.908222e-04 | 3.050 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.523342e-04 | 3.069 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.523175e-04 | 3.069 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.267700e-04 | 3.083 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.267700e-04 | 3.083 | 1 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.911170e-04 | 3.050 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.095127e-04 | 3.092 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.991092e-04 | 3.046 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.000630e-03 | 3.000 | 1 | 1 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.002031e-03 | 2.999 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.006584e-03 | 2.997 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.051134e-03 | 2.978 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.143408e-03 | 2.942 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.081136e-03 | 2.966 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.390675e-03 | 2.857 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.475672e-03 | 2.831 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.610278e-03 | 2.793 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.610278e-03 | 2.793 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.655385e-03 | 2.781 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.658629e-03 | 2.780 | 1 | 1 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.668582e-03 | 2.778 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.683930e-03 | 2.774 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.812556e-03 | 2.742 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.862914e-03 | 2.730 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.877795e-03 | 2.726 | 1 | 1 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.948766e-03 | 2.710 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.974370e-03 | 2.705 | 1 | 1 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.974370e-03 | 2.705 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.221063e-03 | 2.653 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.227302e-03 | 2.652 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.227302e-03 | 2.652 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.233279e-03 | 2.651 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.437159e-03 | 2.613 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.437159e-03 | 2.613 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.462006e-03 | 2.609 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.310370e-03 | 2.636 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.569746e-03 | 2.590 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.587743e-03 | 2.587 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.587743e-03 | 2.587 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.674847e-03 | 2.573 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.683187e-03 | 2.571 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.725861e-03 | 2.564 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.746971e-03 | 2.561 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.746971e-03 | 2.561 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.789626e-03 | 2.554 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.954781e-03 | 2.529 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.993670e-03 | 2.524 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.084028e-03 | 2.511 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.226651e-03 | 2.491 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.761270e-03 | 2.425 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.827552e-03 | 2.417 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.831945e-03 | 2.417 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.201769e-03 | 2.377 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.538379e-03 | 2.343 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.262157e-03 | 2.279 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.262157e-03 | 2.279 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.312542e-03 | 2.275 | 1 | 1 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.567246e-03 | 2.254 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.567246e-03 | 2.254 | 1 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.896968e-03 | 2.229 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.896968e-03 | 2.229 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.081429e-03 | 2.216 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.160922e-03 | 2.210 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.332990e-03 | 2.198 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.180685e-03 | 2.144 | 1 | 1 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.180685e-03 | 2.144 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 7.399505e-03 | 2.131 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.779173e-03 | 2.169 | 1 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.797305e-03 | 2.108 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.029680e-03 | 2.095 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.156934e-03 | 2.088 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.156934e-03 | 2.088 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.209661e-03 | 2.086 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.604928e-03 | 2.065 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.650208e-03 | 2.063 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.756465e-03 | 2.058 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.999476e-03 | 2.046 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.056074e-03 | 2.043 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.429661e-03 | 2.026 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.482467e-03 | 2.023 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.518966e-03 | 2.021 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 9.800786e-03 | 2.009 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.034850e-02 | 1.985 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.030346e-02 | 1.987 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.128346e-02 | 1.948 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.058947e-02 | 1.975 | 1 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.030346e-02 | 1.987 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.070538e-02 | 1.970 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.030346e-02 | 1.987 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.163135e-02 | 1.934 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.205554e-02 | 1.919 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.210712e-02 | 1.917 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.216412e-02 | 1.915 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.226696e-02 | 1.911 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.228584e-02 | 1.911 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.235392e-02 | 1.908 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.332566e-02 | 1.875 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.347071e-02 | 1.871 | 1 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.523030e-02 | 1.817 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.558086e-02 | 1.807 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.453950e-02 | 1.837 | 1 | 1 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.517899e-02 | 1.819 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.402020e-02 | 1.853 | 1 | 1 |
| Signalling to ERKs | R-HSA-187687 | 1.402020e-02 | 1.853 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.453950e-02 | 1.837 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.569016e-02 | 1.804 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.588844e-02 | 1.799 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.704143e-02 | 1.768 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.730688e-02 | 1.762 | 1 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.730874e-02 | 1.762 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.730874e-02 | 1.762 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.741936e-02 | 1.759 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.820045e-02 | 1.740 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.880969e-02 | 1.726 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.880969e-02 | 1.726 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.880969e-02 | 1.726 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.880969e-02 | 1.726 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.880969e-02 | 1.726 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.880969e-02 | 1.726 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.880969e-02 | 1.726 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.880969e-02 | 1.726 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.880969e-02 | 1.726 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.882079e-02 | 1.725 | 1 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.936058e-02 | 1.713 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.937933e-02 | 1.713 | 1 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.142876e-02 | 1.669 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.142876e-02 | 1.669 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.051773e-02 | 1.688 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.287478e-02 | 1.641 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.312256e-02 | 1.636 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.081756e-02 | 1.682 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.043785e-02 | 1.690 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.089643e-02 | 1.680 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.089643e-02 | 1.680 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.201155e-02 | 1.657 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.043785e-02 | 1.690 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.287478e-02 | 1.641 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.394873e-02 | 1.621 | 1 | 1 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.394873e-02 | 1.621 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.451034e-02 | 1.611 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.620519e-02 | 1.582 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.720874e-02 | 1.565 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.758296e-02 | 1.559 | 1 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.758296e-02 | 1.559 | 1 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.897161e-02 | 1.538 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.897161e-02 | 1.538 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.900551e-02 | 1.538 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.900551e-02 | 1.538 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.911304e-02 | 1.536 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.911304e-02 | 1.536 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.911304e-02 | 1.536 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.057292e-02 | 1.515 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.114066e-02 | 1.507 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.141059e-02 | 1.503 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.219637e-02 | 1.492 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.227453e-02 | 1.491 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.750591e-02 | 1.426 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.750591e-02 | 1.426 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.750591e-02 | 1.426 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.790358e-02 | 1.421 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.790358e-02 | 1.421 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.790358e-02 | 1.421 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.493631e-02 | 1.457 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.402648e-02 | 1.468 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.696928e-02 | 1.432 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.920138e-02 | 1.407 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.919722e-02 | 1.407 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.722823e-02 | 1.429 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.363054e-02 | 1.473 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.406758e-02 | 1.468 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.790358e-02 | 1.421 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.750591e-02 | 1.426 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.393093e-02 | 1.469 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.697819e-02 | 1.432 | 1 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.873953e-02 | 1.412 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.632953e-02 | 1.440 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.855424e-02 | 1.414 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.493631e-02 | 1.457 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.493631e-02 | 1.457 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.873953e-02 | 1.412 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.750591e-02 | 1.426 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.955278e-02 | 1.403 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.030358e-02 | 1.395 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.158572e-02 | 1.381 | 1 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.159851e-02 | 1.381 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.159851e-02 | 1.381 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.219585e-02 | 1.375 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.219585e-02 | 1.375 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.339619e-02 | 1.363 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.372579e-02 | 1.359 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.555618e-02 | 1.341 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.564209e-02 | 1.341 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.564379e-02 | 1.341 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.572342e-02 | 1.340 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.572342e-02 | 1.340 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.615758e-02 | 1.336 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.824284e-02 | 1.317 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.824284e-02 | 1.317 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.824284e-02 | 1.317 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.824284e-02 | 1.317 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.824284e-02 | 1.317 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.852095e-02 | 1.314 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.859215e-02 | 1.313 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.859215e-02 | 1.313 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.870503e-02 | 1.312 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.870503e-02 | 1.312 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.870503e-02 | 1.312 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.870503e-02 | 1.312 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.023085e-02 | 1.299 | 1 | 1 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.196172e-02 | 1.284 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.196172e-02 | 1.284 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.196172e-02 | 1.284 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.196172e-02 | 1.284 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.196172e-02 | 1.284 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.998315e-02 | 1.222 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.998315e-02 | 1.222 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.983634e-02 | 1.223 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.668163e-02 | 1.247 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.668163e-02 | 1.247 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.044705e-02 | 1.219 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.380856e-02 | 1.269 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.983634e-02 | 1.223 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.531793e-02 | 1.185 | 1 | 1 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.554576e-02 | 1.255 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.406014e-02 | 1.267 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.242983e-02 | 1.280 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.030863e-02 | 1.220 | 1 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.434761e-02 | 1.191 | 1 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.847522e-02 | 1.233 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.679173e-02 | 1.246 | 1 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.423965e-02 | 1.266 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.436249e-02 | 1.265 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.414783e-02 | 1.266 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.044705e-02 | 1.219 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.746742e-02 | 1.241 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.998315e-02 | 1.222 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.539731e-02 | 1.184 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 6.575615e-02 | 1.182 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 6.575615e-02 | 1.182 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 6.575615e-02 | 1.182 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 6.575615e-02 | 1.182 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 6.575615e-02 | 1.182 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.620939e-02 | 1.179 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.695043e-02 | 1.174 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.786659e-02 | 1.168 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.786659e-02 | 1.168 | 1 | 1 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.869847e-02 | 1.163 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.008440e-02 | 1.154 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.041275e-02 | 1.152 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.155690e-02 | 1.145 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.162102e-02 | 1.145 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.201843e-02 | 1.143 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.270165e-02 | 1.138 | 1 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.309635e-02 | 1.136 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.309635e-02 | 1.136 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.309635e-02 | 1.136 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.381528e-02 | 1.132 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.485293e-02 | 1.126 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.485293e-02 | 1.126 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.485293e-02 | 1.126 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.551186e-02 | 1.122 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.608899e-02 | 1.119 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.608899e-02 | 1.119 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.608899e-02 | 1.119 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.841906e-02 | 1.106 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.882841e-02 | 1.103 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.069904e-02 | 1.093 | 1 | 1 |
| MTOR signalling | R-HSA-165159 | 8.122864e-02 | 1.090 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.148082e-02 | 1.089 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.186913e-02 | 1.087 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.365422e-02 | 1.078 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.365422e-02 | 1.078 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.365422e-02 | 1.078 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.365422e-02 | 1.078 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.379610e-02 | 1.077 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.516425e-02 | 1.070 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.531662e-02 | 1.069 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 9.868179e-02 | 1.006 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.868179e-02 | 1.006 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 9.614141e-02 | 1.017 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 9.614141e-02 | 1.017 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 9.614141e-02 | 1.017 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.614141e-02 | 1.017 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.614141e-02 | 1.017 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 8.754402e-02 | 1.058 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 8.754402e-02 | 1.058 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 8.754402e-02 | 1.058 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 8.754402e-02 | 1.058 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 1.082967e-01 | 0.965 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 1.082967e-01 | 0.965 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.082967e-01 | 0.965 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.753514e-02 | 1.058 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.753514e-02 | 1.058 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.032359e-01 | 0.986 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.441986e-02 | 1.025 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.441986e-02 | 1.025 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.077988e-01 | 0.967 | 1 | 1 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.595916e-02 | 1.018 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.595916e-02 | 1.018 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 1.075839e-01 | 0.968 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.482939e-02 | 1.023 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.158941e-01 | 0.936 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.082967e-01 | 0.965 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.275756e-02 | 1.033 | 1 | 1 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.050764e-01 | 0.978 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.595916e-02 | 1.018 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.441986e-02 | 1.025 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.066107e-01 | 0.972 | 1 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.753514e-02 | 1.058 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.110391e-01 | 0.955 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.066107e-01 | 0.972 | 1 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.032359e-01 | 0.986 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.713061e-02 | 1.060 | 1 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.441986e-02 | 1.025 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.058343e-01 | 0.975 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.032359e-01 | 0.986 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.770552e-02 | 1.010 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.132601e-01 | 0.946 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.753514e-02 | 1.058 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.077988e-01 | 0.967 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.087060e-01 | 0.964 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 1.077988e-01 | 0.967 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 9.595916e-02 | 1.018 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 9.595916e-02 | 1.018 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.032359e-01 | 0.986 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.158941e-01 | 0.936 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.047124e-01 | 0.980 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.159598e-01 | 0.936 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.160859e-01 | 0.935 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.175881e-01 | 0.930 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.189536e-01 | 0.925 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.198976e-01 | 0.921 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.201216e-01 | 0.920 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.211332e-01 | 0.917 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.213898e-01 | 0.916 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.220469e-01 | 0.913 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.220469e-01 | 0.913 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.229343e-01 | 0.910 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.237278e-01 | 0.908 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.237278e-01 | 0.908 | 1 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.269008e-01 | 0.897 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.269008e-01 | 0.897 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.269560e-01 | 0.896 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.272679e-01 | 0.895 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.296290e-01 | 0.887 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.296290e-01 | 0.887 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.296290e-01 | 0.887 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.296290e-01 | 0.887 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.296290e-01 | 0.887 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.296290e-01 | 0.887 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.296290e-01 | 0.887 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.296290e-01 | 0.887 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.296290e-01 | 0.887 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.296290e-01 | 0.887 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.297775e-01 | 0.887 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.307371e-01 | 0.884 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.307371e-01 | 0.884 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.307371e-01 | 0.884 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.307371e-01 | 0.884 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.307371e-01 | 0.884 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.307371e-01 | 0.884 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.307371e-01 | 0.884 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.313084e-01 | 0.882 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.316943e-01 | 0.880 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.328754e-01 | 0.877 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.328754e-01 | 0.877 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.329775e-01 | 0.876 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.876307e-01 | 0.727 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.876307e-01 | 0.727 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.876307e-01 | 0.727 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.876307e-01 | 0.727 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.653117e-01 | 0.782 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 1.653117e-01 | 0.782 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.024307e-01 | 0.694 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.024307e-01 | 0.694 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.024307e-01 | 0.694 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.546367e-01 | 0.811 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.797656e-01 | 0.745 | 1 | 1 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.381042e-01 | 0.860 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.381042e-01 | 0.860 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.570877e-01 | 0.804 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.570877e-01 | 0.804 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.570877e-01 | 0.804 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.570877e-01 | 0.804 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.570877e-01 | 0.804 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.570877e-01 | 0.804 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.371198e-01 | 0.863 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.769700e-01 | 0.752 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.976452e-01 | 0.704 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.976452e-01 | 0.704 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.464884e-01 | 0.834 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.867616e-01 | 0.729 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.867616e-01 | 0.729 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.391806e-01 | 0.856 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.516119e-01 | 0.819 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.779379e-01 | 0.750 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.917809e-01 | 0.717 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.550703e-01 | 0.809 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.525247e-01 | 0.817 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.525247e-01 | 0.817 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.734377e-01 | 0.761 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.976452e-01 | 0.704 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.367591e-01 | 0.864 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.754869e-01 | 0.756 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.891340e-01 | 0.723 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.546367e-01 | 0.811 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.695340e-01 | 0.771 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.353579e-01 | 0.869 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.351709e-01 | 0.869 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.737339e-01 | 0.760 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.821932e-01 | 0.739 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.653117e-01 | 0.782 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.769700e-01 | 0.752 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.524437e-01 | 0.817 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.905630e-01 | 0.720 | 1 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.607041e-01 | 0.794 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.754869e-01 | 0.756 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.540058e-01 | 0.812 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.990198e-01 | 0.701 | 1 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.561915e-01 | 0.806 | 1 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.698643e-01 | 0.770 | 1 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.865931e-01 | 0.729 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.698643e-01 | 0.770 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.698643e-01 | 0.770 | 1 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.381042e-01 | 0.860 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.516119e-01 | 0.819 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.541652e-01 | 0.812 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.546367e-01 | 0.811 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.381042e-01 | 0.860 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.381042e-01 | 0.860 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.546367e-01 | 0.811 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.669839e-01 | 0.777 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.965953e-01 | 0.706 | 1 | 0 |
| SDK interactions | R-HSA-373756 | 1.876307e-01 | 0.727 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.653117e-01 | 0.782 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 1.653117e-01 | 0.782 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.024307e-01 | 0.694 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.797656e-01 | 0.745 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.695340e-01 | 0.771 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.867616e-01 | 0.729 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.907984e-01 | 0.719 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.539236e-01 | 0.813 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.977719e-01 | 0.704 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.815987e-01 | 0.741 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.769508e-01 | 0.752 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.537953e-01 | 0.813 | 1 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.689340e-01 | 0.772 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.434019e-01 | 0.843 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.797656e-01 | 0.745 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.406063e-01 | 0.852 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.452136e-01 | 0.838 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.877840e-01 | 0.726 | 1 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.754869e-01 | 0.756 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.352125e-01 | 0.869 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.956936e-01 | 0.708 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.024307e-01 | 0.694 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.529671e-01 | 0.815 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.917809e-01 | 0.717 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.901883e-01 | 0.721 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.653117e-01 | 0.782 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.653117e-01 | 0.782 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.024307e-01 | 0.694 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.024307e-01 | 0.694 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.769700e-01 | 0.752 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 1.917809e-01 | 0.717 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.867616e-01 | 0.729 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.976452e-01 | 0.704 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.972250e-01 | 0.705 | 1 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.452892e-01 | 0.838 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.045881e-01 | 0.689 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.045881e-01 | 0.689 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.045881e-01 | 0.689 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.058978e-01 | 0.686 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.058978e-01 | 0.686 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.058978e-01 | 0.686 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.058978e-01 | 0.686 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.058978e-01 | 0.686 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.060395e-01 | 0.686 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.134947e-01 | 0.671 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.174044e-01 | 0.663 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.190057e-01 | 0.660 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.190057e-01 | 0.660 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.190057e-01 | 0.660 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.197749e-01 | 0.658 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.206838e-01 | 0.656 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.228435e-01 | 0.652 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.228435e-01 | 0.652 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.228435e-01 | 0.652 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.228435e-01 | 0.652 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.229497e-01 | 0.652 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.241923e-01 | 0.649 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.290258e-01 | 0.640 | 1 | 1 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.328152e-01 | 0.633 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.328152e-01 | 0.633 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.328152e-01 | 0.633 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.328152e-01 | 0.633 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.328152e-01 | 0.633 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.328152e-01 | 0.633 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.328152e-01 | 0.633 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.328152e-01 | 0.633 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.328152e-01 | 0.633 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 2.328152e-01 | 0.633 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.328152e-01 | 0.633 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.339548e-01 | 0.631 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.345244e-01 | 0.630 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.349068e-01 | 0.629 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.678062e-01 | 0.572 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.678062e-01 | 0.572 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.678062e-01 | 0.572 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.678062e-01 | 0.572 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.678062e-01 | 0.572 | 1 | 1 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.678062e-01 | 0.572 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.678062e-01 | 0.572 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.678062e-01 | 0.572 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.678062e-01 | 0.572 | 1 | 1 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.678062e-01 | 0.572 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.678062e-01 | 0.572 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.678062e-01 | 0.572 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.678062e-01 | 0.572 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.400732e-01 | 0.468 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.400732e-01 | 0.468 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.400732e-01 | 0.468 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.400732e-01 | 0.468 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.400732e-01 | 0.468 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.400732e-01 | 0.468 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.403555e-01 | 0.619 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.403555e-01 | 0.619 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.785661e-01 | 0.555 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.785661e-01 | 0.555 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.785661e-01 | 0.555 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.785661e-01 | 0.555 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.052113e-01 | 0.392 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.052113e-01 | 0.392 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.052113e-01 | 0.392 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.052113e-01 | 0.392 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.052113e-01 | 0.392 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.166369e-01 | 0.499 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.166369e-01 | 0.499 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.166369e-01 | 0.499 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.603109e-01 | 0.585 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.409436e-01 | 0.618 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.409436e-01 | 0.618 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.409436e-01 | 0.618 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.881912e-01 | 0.540 | 1 | 1 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.881912e-01 | 0.540 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.542236e-01 | 0.451 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.542236e-01 | 0.451 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.542236e-01 | 0.451 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.639234e-01 | 0.334 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.639234e-01 | 0.334 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.639234e-01 | 0.334 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.639234e-01 | 0.334 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.633521e-01 | 0.579 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.633521e-01 | 0.579 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.633521e-01 | 0.579 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.633521e-01 | 0.579 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.633521e-01 | 0.579 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.162769e-01 | 0.500 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.162769e-01 | 0.500 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.162769e-01 | 0.500 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.861270e-01 | 0.543 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.861270e-01 | 0.543 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.861270e-01 | 0.543 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.910512e-01 | 0.408 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.910512e-01 | 0.408 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.910512e-01 | 0.408 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.910512e-01 | 0.408 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.910512e-01 | 0.408 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.910512e-01 | 0.408 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.091675e-01 | 0.510 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.091675e-01 | 0.510 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.004363e-01 | 0.522 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.323772e-01 | 0.478 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.724252e-01 | 0.429 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.724252e-01 | 0.429 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.269034e-01 | 0.370 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.269034e-01 | 0.370 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.269034e-01 | 0.370 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.269034e-01 | 0.370 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.002071e-01 | 0.398 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.789434e-01 | 0.421 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.616141e-01 | 0.336 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.616141e-01 | 0.336 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.616141e-01 | 0.336 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.616141e-01 | 0.336 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.148362e-01 | 0.502 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.148362e-01 | 0.502 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.021335e-01 | 0.396 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.021335e-01 | 0.396 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.644475e-01 | 0.438 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.015984e-01 | 0.396 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.545997e-01 | 0.342 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.218147e-01 | 0.375 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.479568e-01 | 0.349 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.479568e-01 | 0.349 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.479568e-01 | 0.349 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.629484e-01 | 0.440 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.704600e-01 | 0.327 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.704600e-01 | 0.327 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.704600e-01 | 0.327 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.312360e-01 | 0.365 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.006395e-01 | 0.397 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.478453e-01 | 0.349 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.643637e-01 | 0.333 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.364762e-01 | 0.360 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.364762e-01 | 0.360 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.346579e-01 | 0.475 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 4.219605e-01 | 0.375 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.556645e-01 | 0.449 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.419156e-01 | 0.355 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.795853e-01 | 0.421 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.910512e-01 | 0.408 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.538029e-01 | 0.596 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.251607e-01 | 0.371 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.251607e-01 | 0.371 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.450849e-01 | 0.611 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.021335e-01 | 0.396 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.609852e-01 | 0.443 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.913944e-01 | 0.536 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.616141e-01 | 0.336 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.817366e-01 | 0.418 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.394908e-01 | 0.621 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.542236e-01 | 0.451 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.204922e-01 | 0.494 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.813046e-01 | 0.419 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.128349e-01 | 0.505 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.091675e-01 | 0.510 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.269034e-01 | 0.370 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.276327e-01 | 0.369 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.527377e-01 | 0.344 | 1 | 1 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.738117e-01 | 0.563 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.091675e-01 | 0.510 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 3.323772e-01 | 0.478 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.218147e-01 | 0.375 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 4.704600e-01 | 0.327 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.913944e-01 | 0.536 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.655411e-01 | 0.576 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.490686e-01 | 0.457 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.913944e-01 | 0.536 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.157296e-01 | 0.381 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.409436e-01 | 0.618 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.802133e-01 | 0.553 | 1 | 1 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.700211e-01 | 0.432 | 1 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.269034e-01 | 0.370 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.545997e-01 | 0.342 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.479568e-01 | 0.349 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.954445e-01 | 0.403 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.510027e-01 | 0.600 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.166369e-01 | 0.499 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.176672e-01 | 0.379 | 1 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.479568e-01 | 0.349 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.587887e-01 | 0.338 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.881912e-01 | 0.540 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.542236e-01 | 0.451 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.724252e-01 | 0.429 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.204922e-01 | 0.494 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 3.556645e-01 | 0.449 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.813046e-01 | 0.419 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.783809e-01 | 0.422 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.738117e-01 | 0.563 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.470121e-01 | 0.460 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.204922e-01 | 0.494 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.118364e-01 | 0.506 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.783809e-01 | 0.422 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.406952e-01 | 0.468 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.802133e-01 | 0.553 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.875990e-01 | 0.541 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.166369e-01 | 0.499 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.542236e-01 | 0.451 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.639234e-01 | 0.334 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.162769e-01 | 0.500 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.954445e-01 | 0.403 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.929104e-01 | 0.533 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.898285e-01 | 0.538 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.644475e-01 | 0.438 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.409436e-01 | 0.618 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.960501e-01 | 0.529 | 1 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.924020e-01 | 0.534 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.627451e-01 | 0.580 | 1 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.276327e-01 | 0.369 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.744230e-01 | 0.562 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.452893e-01 | 0.462 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.724252e-01 | 0.429 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.849580e-01 | 0.545 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.314301e-01 | 0.365 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.512442e-01 | 0.600 | 1 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.985626e-01 | 0.525 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.678062e-01 | 0.572 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.678062e-01 | 0.572 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.400732e-01 | 0.468 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.400732e-01 | 0.468 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.785661e-01 | 0.555 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.052113e-01 | 0.392 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.166369e-01 | 0.499 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.166369e-01 | 0.499 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.881912e-01 | 0.540 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.542236e-01 | 0.451 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 4.639234e-01 | 0.334 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.417810e-01 | 0.617 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.910512e-01 | 0.408 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.269034e-01 | 0.370 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.616141e-01 | 0.336 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.015984e-01 | 0.396 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.218147e-01 | 0.375 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.145629e-01 | 0.382 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.704600e-01 | 0.327 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.824765e-01 | 0.549 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.861270e-01 | 0.543 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.251607e-01 | 0.371 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.482286e-01 | 0.605 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.148362e-01 | 0.502 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.783809e-01 | 0.422 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.409436e-01 | 0.618 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.881912e-01 | 0.540 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.542236e-01 | 0.451 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.813046e-01 | 0.419 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.663031e-01 | 0.575 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.910512e-01 | 0.408 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.444043e-01 | 0.463 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.403555e-01 | 0.619 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.162769e-01 | 0.500 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.813046e-01 | 0.419 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.545997e-01 | 0.342 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.052113e-01 | 0.392 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.052113e-01 | 0.392 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.166369e-01 | 0.499 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.542236e-01 | 0.451 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.639234e-01 | 0.334 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.639234e-01 | 0.334 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.910512e-01 | 0.408 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.610163e-01 | 0.583 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.002071e-01 | 0.398 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.002071e-01 | 0.398 | 1 | 1 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.383508e-01 | 0.623 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.597758e-01 | 0.444 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.394908e-01 | 0.621 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.458315e-01 | 0.461 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.419156e-01 | 0.355 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.403555e-01 | 0.619 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.162769e-01 | 0.500 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.805897e-01 | 0.552 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.702285e-01 | 0.568 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 3.978539e-01 | 0.400 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.419045e-01 | 0.355 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.052113e-01 | 0.392 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.542236e-01 | 0.451 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.639234e-01 | 0.334 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.910512e-01 | 0.408 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.269034e-01 | 0.370 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.616141e-01 | 0.336 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.954445e-01 | 0.403 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.177107e-01 | 0.379 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.323772e-01 | 0.478 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.785661e-01 | 0.555 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.542236e-01 | 0.451 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.002071e-01 | 0.398 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.574968e-01 | 0.340 | 1 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.480348e-01 | 0.458 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.564953e-01 | 0.591 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.479568e-01 | 0.349 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.049343e-01 | 0.393 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.910512e-01 | 0.408 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.910512e-01 | 0.408 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.444043e-01 | 0.463 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 4.595766e-01 | 0.338 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.723150e-01 | 0.326 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.786207e-01 | 0.320 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.797269e-01 | 0.319 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.798443e-01 | 0.319 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.815253e-01 | 0.317 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.815253e-01 | 0.317 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.900529e-01 | 0.310 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.900529e-01 | 0.310 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.900529e-01 | 0.310 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.926146e-01 | 0.307 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.926146e-01 | 0.307 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.926146e-01 | 0.307 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.950594e-01 | 0.305 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.950594e-01 | 0.305 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.950594e-01 | 0.305 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.950594e-01 | 0.305 | 1 | 1 |
| Leading Strand Synthesis | R-HSA-69109 | 4.950594e-01 | 0.305 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.950594e-01 | 0.305 | 1 | 1 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.950594e-01 | 0.305 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.950594e-01 | 0.305 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.950594e-01 | 0.305 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.950594e-01 | 0.305 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.950594e-01 | 0.305 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.950594e-01 | 0.305 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.950594e-01 | 0.305 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.950594e-01 | 0.305 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.970267e-01 | 0.304 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.970267e-01 | 0.304 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.970267e-01 | 0.304 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.009750e-01 | 0.300 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.068169e-01 | 0.295 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.068169e-01 | 0.295 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.068169e-01 | 0.295 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.075921e-01 | 0.294 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.091881e-01 | 0.293 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.143709e-01 | 0.289 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.162562e-01 | 0.287 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 5.168431e-01 | 0.287 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.168431e-01 | 0.287 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.168431e-01 | 0.287 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.168431e-01 | 0.287 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.168431e-01 | 0.287 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.168431e-01 | 0.287 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.168431e-01 | 0.287 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.168431e-01 | 0.287 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.168431e-01 | 0.287 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.168431e-01 | 0.287 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.168431e-01 | 0.287 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.168431e-01 | 0.287 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.260174e-01 | 0.279 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.271510e-01 | 0.278 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 5.271510e-01 | 0.278 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.271510e-01 | 0.278 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.271510e-01 | 0.278 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.290363e-01 | 0.277 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.290363e-01 | 0.277 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.290363e-01 | 0.277 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.319290e-01 | 0.274 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.319290e-01 | 0.274 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 5.319290e-01 | 0.274 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.356851e-01 | 0.271 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.356851e-01 | 0.271 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.356851e-01 | 0.271 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.472885e-01 | 0.262 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.473478e-01 | 0.262 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.543972e-01 | 0.256 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.563041e-01 | 0.255 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.563041e-01 | 0.255 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.563041e-01 | 0.255 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.563041e-01 | 0.255 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.565190e-01 | 0.255 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.565190e-01 | 0.255 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.574637e-01 | 0.254 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.578302e-01 | 0.253 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.578302e-01 | 0.253 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.578302e-01 | 0.253 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.578302e-01 | 0.253 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.602272e-01 | 0.252 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.617883e-01 | 0.250 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.633930e-01 | 0.249 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.644393e-01 | 0.248 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.644393e-01 | 0.248 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.644393e-01 | 0.248 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.645416e-01 | 0.248 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.645416e-01 | 0.248 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.645416e-01 | 0.248 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.645416e-01 | 0.248 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.645416e-01 | 0.248 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.645416e-01 | 0.248 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.645416e-01 | 0.248 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.645416e-01 | 0.248 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.645416e-01 | 0.248 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.645416e-01 | 0.248 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.645416e-01 | 0.248 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.645416e-01 | 0.248 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.645416e-01 | 0.248 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.645416e-01 | 0.248 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.645416e-01 | 0.248 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.645416e-01 | 0.248 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.645416e-01 | 0.248 | 1 | 1 |
| TRAIL signaling | R-HSA-75158 | 5.645416e-01 | 0.248 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.659318e-01 | 0.247 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.666368e-01 | 0.247 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.755766e-01 | 0.240 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.760258e-01 | 0.240 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.767996e-01 | 0.239 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.768401e-01 | 0.239 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.799013e-01 | 0.237 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 5.799013e-01 | 0.237 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.799013e-01 | 0.237 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.870631e-01 | 0.231 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.870631e-01 | 0.231 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.870631e-01 | 0.231 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.870631e-01 | 0.231 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.870631e-01 | 0.231 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.870631e-01 | 0.231 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.870631e-01 | 0.231 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.870631e-01 | 0.231 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.870631e-01 | 0.231 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.870631e-01 | 0.231 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.870631e-01 | 0.231 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.884249e-01 | 0.230 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.904574e-01 | 0.229 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.906944e-01 | 0.229 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.914335e-01 | 0.228 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.914335e-01 | 0.228 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.917824e-01 | 0.228 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.072859e-01 | 0.217 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.072859e-01 | 0.217 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.072859e-01 | 0.217 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.072859e-01 | 0.217 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.075337e-01 | 0.216 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.075337e-01 | 0.216 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.075337e-01 | 0.216 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.075337e-01 | 0.216 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.075337e-01 | 0.216 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.075337e-01 | 0.216 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.075337e-01 | 0.216 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.075337e-01 | 0.216 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.075337e-01 | 0.216 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.075337e-01 | 0.216 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.075337e-01 | 0.216 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.075337e-01 | 0.216 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.075337e-01 | 0.216 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.075337e-01 | 0.216 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.105865e-01 | 0.214 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.135539e-01 | 0.212 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.148363e-01 | 0.211 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.148363e-01 | 0.211 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.148363e-01 | 0.211 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.148363e-01 | 0.211 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.148363e-01 | 0.211 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.158377e-01 | 0.211 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.158377e-01 | 0.211 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.162358e-01 | 0.210 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.246440e-01 | 0.204 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.246440e-01 | 0.204 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.246440e-01 | 0.204 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.246440e-01 | 0.204 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.256040e-01 | 0.204 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.282917e-01 | 0.202 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.284589e-01 | 0.202 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.326733e-01 | 0.199 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.333326e-01 | 0.198 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.379460e-01 | 0.195 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.411531e-01 | 0.193 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.411531e-01 | 0.193 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.411531e-01 | 0.193 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.411531e-01 | 0.193 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.411531e-01 | 0.193 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.411531e-01 | 0.193 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.411531e-01 | 0.193 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.411531e-01 | 0.193 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.411531e-01 | 0.193 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.411531e-01 | 0.193 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.411531e-01 | 0.193 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.438593e-01 | 0.191 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.448979e-01 | 0.191 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.457516e-01 | 0.190 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.457516e-01 | 0.190 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.457516e-01 | 0.190 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.457516e-01 | 0.190 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.457516e-01 | 0.190 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.462835e-01 | 0.190 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.462835e-01 | 0.190 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.462835e-01 | 0.190 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.462835e-01 | 0.190 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.462835e-01 | 0.190 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.462835e-01 | 0.190 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.462835e-01 | 0.190 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.462835e-01 | 0.190 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.462835e-01 | 0.190 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.462835e-01 | 0.190 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.462835e-01 | 0.190 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.462835e-01 | 0.190 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.462835e-01 | 0.190 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.480101e-01 | 0.188 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.515632e-01 | 0.186 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.525135e-01 | 0.185 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.527302e-01 | 0.185 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.527302e-01 | 0.185 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.587785e-01 | 0.181 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.588967e-01 | 0.181 | 1 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.598109e-01 | 0.181 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.598109e-01 | 0.181 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.598109e-01 | 0.181 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.598109e-01 | 0.181 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.598109e-01 | 0.181 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.660031e-01 | 0.177 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.660302e-01 | 0.177 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.660302e-01 | 0.177 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.660302e-01 | 0.177 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.660302e-01 | 0.177 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.671377e-01 | 0.176 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.699480e-01 | 0.174 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.772912e-01 | 0.169 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.779618e-01 | 0.169 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.812095e-01 | 0.167 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.812095e-01 | 0.167 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.812095e-01 | 0.167 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.812095e-01 | 0.167 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.812095e-01 | 0.167 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.812095e-01 | 0.167 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.812095e-01 | 0.167 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.812095e-01 | 0.167 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.812095e-01 | 0.167 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.812095e-01 | 0.167 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.812095e-01 | 0.167 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.837118e-01 | 0.165 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.853966e-01 | 0.164 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.853966e-01 | 0.164 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.853966e-01 | 0.164 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.853966e-01 | 0.164 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.853966e-01 | 0.164 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.894954e-01 | 0.161 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.894954e-01 | 0.161 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.894954e-01 | 0.161 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.894954e-01 | 0.161 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.894954e-01 | 0.161 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.894954e-01 | 0.161 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.894954e-01 | 0.161 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.896087e-01 | 0.161 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.960700e-01 | 0.157 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.006706e-01 | 0.154 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.029778e-01 | 0.153 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.039350e-01 | 0.152 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.048646e-01 | 0.152 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.080350e-01 | 0.150 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.080350e-01 | 0.150 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.080350e-01 | 0.150 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.080350e-01 | 0.150 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.080350e-01 | 0.150 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.080350e-01 | 0.150 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.115848e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.115848e-01 | 0.148 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.115848e-01 | 0.148 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.115848e-01 | 0.148 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.126887e-01 | 0.147 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.126887e-01 | 0.147 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.126887e-01 | 0.147 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.126887e-01 | 0.147 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.126887e-01 | 0.147 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.126887e-01 | 0.147 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.126887e-01 | 0.147 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.126887e-01 | 0.147 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.126887e-01 | 0.147 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.180677e-01 | 0.144 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.185696e-01 | 0.144 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.185696e-01 | 0.144 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.185696e-01 | 0.144 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.185696e-01 | 0.144 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.185696e-01 | 0.144 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.185696e-01 | 0.144 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.185696e-01 | 0.144 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.216262e-01 | 0.142 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.216262e-01 | 0.142 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.216262e-01 | 0.142 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.238217e-01 | 0.140 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.253205e-01 | 0.139 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.254851e-01 | 0.139 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.287083e-01 | 0.137 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.323414e-01 | 0.135 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.323414e-01 | 0.135 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.323414e-01 | 0.135 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.323414e-01 | 0.135 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.323414e-01 | 0.135 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.333231e-01 | 0.135 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.353572e-01 | 0.134 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.410612e-01 | 0.130 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.410612e-01 | 0.130 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.410612e-01 | 0.130 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.410612e-01 | 0.130 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.410612e-01 | 0.130 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.410612e-01 | 0.130 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.455131e-01 | 0.128 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.455131e-01 | 0.128 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.455131e-01 | 0.128 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.455131e-01 | 0.128 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.465529e-01 | 0.127 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.472683e-01 | 0.127 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.479190e-01 | 0.126 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.479190e-01 | 0.126 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.479190e-01 | 0.126 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.479190e-01 | 0.126 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.485565e-01 | 0.126 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.501994e-01 | 0.125 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.518129e-01 | 0.124 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.518129e-01 | 0.124 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.518129e-01 | 0.124 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.518129e-01 | 0.124 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.518129e-01 | 0.124 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.518129e-01 | 0.124 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.518129e-01 | 0.124 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.545178e-01 | 0.122 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.560515e-01 | 0.121 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.574088e-01 | 0.121 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.581143e-01 | 0.120 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.587391e-01 | 0.120 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.616886e-01 | 0.118 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.616886e-01 | 0.118 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.630438e-01 | 0.117 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.666333e-01 | 0.115 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.666333e-01 | 0.115 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.666333e-01 | 0.115 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.666333e-01 | 0.115 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.666333e-01 | 0.115 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.666333e-01 | 0.115 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.666333e-01 | 0.115 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.666333e-01 | 0.115 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.666333e-01 | 0.115 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.666333e-01 | 0.115 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.666333e-01 | 0.115 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.666333e-01 | 0.115 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.666333e-01 | 0.115 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.679260e-01 | 0.115 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.697515e-01 | 0.114 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.697515e-01 | 0.114 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.700507e-01 | 0.113 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.700507e-01 | 0.113 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.700507e-01 | 0.113 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.702407e-01 | 0.113 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.748660e-01 | 0.111 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.781062e-01 | 0.109 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.818979e-01 | 0.107 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.842037e-01 | 0.106 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.842037e-01 | 0.106 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.871084e-01 | 0.104 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.871084e-01 | 0.104 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.875138e-01 | 0.104 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.879518e-01 | 0.104 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.889032e-01 | 0.103 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.896814e-01 | 0.103 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 7.896814e-01 | 0.103 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.896814e-01 | 0.103 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.896814e-01 | 0.103 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.898975e-01 | 0.102 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.903199e-01 | 0.102 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.903199e-01 | 0.102 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.965196e-01 | 0.099 | 1 | 1 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.970519e-01 | 0.099 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.978968e-01 | 0.098 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.978968e-01 | 0.098 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.978968e-01 | 0.098 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.981036e-01 | 0.098 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.994878e-01 | 0.097 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.994878e-01 | 0.097 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.996946e-01 | 0.097 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.996946e-01 | 0.097 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.030413e-01 | 0.095 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.030413e-01 | 0.095 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.030413e-01 | 0.095 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.030413e-01 | 0.095 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.047618e-01 | 0.094 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.104543e-01 | 0.091 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.104543e-01 | 0.091 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.104543e-01 | 0.091 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.104543e-01 | 0.091 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.104543e-01 | 0.091 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.104543e-01 | 0.091 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.104543e-01 | 0.091 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.104543e-01 | 0.091 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.104543e-01 | 0.091 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.104543e-01 | 0.091 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.104543e-01 | 0.091 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.108547e-01 | 0.091 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.108547e-01 | 0.091 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.109574e-01 | 0.091 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.114568e-01 | 0.091 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.141255e-01 | 0.089 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.141255e-01 | 0.089 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.179050e-01 | 0.087 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.179050e-01 | 0.087 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.179050e-01 | 0.087 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.181639e-01 | 0.087 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.187436e-01 | 0.087 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.218847e-01 | 0.085 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.226158e-01 | 0.085 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.239085e-01 | 0.084 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.291767e-01 | 0.081 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.291767e-01 | 0.081 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.291767e-01 | 0.081 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.291767e-01 | 0.081 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.291767e-01 | 0.081 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.291767e-01 | 0.081 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.291767e-01 | 0.081 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.291767e-01 | 0.081 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.291767e-01 | 0.081 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.291767e-01 | 0.081 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.291767e-01 | 0.081 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.291767e-01 | 0.081 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.317553e-01 | 0.080 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.317553e-01 | 0.080 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.317553e-01 | 0.080 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.317553e-01 | 0.080 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.317553e-01 | 0.080 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.334105e-01 | 0.079 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.338570e-01 | 0.079 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.346579e-01 | 0.078 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.363313e-01 | 0.078 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.401591e-01 | 0.076 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.421736e-01 | 0.075 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.424626e-01 | 0.074 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.425162e-01 | 0.074 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.438428e-01 | 0.074 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.445956e-01 | 0.073 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.446472e-01 | 0.073 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.446472e-01 | 0.073 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.446472e-01 | 0.073 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.446472e-01 | 0.073 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.454572e-01 | 0.073 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.460508e-01 | 0.073 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.460508e-01 | 0.073 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.460508e-01 | 0.073 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.460508e-01 | 0.073 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.460508e-01 | 0.073 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.460508e-01 | 0.073 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.460508e-01 | 0.073 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.460508e-01 | 0.073 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.460508e-01 | 0.073 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.460508e-01 | 0.073 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.522162e-01 | 0.069 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.522162e-01 | 0.069 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.558493e-01 | 0.068 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.558493e-01 | 0.068 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.558493e-01 | 0.068 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.558493e-01 | 0.068 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.566351e-01 | 0.067 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.566351e-01 | 0.067 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.566351e-01 | 0.067 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.566351e-01 | 0.067 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.592418e-01 | 0.066 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.601054e-01 | 0.065 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.604820e-01 | 0.065 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.604820e-01 | 0.065 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.612589e-01 | 0.065 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.612589e-01 | 0.065 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 8.612589e-01 | 0.065 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.612589e-01 | 0.065 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.612589e-01 | 0.065 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.612589e-01 | 0.065 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.612589e-01 | 0.065 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.655220e-01 | 0.063 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.655220e-01 | 0.063 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.655220e-01 | 0.063 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.658531e-01 | 0.063 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.670717e-01 | 0.062 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.673681e-01 | 0.062 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.677715e-01 | 0.062 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.677715e-01 | 0.062 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.681884e-01 | 0.061 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.689353e-01 | 0.061 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.746182e-01 | 0.058 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.746182e-01 | 0.058 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.749654e-01 | 0.058 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.749654e-01 | 0.058 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.749654e-01 | 0.058 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.749654e-01 | 0.058 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.749654e-01 | 0.058 | 1 | 1 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.749654e-01 | 0.058 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.749654e-01 | 0.058 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.749654e-01 | 0.058 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.749654e-01 | 0.058 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.781077e-01 | 0.056 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.781077e-01 | 0.056 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.781077e-01 | 0.056 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.781077e-01 | 0.056 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.809535e-01 | 0.055 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.816755e-01 | 0.055 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.841398e-01 | 0.053 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.873186e-01 | 0.052 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.873186e-01 | 0.052 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.873186e-01 | 0.052 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.873186e-01 | 0.052 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.873186e-01 | 0.052 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.873186e-01 | 0.052 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.873186e-01 | 0.052 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.873186e-01 | 0.052 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.876931e-01 | 0.052 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.883862e-01 | 0.051 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.888023e-01 | 0.051 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.898863e-01 | 0.051 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.916961e-01 | 0.050 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.932947e-01 | 0.049 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.952547e-01 | 0.048 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.957980e-01 | 0.048 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.965750e-01 | 0.047 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.965750e-01 | 0.047 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.984520e-01 | 0.047 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.984520e-01 | 0.047 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.984520e-01 | 0.047 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.984520e-01 | 0.047 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.984520e-01 | 0.047 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.984520e-01 | 0.047 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.987130e-01 | 0.046 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.021702e-01 | 0.045 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.046403e-01 | 0.044 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.047990e-01 | 0.043 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.057661e-01 | 0.043 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.084860e-01 | 0.042 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.084860e-01 | 0.042 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.084860e-01 | 0.042 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.084860e-01 | 0.042 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.089366e-01 | 0.041 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.089437e-01 | 0.041 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.098644e-01 | 0.041 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.123716e-01 | 0.040 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.123716e-01 | 0.040 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.124082e-01 | 0.040 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.149367e-01 | 0.039 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.166116e-01 | 0.038 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.173898e-01 | 0.037 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.175290e-01 | 0.037 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.175290e-01 | 0.037 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.175290e-01 | 0.037 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.175290e-01 | 0.037 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.175290e-01 | 0.037 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.175290e-01 | 0.037 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.175290e-01 | 0.037 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.181109e-01 | 0.037 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.194438e-01 | 0.036 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.194438e-01 | 0.036 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.209875e-01 | 0.036 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.219804e-01 | 0.035 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.225819e-01 | 0.035 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.256789e-01 | 0.034 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.256789e-01 | 0.034 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.256789e-01 | 0.034 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.256789e-01 | 0.034 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.256789e-01 | 0.034 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.256789e-01 | 0.034 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.259448e-01 | 0.033 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.259448e-01 | 0.033 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.259448e-01 | 0.033 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.259448e-01 | 0.033 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.259448e-01 | 0.033 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.259448e-01 | 0.033 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.270303e-01 | 0.033 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.270367e-01 | 0.033 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.297369e-01 | 0.032 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.297369e-01 | 0.032 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.297369e-01 | 0.032 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.297404e-01 | 0.032 | 1 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.297404e-01 | 0.032 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.319482e-01 | 0.031 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.330239e-01 | 0.030 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.330239e-01 | 0.030 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.330239e-01 | 0.030 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.330239e-01 | 0.030 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.333593e-01 | 0.030 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.347826e-01 | 0.029 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.347826e-01 | 0.029 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.351273e-01 | 0.029 | 1 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.355834e-01 | 0.029 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.362720e-01 | 0.029 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.374888e-01 | 0.028 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.374888e-01 | 0.028 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.374888e-01 | 0.028 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.374888e-01 | 0.028 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.396433e-01 | 0.027 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.396433e-01 | 0.027 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.396433e-01 | 0.027 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.413813e-01 | 0.026 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.425994e-01 | 0.026 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.425994e-01 | 0.026 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.432594e-01 | 0.025 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.456089e-01 | 0.024 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.456089e-01 | 0.024 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.456089e-01 | 0.024 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.456089e-01 | 0.024 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.456089e-01 | 0.024 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.462546e-01 | 0.024 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.479797e-01 | 0.023 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.509852e-01 | 0.022 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.509852e-01 | 0.022 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.509852e-01 | 0.022 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.509852e-01 | 0.022 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.516277e-01 | 0.022 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.516521e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.516521e-01 | 0.022 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.517950e-01 | 0.021 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.528867e-01 | 0.021 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.556503e-01 | 0.020 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.556503e-01 | 0.020 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.556503e-01 | 0.020 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.556865e-01 | 0.020 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.558304e-01 | 0.020 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.558304e-01 | 0.020 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.558304e-01 | 0.020 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.558304e-01 | 0.020 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.586540e-01 | 0.018 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.586540e-01 | 0.018 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.589633e-01 | 0.018 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.593308e-01 | 0.018 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.593308e-01 | 0.018 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.601968e-01 | 0.018 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.601968e-01 | 0.018 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.601968e-01 | 0.018 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.601968e-01 | 0.018 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.601968e-01 | 0.018 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.601968e-01 | 0.018 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.608256e-01 | 0.017 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.615812e-01 | 0.017 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.627173e-01 | 0.017 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.632047e-01 | 0.016 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.635122e-01 | 0.016 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.641319e-01 | 0.016 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.641319e-01 | 0.016 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.641319e-01 | 0.016 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.641319e-01 | 0.016 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.648727e-01 | 0.016 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.658320e-01 | 0.015 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.666205e-01 | 0.015 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.676781e-01 | 0.014 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.676781e-01 | 0.014 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.676781e-01 | 0.014 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.676781e-01 | 0.014 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.676781e-01 | 0.014 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.676835e-01 | 0.014 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.686955e-01 | 0.014 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.708739e-01 | 0.013 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.708739e-01 | 0.013 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.713270e-01 | 0.013 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.713270e-01 | 0.013 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.713270e-01 | 0.013 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.713270e-01 | 0.013 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.713270e-01 | 0.013 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.723192e-01 | 0.012 | 1 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.725131e-01 | 0.012 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.727072e-01 | 0.012 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.737444e-01 | 0.012 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.737444e-01 | 0.012 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.737444e-01 | 0.012 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.737444e-01 | 0.012 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.737444e-01 | 0.012 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.737444e-01 | 0.012 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.737539e-01 | 0.012 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.737539e-01 | 0.012 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.741321e-01 | 0.011 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.741321e-01 | 0.011 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.742356e-01 | 0.011 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.754697e-01 | 0.011 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.760148e-01 | 0.011 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.760148e-01 | 0.011 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.761046e-01 | 0.011 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.763492e-01 | 0.010 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.763492e-01 | 0.010 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.779334e-01 | 0.010 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.780230e-01 | 0.010 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.786881e-01 | 0.009 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.788120e-01 | 0.009 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.795850e-01 | 0.009 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.799488e-01 | 0.009 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.807958e-01 | 0.008 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.807958e-01 | 0.008 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.807958e-01 | 0.008 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.810419e-01 | 0.008 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.815873e-01 | 0.008 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.818053e-01 | 0.008 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.820025e-01 | 0.008 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.826951e-01 | 0.008 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.826951e-01 | 0.008 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.830156e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.830326e-01 | 0.007 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.831604e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.844068e-01 | 0.007 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.844068e-01 | 0.007 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.844068e-01 | 0.007 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.847086e-01 | 0.007 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.852810e-01 | 0.006 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.859243e-01 | 0.006 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.859492e-01 | 0.006 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.859492e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.859492e-01 | 0.006 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.859492e-01 | 0.006 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.859492e-01 | 0.006 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.859492e-01 | 0.006 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.859492e-01 | 0.006 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.859492e-01 | 0.006 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.862635e-01 | 0.006 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.864829e-01 | 0.006 | 1 | 1 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.873391e-01 | 0.006 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.873391e-01 | 0.006 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.873391e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.873391e-01 | 0.006 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.875000e-01 | 0.005 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.879121e-01 | 0.005 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.882446e-01 | 0.005 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.885916e-01 | 0.005 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.885916e-01 | 0.005 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.885916e-01 | 0.005 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.885916e-01 | 0.005 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.885916e-01 | 0.005 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.886435e-01 | 0.005 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.886435e-01 | 0.005 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.893593e-01 | 0.005 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.896238e-01 | 0.005 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.897202e-01 | 0.004 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.897202e-01 | 0.004 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.897202e-01 | 0.004 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.897202e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.897202e-01 | 0.004 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.907373e-01 | 0.004 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.907373e-01 | 0.004 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.908492e-01 | 0.004 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.910414e-01 | 0.004 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.910414e-01 | 0.004 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.911823e-01 | 0.004 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.916538e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.916538e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.916946e-01 | 0.004 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.919389e-01 | 0.004 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.921472e-01 | 0.003 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.923724e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.924797e-01 | 0.003 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.924797e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.925326e-01 | 0.003 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.925326e-01 | 0.003 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.925326e-01 | 0.003 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.927422e-01 | 0.003 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.929416e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.929840e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.930579e-01 | 0.003 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.931842e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.932238e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.932238e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.935308e-01 | 0.003 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.937800e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.938686e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.938944e-01 | 0.003 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.938944e-01 | 0.003 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.938944e-01 | 0.003 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.938944e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.938944e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.944987e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.944987e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.944987e-01 | 0.002 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.944987e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.944987e-01 | 0.002 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.948365e-01 | 0.002 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.949711e-01 | 0.002 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.950432e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.952274e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.955338e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.955338e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.955338e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.960728e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.962362e-01 | 0.002 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.962875e-01 | 0.002 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.962875e-01 | 0.002 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.962875e-01 | 0.002 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.963742e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.964195e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.965448e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.967332e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.970375e-01 | 0.001 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.970566e-01 | 0.001 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.972658e-01 | 0.001 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.972889e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.972889e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.973480e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.973480e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.974770e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.975296e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.975296e-01 | 0.001 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.975296e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.975296e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.975296e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.976106e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.978472e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.978472e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.978472e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.978472e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.978472e-01 | 0.001 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.978530e-01 | 0.001 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.978530e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.982525e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.982830e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.982992e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.982992e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.983169e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.983392e-01 | 0.001 | 1 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.983452e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.983452e-01 | 0.001 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.984255e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.985899e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.987162e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.987220e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.988783e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.989291e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.990320e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.990654e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.990654e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.991012e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.991275e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.991580e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.991580e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.991580e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.991767e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.992346e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.992346e-01 | 0.000 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.993166e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.993807e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.994214e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.994453e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.994512e-01 | 0.000 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.995003e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.995944e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.996570e-01 | 0.000 | 1 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.996984e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.997035e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.997101e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997160e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.997329e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997594e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.997672e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.997832e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998047e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998254e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998406e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.998450e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998559e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998714e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999215e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999263e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999313e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999365e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999548e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999573e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999628e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999669e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999860e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999900e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999903e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999929e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999940e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999945e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999954e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999964e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999965e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999973e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999986e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999989e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999994e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999994e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999995e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999995e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999997e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.771561e-16 | 15.109 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.031708e-14 | 13.692 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.574918e-14 | 13.447 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.948398e-14 | 13.048 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.774803e-12 | 11.751 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.168821e-12 | 11.145 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.402289e-11 | 10.853 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.995604e-11 | 10.524 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.515011e-11 | 10.345 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.172818e-11 | 10.088 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.237828e-10 | 9.650 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.287615e-10 | 9.368 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.996035e-10 | 9.301 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.844498e-10 | 9.233 | 1 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.200943e-10 | 9.208 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.565811e-10 | 9.183 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.645884e-10 | 9.117 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.019018e-10 | 9.096 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.426045e-10 | 9.129 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.988725e-10 | 9.156 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.396506e-10 | 9.027 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.156598e-09 | 8.937 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.341393e-09 | 8.631 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.964445e-09 | 8.528 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.531060e-09 | 8.452 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.735029e-09 | 8.428 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.735029e-09 | 8.428 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.723092e-09 | 8.429 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.597059e-09 | 8.444 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.780311e-09 | 8.422 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.258027e-09 | 8.371 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.855402e-09 | 8.314 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.783989e-09 | 8.320 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.645029e-09 | 8.248 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.943891e-09 | 8.226 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.002781e-09 | 8.222 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.322823e-09 | 8.135 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.783604e-09 | 8.109 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.733312e-09 | 8.059 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.245565e-09 | 8.034 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.039147e-08 | 7.983 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.187262e-08 | 7.925 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.301695e-08 | 7.885 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.301695e-08 | 7.885 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.639087e-08 | 7.785 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.276265e-08 | 7.643 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.739038e-08 | 7.562 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.826829e-08 | 7.417 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.876756e-08 | 7.412 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.283885e-08 | 7.138 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.504348e-08 | 7.070 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.805003e-08 | 7.055 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.329171e-08 | 7.030 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.753242e-08 | 7.011 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.047488e-07 | 6.980 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.099864e-07 | 6.959 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.103344e-07 | 6.957 | 1 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.167367e-07 | 6.933 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.194321e-07 | 6.923 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.791630e-07 | 6.747 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.868682e-07 | 6.728 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.881938e-07 | 6.725 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.051175e-07 | 6.688 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.284438e-07 | 6.641 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.324159e-07 | 6.634 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.637907e-07 | 6.579 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.712674e-07 | 6.567 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.880055e-07 | 6.541 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.554106e-07 | 6.449 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.638075e-07 | 6.439 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.903322e-07 | 6.409 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.054408e-07 | 6.392 | 1 | 1 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.054408e-07 | 6.392 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.203756e-07 | 6.376 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.771679e-07 | 6.321 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.092803e-07 | 6.293 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.898222e-07 | 6.229 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.080540e-07 | 6.150 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.607290e-07 | 6.119 | 1 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.608645e-07 | 6.119 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.138025e-07 | 6.089 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.293595e-07 | 6.081 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.031571e-07 | 6.044 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.063413e-06 | 5.973 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.186149e-06 | 5.926 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.364635e-06 | 5.865 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.417527e-06 | 5.848 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.832780e-06 | 5.737 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.228541e-06 | 5.652 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.550269e-06 | 5.593 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.922349e-06 | 5.534 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.398685e-06 | 5.469 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.553634e-06 | 5.449 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.083921e-06 | 5.389 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.898072e-06 | 5.409 | 1 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.136377e-06 | 5.383 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.226728e-06 | 5.374 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.226728e-06 | 5.374 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.670955e-06 | 5.331 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.656826e-06 | 5.247 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.717509e-06 | 5.243 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.739289e-06 | 5.241 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.356817e-06 | 5.197 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.386128e-06 | 5.195 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.429792e-06 | 5.192 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.345090e-06 | 5.134 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.345090e-06 | 5.134 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.689551e-06 | 5.114 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.159026e-06 | 5.088 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.159026e-06 | 5.088 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.102806e-06 | 5.091 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.344054e-06 | 5.079 | 1 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.086891e-06 | 5.042 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.086891e-06 | 5.042 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.708256e-06 | 5.013 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.359816e-06 | 5.029 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.801850e-06 | 5.009 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.801850e-06 | 5.009 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.753218e-06 | 5.011 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.089150e-05 | 4.963 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.192643e-05 | 4.923 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.228184e-05 | 4.911 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.326011e-05 | 4.877 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.354289e-05 | 4.868 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.367148e-05 | 4.864 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.529612e-05 | 4.815 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.434217e-05 | 4.843 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.513343e-05 | 4.820 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.542797e-05 | 4.812 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.727275e-05 | 4.763 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.768296e-05 | 4.752 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.776285e-05 | 4.750 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.838929e-05 | 4.735 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.922351e-05 | 4.716 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.105587e-05 | 4.677 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.494498e-05 | 4.603 | 1 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.618077e-05 | 4.582 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.165766e-05 | 4.500 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.165766e-05 | 4.500 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.023706e-05 | 4.519 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.212161e-05 | 4.493 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.212161e-05 | 4.493 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.365459e-05 | 4.473 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.508405e-05 | 4.455 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.729192e-05 | 4.428 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.794885e-05 | 4.421 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.969366e-05 | 4.401 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.986881e-05 | 4.399 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.266139e-05 | 4.370 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.302331e-05 | 4.366 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.314417e-05 | 4.365 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.759117e-05 | 4.322 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.865023e-05 | 4.313 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.955594e-05 | 4.305 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.588570e-05 | 4.253 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.595984e-05 | 4.252 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.743805e-05 | 4.241 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.330296e-05 | 4.199 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.341062e-05 | 4.198 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.525579e-05 | 4.185 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.957957e-05 | 4.158 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.473902e-05 | 4.126 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.587109e-05 | 4.120 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.587109e-05 | 4.120 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.609707e-05 | 4.119 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.002694e-05 | 4.097 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.609921e-05 | 4.065 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.713336e-05 | 4.013 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.308713e-05 | 4.031 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.969326e-05 | 4.001 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.009909e-04 | 3.996 | 1 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.024019e-04 | 3.990 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.026703e-04 | 3.989 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.061909e-04 | 3.974 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.064717e-04 | 3.973 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.168491e-04 | 3.932 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.292448e-04 | 3.889 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.296087e-04 | 3.887 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.437492e-04 | 3.842 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.462693e-04 | 3.835 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.476646e-04 | 3.831 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.518198e-04 | 3.819 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.554785e-04 | 3.808 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.636356e-04 | 3.786 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.856102e-04 | 3.731 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.669835e-04 | 3.777 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.666258e-04 | 3.778 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.794275e-04 | 3.746 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.742497e-04 | 3.759 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.813132e-04 | 3.742 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.862391e-04 | 3.730 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.862391e-04 | 3.730 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.862391e-04 | 3.730 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.924859e-04 | 3.716 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.003450e-04 | 3.698 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.080236e-04 | 3.682 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.148163e-04 | 3.668 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.151230e-04 | 3.667 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.375692e-04 | 3.624 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.412549e-04 | 3.618 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.478470e-04 | 3.606 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.497215e-04 | 3.603 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.526977e-04 | 3.597 | 1 | 1 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.526977e-04 | 3.597 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.526977e-04 | 3.597 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.526977e-04 | 3.597 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.073898e-04 | 3.512 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.877587e-04 | 3.541 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.732265e-04 | 3.563 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.710270e-04 | 3.567 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.039480e-04 | 3.517 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.818814e-04 | 3.550 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.073898e-04 | 3.512 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.039480e-04 | 3.517 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.609052e-04 | 3.443 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.704605e-04 | 3.431 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.810396e-04 | 3.419 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.050319e-04 | 3.393 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.228458e-04 | 3.374 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.238001e-04 | 3.373 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.338034e-04 | 3.363 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.428744e-04 | 3.354 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.488796e-04 | 3.348 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.676652e-04 | 3.330 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.982878e-04 | 3.303 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.174958e-04 | 3.286 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.291657e-04 | 3.276 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.291657e-04 | 3.276 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.341185e-04 | 3.272 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.408468e-04 | 3.267 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.088454e-04 | 3.215 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.384247e-04 | 3.195 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.455441e-04 | 3.190 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.481552e-04 | 3.188 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.504155e-04 | 3.187 | 1 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 7.373260e-04 | 3.132 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.727547e-04 | 3.112 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.004720e-04 | 3.097 | 1 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.585470e-04 | 3.120 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.004720e-04 | 3.097 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.881186e-04 | 3.103 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.916289e-04 | 3.101 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.138043e-04 | 3.146 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.135125e-04 | 3.147 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.648597e-04 | 3.116 | 1 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.080405e-04 | 3.093 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.183365e-04 | 3.087 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.664079e-04 | 3.062 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.664079e-04 | 3.062 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.713211e-04 | 3.060 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.167563e-04 | 3.038 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.000575e-03 | 3.000 | 1 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.002930e-03 | 2.999 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.002930e-03 | 2.999 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.005473e-03 | 2.998 | 1 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.005473e-03 | 2.998 | 1 | 1 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.005473e-03 | 2.998 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.051152e-03 | 2.978 | 1 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.069532e-03 | 2.971 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.085199e-03 | 2.964 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.103452e-03 | 2.957 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.156824e-03 | 2.937 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.172159e-03 | 2.931 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.288663e-03 | 2.890 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.348366e-03 | 2.870 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.422396e-03 | 2.847 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.474593e-03 | 2.831 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.474593e-03 | 2.831 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.489011e-03 | 2.827 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.513168e-03 | 2.820 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.543185e-03 | 2.812 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.585949e-03 | 2.800 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.604105e-03 | 2.795 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.778886e-03 | 2.750 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.778886e-03 | 2.750 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.778886e-03 | 2.750 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.734801e-03 | 2.761 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.734801e-03 | 2.761 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.734801e-03 | 2.761 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.734801e-03 | 2.761 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.955355e-03 | 2.709 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.785795e-03 | 2.748 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.770323e-03 | 2.752 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.085071e-03 | 2.681 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.086604e-03 | 2.681 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.145001e-03 | 2.669 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.166006e-03 | 2.664 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.247630e-03 | 2.648 | 1 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.261825e-03 | 2.646 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.472140e-03 | 2.607 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.505421e-03 | 2.601 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.576341e-03 | 2.589 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.630374e-03 | 2.580 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.630374e-03 | 2.580 | 1 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.630845e-03 | 2.580 | 1 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.647875e-03 | 2.577 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.828110e-03 | 2.549 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.918951e-03 | 2.535 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.941377e-03 | 2.531 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.944087e-03 | 2.531 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.105362e-03 | 2.508 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.253525e-03 | 2.488 | 1 | 1 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.361117e-03 | 2.474 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.511178e-03 | 2.455 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.618436e-03 | 2.441 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.618436e-03 | 2.441 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.640127e-03 | 2.439 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.656683e-03 | 2.437 | 1 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.841091e-03 | 2.416 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.079176e-03 | 2.389 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.079176e-03 | 2.389 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.084550e-03 | 2.389 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.242778e-03 | 2.372 | 1 | 1 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.242778e-03 | 2.372 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.331460e-03 | 2.363 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.331460e-03 | 2.363 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.331460e-03 | 2.363 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.331460e-03 | 2.363 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.331460e-03 | 2.363 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.331460e-03 | 2.363 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.331460e-03 | 2.363 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.331460e-03 | 2.363 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.331460e-03 | 2.363 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.331460e-03 | 2.363 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.331460e-03 | 2.363 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.342379e-03 | 2.362 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.380601e-03 | 2.358 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.494539e-03 | 2.347 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.566760e-03 | 2.340 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.566760e-03 | 2.340 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.780371e-03 | 2.321 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.616700e-03 | 2.251 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.616700e-03 | 2.251 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.864541e-03 | 2.232 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.780371e-03 | 2.321 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.908339e-03 | 2.309 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.908339e-03 | 2.309 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.908339e-03 | 2.309 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.014300e-03 | 2.300 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.780350e-03 | 2.238 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.922015e-03 | 2.308 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.545466e-03 | 2.256 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.895493e-03 | 2.229 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.255831e-03 | 2.204 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.456301e-03 | 2.190 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.576855e-03 | 2.182 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.649401e-03 | 2.177 | 1 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.702797e-03 | 2.174 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.837516e-03 | 2.165 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.945240e-03 | 2.158 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.769978e-03 | 2.110 | 1 | 1 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.803150e-03 | 2.108 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.803150e-03 | 2.108 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 7.975712e-03 | 2.098 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.124965e-03 | 2.090 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.189626e-03 | 2.087 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.189626e-03 | 2.087 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.595899e-03 | 2.066 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.836586e-03 | 2.054 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.961928e-03 | 2.048 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.996561e-03 | 2.046 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 9.143346e-03 | 2.039 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.582905e-03 | 2.019 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.613022e-03 | 2.017 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.867421e-03 | 2.006 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.872702e-03 | 2.006 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.010213e-02 | 1.996 | 1 | 1 |
| Deubiquitination | R-HSA-5688426 | 1.031471e-02 | 1.987 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.081863e-02 | 1.966 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.100128e-02 | 1.959 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.154381e-02 | 1.938 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.156983e-02 | 1.937 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.156983e-02 | 1.937 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.156983e-02 | 1.937 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.156983e-02 | 1.937 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.156983e-02 | 1.937 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.156983e-02 | 1.937 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.156983e-02 | 1.937 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.189472e-02 | 1.925 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.189472e-02 | 1.925 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.193320e-02 | 1.923 | 1 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.234039e-02 | 1.909 | 1 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.256260e-02 | 1.901 | 1 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.258079e-02 | 1.900 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.272595e-02 | 1.895 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.282695e-02 | 1.892 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.299656e-02 | 1.886 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.299656e-02 | 1.886 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.299656e-02 | 1.886 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.299656e-02 | 1.886 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.337344e-02 | 1.874 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.360124e-02 | 1.866 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.397655e-02 | 1.855 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.439365e-02 | 1.842 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.439365e-02 | 1.842 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.452981e-02 | 1.838 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.455410e-02 | 1.837 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.455410e-02 | 1.837 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.592078e-02 | 1.798 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.600939e-02 | 1.796 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.600939e-02 | 1.796 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.605134e-02 | 1.794 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.669060e-02 | 1.778 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.674860e-02 | 1.776 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.674860e-02 | 1.776 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.695860e-02 | 1.771 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.709745e-02 | 1.767 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.733654e-02 | 1.761 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.740062e-02 | 1.759 | 1 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.946686e-02 | 1.711 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.946686e-02 | 1.711 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.168848e-02 | 1.664 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.967805e-02 | 1.706 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.967805e-02 | 1.706 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.967805e-02 | 1.706 | 1 | 1 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.862185e-02 | 1.730 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.862185e-02 | 1.730 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.152658e-02 | 1.667 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.946686e-02 | 1.711 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.168848e-02 | 1.664 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.988174e-02 | 1.702 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.865906e-02 | 1.729 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.942616e-02 | 1.712 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.808946e-02 | 1.743 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.146792e-02 | 1.668 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.044032e-02 | 1.690 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.946686e-02 | 1.711 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.862185e-02 | 1.730 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.138341e-02 | 1.670 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.168848e-02 | 1.664 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.074145e-02 | 1.683 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.323224e-02 | 1.634 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.793996e-02 | 1.746 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.323224e-02 | 1.634 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.389501e-02 | 1.622 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.455985e-02 | 1.610 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.460228e-02 | 1.609 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.460228e-02 | 1.609 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.468709e-02 | 1.608 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.468709e-02 | 1.608 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.468709e-02 | 1.608 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.470046e-02 | 1.607 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.470046e-02 | 1.607 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.546094e-02 | 1.594 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.546094e-02 | 1.594 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.554533e-02 | 1.593 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.601575e-02 | 1.585 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.710443e-02 | 1.567 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.719353e-02 | 1.566 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.741647e-02 | 1.562 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.741647e-02 | 1.562 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.773535e-02 | 1.557 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.803676e-02 | 1.552 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.848963e-02 | 1.545 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.861087e-02 | 1.543 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.934823e-02 | 1.532 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.091977e-02 | 1.510 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.100584e-02 | 1.509 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.100584e-02 | 1.509 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.130444e-02 | 1.504 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.139681e-02 | 1.503 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.275024e-02 | 1.485 | 1 | 1 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.347075e-02 | 1.475 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.383383e-02 | 1.471 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.383383e-02 | 1.471 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.400059e-02 | 1.469 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.459292e-02 | 1.461 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.594920e-02 | 1.444 | 1 | 1 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.609017e-02 | 1.443 | 1 | 1 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.616842e-02 | 1.442 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.668058e-02 | 1.436 | 1 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.668058e-02 | 1.436 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.684032e-02 | 1.434 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.684032e-02 | 1.434 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.721246e-02 | 1.429 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.739774e-02 | 1.427 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.739774e-02 | 1.427 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.739774e-02 | 1.427 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.792277e-02 | 1.421 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.926552e-02 | 1.406 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.966073e-02 | 1.402 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.024407e-02 | 1.395 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.024407e-02 | 1.395 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.140637e-02 | 1.383 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.168087e-02 | 1.380 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.168087e-02 | 1.380 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.168087e-02 | 1.380 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.168087e-02 | 1.380 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 4.168087e-02 | 1.380 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.168087e-02 | 1.380 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.183404e-02 | 1.378 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.251541e-02 | 1.371 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.272971e-02 | 1.369 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.296054e-02 | 1.367 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.345371e-02 | 1.362 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.373102e-02 | 1.359 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.373102e-02 | 1.359 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.606112e-02 | 1.337 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.606112e-02 | 1.337 | 1 | 1 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.650837e-02 | 1.332 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.689212e-02 | 1.329 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.770523e-02 | 1.321 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.770523e-02 | 1.321 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.770523e-02 | 1.321 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.792160e-02 | 1.319 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.814297e-02 | 1.317 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.865964e-02 | 1.313 | 1 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 6.184026e-02 | 1.209 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 6.184026e-02 | 1.209 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.995583e-02 | 1.222 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.995583e-02 | 1.222 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.351958e-02 | 1.134 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.351958e-02 | 1.134 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.351958e-02 | 1.134 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.965225e-02 | 1.304 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.873278e-02 | 1.231 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.863485e-02 | 1.163 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.060111e-02 | 1.218 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.060111e-02 | 1.218 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.874060e-02 | 1.163 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.286756e-02 | 1.137 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.628139e-02 | 1.250 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.628139e-02 | 1.250 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.104821e-02 | 1.214 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.130943e-02 | 1.212 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.286756e-02 | 1.137 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.873278e-02 | 1.231 | 1 | 1 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.863485e-02 | 1.163 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.995583e-02 | 1.222 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.527762e-02 | 1.257 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.628139e-02 | 1.250 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.351958e-02 | 1.134 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.727721e-02 | 1.172 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.214422e-02 | 1.142 | 1 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.174241e-02 | 1.209 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.650179e-02 | 1.248 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.737763e-02 | 1.241 | 1 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.561603e-02 | 1.183 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.759998e-02 | 1.240 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.194157e-02 | 1.284 | 1 | 0 |
| Protein methylation | R-HSA-8876725 | 6.863485e-02 | 1.163 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.005224e-02 | 1.301 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.351958e-02 | 1.134 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.863485e-02 | 1.163 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.351958e-02 | 1.134 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.873278e-02 | 1.231 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.245450e-02 | 1.140 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.995583e-02 | 1.222 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.873278e-02 | 1.231 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.924299e-02 | 1.308 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.151804e-02 | 1.288 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.874060e-02 | 1.163 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.432496e-02 | 1.192 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.908033e-02 | 1.309 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.962596e-02 | 1.225 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.386630e-02 | 1.132 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.386630e-02 | 1.132 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.685734e-02 | 1.114 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 7.710147e-02 | 1.113 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 7.710147e-02 | 1.113 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 7.710147e-02 | 1.113 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 7.710147e-02 | 1.113 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 7.710147e-02 | 1.113 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 7.710147e-02 | 1.113 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 7.710147e-02 | 1.113 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 7.710147e-02 | 1.113 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 7.710147e-02 | 1.113 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 7.710147e-02 | 1.113 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 7.710147e-02 | 1.113 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.710147e-02 | 1.113 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 7.710147e-02 | 1.113 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 7.710147e-02 | 1.113 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 7.710147e-02 | 1.113 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 7.710147e-02 | 1.113 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 7.710147e-02 | 1.113 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.745365e-02 | 1.111 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.745365e-02 | 1.111 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.745365e-02 | 1.111 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.933842e-02 | 1.101 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.933842e-02 | 1.101 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.933842e-02 | 1.101 | 1 | 1 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.953370e-02 | 1.099 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.055864e-02 | 1.094 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.055864e-02 | 1.094 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.070641e-02 | 1.093 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.074392e-02 | 1.093 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.390914e-02 | 1.076 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 8.458825e-02 | 1.073 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.458825e-02 | 1.073 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 8.458825e-02 | 1.073 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 8.458825e-02 | 1.073 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.673142e-02 | 1.062 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.673142e-02 | 1.062 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.790014e-02 | 1.056 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.790014e-02 | 1.056 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.831109e-02 | 1.054 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.831109e-02 | 1.054 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.831109e-02 | 1.054 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.831109e-02 | 1.054 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 8.831109e-02 | 1.054 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.831109e-02 | 1.054 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.868530e-02 | 1.052 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.868530e-02 | 1.052 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.868530e-02 | 1.052 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.032134e-02 | 1.044 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.081734e-02 | 1.042 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 9.081734e-02 | 1.042 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.542980e-02 | 1.020 | 1 | 1 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.544477e-02 | 1.020 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.621345e-02 | 1.017 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.656191e-02 | 1.015 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 9.724171e-02 | 1.012 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.724171e-02 | 1.012 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.741543e-02 | 1.011 | 1 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.741543e-02 | 1.011 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.005150e-01 | 0.998 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.022877e-01 | 0.990 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.023270e-01 | 0.990 | 1 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.030401e-01 | 0.987 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.040346e-01 | 0.983 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.042357e-01 | 0.982 | 1 | 1 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.042357e-01 | 0.982 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.042357e-01 | 0.982 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.042357e-01 | 0.982 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.057611e-01 | 0.976 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.057611e-01 | 0.976 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.057611e-01 | 0.976 | 1 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.062202e-01 | 0.974 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.066956e-01 | 0.972 | 1 | 1 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.082767e-01 | 0.965 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.086606e-01 | 0.964 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.091346e-01 | 0.962 | 1 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.094065e-01 | 0.961 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.094065e-01 | 0.961 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.094065e-01 | 0.961 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.094065e-01 | 0.961 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.094065e-01 | 0.961 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.115698e-01 | 0.952 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.142873e-01 | 0.942 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.142873e-01 | 0.942 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.142873e-01 | 0.942 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.143814e-01 | 0.942 | 1 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.156114e-01 | 0.937 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.156114e-01 | 0.937 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.156114e-01 | 0.937 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.156114e-01 | 0.937 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.156114e-01 | 0.937 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.159705e-01 | 0.936 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.159705e-01 | 0.936 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.159705e-01 | 0.936 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.159705e-01 | 0.936 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.159705e-01 | 0.936 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.178188e-01 | 0.929 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.211926e-01 | 0.917 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.221622e-01 | 0.913 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.482626e-01 | 0.829 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.482626e-01 | 0.829 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.482626e-01 | 0.829 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.482626e-01 | 0.829 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.482626e-01 | 0.829 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.482626e-01 | 0.829 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 1.482626e-01 | 0.829 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.482626e-01 | 0.829 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.139406e-01 | 0.670 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.139406e-01 | 0.670 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.139406e-01 | 0.670 | 1 | 1 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.139406e-01 | 0.670 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.139406e-01 | 0.670 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.139406e-01 | 0.670 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.139406e-01 | 0.670 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.139406e-01 | 0.670 | 1 | 1 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.139406e-01 | 0.670 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.139406e-01 | 0.670 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.358411e-01 | 0.867 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.358411e-01 | 0.867 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.358411e-01 | 0.867 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.634956e-01 | 0.786 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.920253e-01 | 0.717 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.390773e-01 | 0.857 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.211311e-01 | 0.655 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.211311e-01 | 0.655 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.211311e-01 | 0.655 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.211311e-01 | 0.655 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.211311e-01 | 0.655 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.295687e-01 | 0.887 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.505548e-01 | 0.601 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.505548e-01 | 0.601 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 2.505548e-01 | 0.601 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 2.505548e-01 | 0.601 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.505548e-01 | 0.601 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.972407e-01 | 0.705 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.292077e-01 | 0.889 | 1 | 1 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.292077e-01 | 0.889 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.177854e-01 | 0.662 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.177854e-01 | 0.662 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.177854e-01 | 0.662 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.739270e-01 | 0.760 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.897434e-01 | 0.722 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.387429e-01 | 0.622 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.792976e-01 | 0.746 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.477814e-01 | 0.830 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.477814e-01 | 0.830 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.576097e-01 | 0.802 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.208771e-01 | 0.656 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.289638e-01 | 0.890 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.655827e-01 | 0.781 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.361569e-01 | 0.866 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.164558e-01 | 0.665 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.108464e-01 | 0.676 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.222213e-01 | 0.653 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.222213e-01 | 0.653 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.510388e-01 | 0.821 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.455851e-01 | 0.610 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.534166e-01 | 0.814 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.271734e-01 | 0.896 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.395940e-01 | 0.621 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.799129e-01 | 0.745 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.505548e-01 | 0.601 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.585935e-01 | 0.800 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.661461e-01 | 0.780 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.461441e-01 | 0.835 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.208771e-01 | 0.656 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.983974e-01 | 0.702 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.211311e-01 | 0.655 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.577838e-01 | 0.802 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.066924e-01 | 0.685 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.500706e-01 | 0.602 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.772063e-01 | 0.752 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.505548e-01 | 0.601 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.254043e-01 | 0.902 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.897434e-01 | 0.722 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.540949e-01 | 0.812 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.390773e-01 | 0.857 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.390773e-01 | 0.857 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 1.577838e-01 | 0.802 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.355865e-01 | 0.868 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.792976e-01 | 0.746 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.303154e-01 | 0.885 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.701153e-01 | 0.769 | 1 | 1 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.883615e-01 | 0.725 | 1 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.847020e-01 | 0.734 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.847020e-01 | 0.734 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.847020e-01 | 0.734 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.847020e-01 | 0.734 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.883615e-01 | 0.725 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.097958e-01 | 0.678 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.097958e-01 | 0.678 | 1 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.920253e-01 | 0.717 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.505548e-01 | 0.601 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.387429e-01 | 0.622 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.918105e-01 | 0.717 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.208771e-01 | 0.656 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.174760e-01 | 0.663 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.799129e-01 | 0.745 | 1 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.799129e-01 | 0.745 | 1 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.577838e-01 | 0.802 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.625381e-01 | 0.789 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.435573e-01 | 0.843 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.949692e-01 | 0.710 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.390773e-01 | 0.857 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.390773e-01 | 0.857 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.390773e-01 | 0.857 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.353466e-01 | 0.628 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.634956e-01 | 0.786 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.474321e-01 | 0.831 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.291639e-01 | 0.640 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.946021e-01 | 0.711 | 1 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.949692e-01 | 0.710 | 1 | 1 |
| Opioid Signalling | R-HSA-111885 | 2.188913e-01 | 0.660 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.226266e-01 | 0.652 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.482626e-01 | 0.829 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.139406e-01 | 0.670 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.920253e-01 | 0.717 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.390773e-01 | 0.857 | 1 | 1 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.390773e-01 | 0.857 | 1 | 1 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.211311e-01 | 0.655 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.772063e-01 | 0.752 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.177854e-01 | 0.662 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.387429e-01 | 0.622 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.585935e-01 | 0.800 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.847020e-01 | 0.734 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.368207e-01 | 0.864 | 1 | 0 |
| Heme signaling | R-HSA-9707616 | 2.047161e-01 | 0.689 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.290362e-01 | 0.889 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.387429e-01 | 0.622 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.295687e-01 | 0.887 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.624801e-01 | 0.789 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.952341e-01 | 0.709 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.047161e-01 | 0.689 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.279195e-01 | 0.642 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.400725e-01 | 0.854 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.358411e-01 | 0.867 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.634956e-01 | 0.786 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.920253e-01 | 0.717 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.505548e-01 | 0.601 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.066924e-01 | 0.685 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.996957e-01 | 0.700 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.533961e-01 | 0.814 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.781228e-01 | 0.749 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.158740e-01 | 0.666 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.923213e-01 | 0.716 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.799129e-01 | 0.745 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.799129e-01 | 0.745 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 1.295687e-01 | 0.887 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.187211e-01 | 0.660 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.358411e-01 | 0.867 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.177854e-01 | 0.662 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.387429e-01 | 0.622 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.361569e-01 | 0.866 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.302591e-01 | 0.885 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.255436e-01 | 0.647 | 1 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.897434e-01 | 0.722 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.814594e-01 | 0.741 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.421018e-01 | 0.616 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.376453e-01 | 0.624 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.358411e-01 | 0.867 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.920253e-01 | 0.717 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.920253e-01 | 0.717 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.792976e-01 | 0.746 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.469568e-01 | 0.833 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.291639e-01 | 0.640 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.669611e-01 | 0.777 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.421018e-01 | 0.616 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.358411e-01 | 0.867 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.358411e-01 | 0.867 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.505548e-01 | 0.601 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.505548e-01 | 0.601 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.814736e-01 | 0.741 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.211311e-01 | 0.655 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.533961e-01 | 0.814 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.303154e-01 | 0.885 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.330403e-01 | 0.876 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.478320e-01 | 0.830 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.505548e-01 | 0.601 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.939192e-01 | 0.712 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.552490e-01 | 0.593 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.552490e-01 | 0.593 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.568461e-01 | 0.590 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.568461e-01 | 0.590 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.575440e-01 | 0.589 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.575440e-01 | 0.589 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.575986e-01 | 0.589 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.575986e-01 | 0.589 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.584993e-01 | 0.588 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.584993e-01 | 0.588 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.600195e-01 | 0.585 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.600195e-01 | 0.585 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.637997e-01 | 0.579 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.650189e-01 | 0.577 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.650189e-01 | 0.577 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.650189e-01 | 0.577 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 2.682924e-01 | 0.571 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.685844e-01 | 0.571 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.692846e-01 | 0.570 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.696669e-01 | 0.569 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.712593e-01 | 0.567 | 1 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 2.743349e-01 | 0.562 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.743349e-01 | 0.562 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.743349e-01 | 0.562 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 2.745578e-01 | 0.561 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.745578e-01 | 0.561 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.745578e-01 | 0.561 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.745578e-01 | 0.561 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.745578e-01 | 0.561 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.759409e-01 | 0.559 | 1 | 1 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.800746e-01 | 0.553 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.800746e-01 | 0.553 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 2.800746e-01 | 0.553 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.800746e-01 | 0.553 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.800746e-01 | 0.553 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.800746e-01 | 0.553 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.800746e-01 | 0.553 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.801612e-01 | 0.553 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.815267e-01 | 0.550 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.815267e-01 | 0.550 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.815267e-01 | 0.550 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.815267e-01 | 0.550 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.820871e-01 | 0.550 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.858976e-01 | 0.544 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.891223e-01 | 0.539 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.920109e-01 | 0.535 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.920109e-01 | 0.535 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.920109e-01 | 0.535 | 1 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.920130e-01 | 0.535 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.920130e-01 | 0.535 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.920130e-01 | 0.535 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.920130e-01 | 0.535 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.920130e-01 | 0.535 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.957361e-01 | 0.529 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.963752e-01 | 0.528 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.969720e-01 | 0.527 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.975338e-01 | 0.526 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.031812e-01 | 0.518 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.031812e-01 | 0.518 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.031812e-01 | 0.518 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.031812e-01 | 0.518 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.035458e-01 | 0.518 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.035458e-01 | 0.518 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.095008e-01 | 0.509 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.095008e-01 | 0.509 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.095008e-01 | 0.509 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.095008e-01 | 0.509 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.095106e-01 | 0.509 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.095106e-01 | 0.509 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.095106e-01 | 0.509 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.098347e-01 | 0.509 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.098347e-01 | 0.509 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.098347e-01 | 0.509 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.109081e-01 | 0.507 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.109081e-01 | 0.507 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.109081e-01 | 0.507 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 3.202638e-01 | 0.494 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.233899e-01 | 0.490 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.249048e-01 | 0.488 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.249048e-01 | 0.488 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.249048e-01 | 0.488 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.249048e-01 | 0.488 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.249048e-01 | 0.488 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.249048e-01 | 0.488 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.249048e-01 | 0.488 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.249048e-01 | 0.488 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.264544e-01 | 0.486 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.264544e-01 | 0.486 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.264544e-01 | 0.486 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.264544e-01 | 0.486 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.264544e-01 | 0.486 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.264544e-01 | 0.486 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.277559e-01 | 0.484 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.277559e-01 | 0.484 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.305038e-01 | 0.481 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.305038e-01 | 0.481 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 3.305038e-01 | 0.481 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.305038e-01 | 0.481 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.305038e-01 | 0.481 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.305038e-01 | 0.481 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.305038e-01 | 0.481 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 3.305038e-01 | 0.481 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.305038e-01 | 0.481 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.305038e-01 | 0.481 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.305038e-01 | 0.481 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.305038e-01 | 0.481 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.305038e-01 | 0.481 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.305038e-01 | 0.481 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.305038e-01 | 0.481 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 3.321997e-01 | 0.479 | 0 | 0 |
| Translation | R-HSA-72766 | 3.349164e-01 | 0.475 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.379805e-01 | 0.471 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 3.386725e-01 | 0.470 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.386725e-01 | 0.470 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.386725e-01 | 0.470 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.386725e-01 | 0.470 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.406746e-01 | 0.468 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.420779e-01 | 0.466 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.420779e-01 | 0.466 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.420779e-01 | 0.466 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.420779e-01 | 0.466 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.420779e-01 | 0.466 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.421850e-01 | 0.466 | 1 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.433535e-01 | 0.464 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.436161e-01 | 0.464 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.457342e-01 | 0.461 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.466251e-01 | 0.460 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.466251e-01 | 0.460 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.466251e-01 | 0.460 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.466251e-01 | 0.460 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.547193e-01 | 0.450 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.577511e-01 | 0.446 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.577511e-01 | 0.446 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.577511e-01 | 0.446 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.577511e-01 | 0.446 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.586715e-01 | 0.445 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.674541e-01 | 0.435 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.674541e-01 | 0.435 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.674541e-01 | 0.435 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.674541e-01 | 0.435 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.674541e-01 | 0.435 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 3.674541e-01 | 0.435 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 3.674541e-01 | 0.435 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 3.674541e-01 | 0.435 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.674541e-01 | 0.435 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.682753e-01 | 0.434 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.703572e-01 | 0.431 | 1 | 0 |
| Integrin signaling | R-HSA-354192 | 3.817020e-01 | 0.418 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.817020e-01 | 0.418 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 3.821383e-01 | 0.418 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 3.821383e-01 | 0.418 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.821383e-01 | 0.418 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 3.821383e-01 | 0.418 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.821383e-01 | 0.418 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 3.821383e-01 | 0.418 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.821383e-01 | 0.418 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.821383e-01 | 0.418 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 3.821383e-01 | 0.418 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.821383e-01 | 0.418 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.821383e-01 | 0.418 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.827825e-01 | 0.417 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.891410e-01 | 0.410 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.891410e-01 | 0.410 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.891410e-01 | 0.410 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.891410e-01 | 0.410 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.943934e-01 | 0.404 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.957324e-01 | 0.403 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.957324e-01 | 0.403 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 3.957324e-01 | 0.403 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 3.957324e-01 | 0.403 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.957324e-01 | 0.403 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 3.957324e-01 | 0.403 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.996167e-01 | 0.398 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.996167e-01 | 0.398 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.001545e-01 | 0.398 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.048073e-01 | 0.393 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.077503e-01 | 0.390 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.111256e-01 | 0.386 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.174389e-01 | 0.379 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.174389e-01 | 0.379 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.174389e-01 | 0.379 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.174389e-01 | 0.379 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.174389e-01 | 0.379 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.174389e-01 | 0.379 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.174389e-01 | 0.379 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.174389e-01 | 0.379 | 1 | 1 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.204228e-01 | 0.376 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.204228e-01 | 0.376 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.204228e-01 | 0.376 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.234139e-01 | 0.373 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.234139e-01 | 0.373 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.234139e-01 | 0.373 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.297934e-01 | 0.367 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.297934e-01 | 0.367 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 4.297934e-01 | 0.367 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.297934e-01 | 0.367 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.297934e-01 | 0.367 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.297934e-01 | 0.367 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.297934e-01 | 0.367 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.297934e-01 | 0.367 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.297934e-01 | 0.367 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 4.297934e-01 | 0.367 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.297934e-01 | 0.367 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.297934e-01 | 0.367 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.297934e-01 | 0.367 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.322193e-01 | 0.364 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.351366e-01 | 0.361 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.351366e-01 | 0.361 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.351366e-01 | 0.361 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.351366e-01 | 0.361 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.351366e-01 | 0.361 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.359649e-01 | 0.361 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.407671e-01 | 0.356 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.497905e-01 | 0.347 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.497905e-01 | 0.347 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.504225e-01 | 0.346 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.504225e-01 | 0.346 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.504225e-01 | 0.346 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 4.504225e-01 | 0.346 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.504225e-01 | 0.346 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.504225e-01 | 0.346 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.504225e-01 | 0.346 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.504225e-01 | 0.346 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.514123e-01 | 0.345 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.526800e-01 | 0.344 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.526800e-01 | 0.344 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.526800e-01 | 0.344 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.530299e-01 | 0.344 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.530299e-01 | 0.344 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.530299e-01 | 0.344 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.530299e-01 | 0.344 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.530299e-01 | 0.344 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.555484e-01 | 0.341 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.556855e-01 | 0.341 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.667448e-01 | 0.331 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.667448e-01 | 0.331 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.700415e-01 | 0.328 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.700415e-01 | 0.328 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.700415e-01 | 0.328 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.700415e-01 | 0.328 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.735168e-01 | 0.325 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.735168e-01 | 0.325 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.735168e-01 | 0.325 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.735168e-01 | 0.325 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.735168e-01 | 0.325 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.735168e-01 | 0.325 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.737756e-01 | 0.324 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.737756e-01 | 0.324 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.737756e-01 | 0.324 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.737756e-01 | 0.324 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.737756e-01 | 0.324 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 4.737756e-01 | 0.324 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.737756e-01 | 0.324 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.737756e-01 | 0.324 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 4.737756e-01 | 0.324 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 4.737756e-01 | 0.324 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 4.737756e-01 | 0.324 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.737756e-01 | 0.324 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 4.737756e-01 | 0.324 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 4.737756e-01 | 0.324 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 4.737756e-01 | 0.324 | 1 | 1 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.766974e-01 | 0.322 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.766974e-01 | 0.322 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.766974e-01 | 0.322 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.766974e-01 | 0.322 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.766974e-01 | 0.322 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.766974e-01 | 0.322 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.766974e-01 | 0.322 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 4.766974e-01 | 0.322 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 4.766974e-01 | 0.322 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.871956e-01 | 0.312 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.871956e-01 | 0.312 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.911379e-01 | 0.309 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.936445e-01 | 0.307 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 4.936445e-01 | 0.307 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.936445e-01 | 0.307 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.936445e-01 | 0.307 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.936445e-01 | 0.307 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.936445e-01 | 0.307 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.972924e-01 | 0.303 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.986726e-01 | 0.302 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.013477e-01 | 0.300 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.021912e-01 | 0.299 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.021912e-01 | 0.299 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.021912e-01 | 0.299 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.021912e-01 | 0.299 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.021912e-01 | 0.299 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.021912e-01 | 0.299 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 5.021912e-01 | 0.299 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.021912e-01 | 0.299 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.021912e-01 | 0.299 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.041191e-01 | 0.297 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.041191e-01 | 0.297 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.041191e-01 | 0.297 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.041191e-01 | 0.297 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.041191e-01 | 0.297 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.041191e-01 | 0.297 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.046993e-01 | 0.297 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.111141e-01 | 0.291 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.118692e-01 | 0.291 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.133816e-01 | 0.290 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.133816e-01 | 0.290 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.133816e-01 | 0.290 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.143676e-01 | 0.289 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.143676e-01 | 0.289 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.143676e-01 | 0.289 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.143676e-01 | 0.289 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.143676e-01 | 0.289 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.143676e-01 | 0.289 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.143676e-01 | 0.289 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.143676e-01 | 0.289 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.143676e-01 | 0.289 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.143676e-01 | 0.289 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.215479e-01 | 0.283 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.268679e-01 | 0.278 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.268679e-01 | 0.278 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.268679e-01 | 0.278 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.268679e-01 | 0.278 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.268679e-01 | 0.278 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.268679e-01 | 0.278 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.268679e-01 | 0.278 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.327012e-01 | 0.274 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.327012e-01 | 0.274 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.327012e-01 | 0.274 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.371916e-01 | 0.270 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.410618e-01 | 0.267 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.507021e-01 | 0.259 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.507021e-01 | 0.259 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.507021e-01 | 0.259 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.507021e-01 | 0.259 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.515803e-01 | 0.258 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.515803e-01 | 0.258 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.518307e-01 | 0.258 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.518307e-01 | 0.258 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.518307e-01 | 0.258 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.518307e-01 | 0.258 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.518307e-01 | 0.258 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.518307e-01 | 0.258 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.518307e-01 | 0.258 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.518307e-01 | 0.258 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.518307e-01 | 0.258 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.518307e-01 | 0.258 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.518307e-01 | 0.258 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.518307e-01 | 0.258 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.518307e-01 | 0.258 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.518307e-01 | 0.258 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.533043e-01 | 0.257 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.533043e-01 | 0.257 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.533043e-01 | 0.257 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.533043e-01 | 0.257 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.533043e-01 | 0.257 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.533043e-01 | 0.257 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.533043e-01 | 0.257 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.597004e-01 | 0.252 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.597004e-01 | 0.252 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 5.601340e-01 | 0.252 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.699995e-01 | 0.244 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.722038e-01 | 0.242 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.736768e-01 | 0.241 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.736768e-01 | 0.241 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.736768e-01 | 0.241 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.736768e-01 | 0.241 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.736768e-01 | 0.241 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.736768e-01 | 0.241 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.736768e-01 | 0.241 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.832427e-01 | 0.234 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.846643e-01 | 0.233 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.864058e-01 | 0.232 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 5.864058e-01 | 0.232 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 5.864058e-01 | 0.232 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.864058e-01 | 0.232 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 5.864058e-01 | 0.232 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 5.864058e-01 | 0.232 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.864058e-01 | 0.232 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 5.864058e-01 | 0.232 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.879429e-01 | 0.231 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.879429e-01 | 0.231 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.957827e-01 | 0.225 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.957827e-01 | 0.225 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.957827e-01 | 0.225 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 5.957827e-01 | 0.225 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.960053e-01 | 0.225 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.997716e-01 | 0.222 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.997716e-01 | 0.222 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 6.029780e-01 | 0.220 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.048386e-01 | 0.218 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.053979e-01 | 0.218 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.053979e-01 | 0.218 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.092823e-01 | 0.215 | 1 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.101654e-01 | 0.215 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.143806e-01 | 0.212 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.145983e-01 | 0.211 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.145983e-01 | 0.211 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.145983e-01 | 0.211 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.170173e-01 | 0.210 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.170173e-01 | 0.210 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.170173e-01 | 0.210 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.183155e-01 | 0.209 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.183155e-01 | 0.209 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.183155e-01 | 0.209 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.183155e-01 | 0.209 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.183155e-01 | 0.209 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.183155e-01 | 0.209 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.183155e-01 | 0.209 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.183155e-01 | 0.209 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.183155e-01 | 0.209 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.183155e-01 | 0.209 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.195511e-01 | 0.208 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.214758e-01 | 0.207 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.214758e-01 | 0.207 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.223549e-01 | 0.206 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.232414e-01 | 0.205 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.259919e-01 | 0.203 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.290786e-01 | 0.201 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.290786e-01 | 0.201 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.290786e-01 | 0.201 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.290786e-01 | 0.201 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 6.360515e-01 | 0.197 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.360515e-01 | 0.197 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.373833e-01 | 0.196 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.373833e-01 | 0.196 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.373833e-01 | 0.196 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.373833e-01 | 0.196 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.388068e-01 | 0.195 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.388068e-01 | 0.195 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 6.477650e-01 | 0.189 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.477650e-01 | 0.189 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.477650e-01 | 0.189 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.477650e-01 | 0.189 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.477650e-01 | 0.189 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.477650e-01 | 0.189 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.477650e-01 | 0.189 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.477650e-01 | 0.189 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.477650e-01 | 0.189 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.477650e-01 | 0.189 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.477650e-01 | 0.189 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.477650e-01 | 0.189 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.477650e-01 | 0.189 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.477650e-01 | 0.189 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.568884e-01 | 0.183 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.568884e-01 | 0.183 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.568884e-01 | 0.183 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.569743e-01 | 0.182 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.749439e-01 | 0.171 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.749439e-01 | 0.171 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.749439e-01 | 0.171 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.749439e-01 | 0.171 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 6.749439e-01 | 0.171 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 6.749439e-01 | 0.171 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.749439e-01 | 0.171 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 6.749439e-01 | 0.171 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 6.749439e-01 | 0.171 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.749439e-01 | 0.171 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 6.749439e-01 | 0.171 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.749439e-01 | 0.171 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.749439e-01 | 0.171 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.755441e-01 | 0.170 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.755441e-01 | 0.170 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.755441e-01 | 0.170 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.755441e-01 | 0.170 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.763407e-01 | 0.170 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.834208e-01 | 0.165 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.870170e-01 | 0.163 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.906012e-01 | 0.161 | 1 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 6.933654e-01 | 0.159 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.933654e-01 | 0.159 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.933654e-01 | 0.159 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.933654e-01 | 0.159 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.959446e-01 | 0.157 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.995063e-01 | 0.155 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 6.995063e-01 | 0.155 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.000272e-01 | 0.155 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.000272e-01 | 0.155 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.000272e-01 | 0.155 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.000272e-01 | 0.155 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.000272e-01 | 0.155 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.000272e-01 | 0.155 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.000272e-01 | 0.155 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.000272e-01 | 0.155 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.000272e-01 | 0.155 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.000272e-01 | 0.155 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.000272e-01 | 0.155 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.004815e-01 | 0.155 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.084005e-01 | 0.150 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.103699e-01 | 0.149 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.132739e-01 | 0.147 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.132739e-01 | 0.147 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.132739e-01 | 0.147 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.186300e-01 | 0.143 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.203396e-01 | 0.142 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.231762e-01 | 0.141 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.231762e-01 | 0.141 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 7.231762e-01 | 0.141 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 7.231762e-01 | 0.141 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.231762e-01 | 0.141 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.231762e-01 | 0.141 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.231762e-01 | 0.141 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.231762e-01 | 0.141 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.231762e-01 | 0.141 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.231762e-01 | 0.141 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.231762e-01 | 0.141 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.231762e-01 | 0.141 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.231762e-01 | 0.141 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.231762e-01 | 0.141 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.231762e-01 | 0.141 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.231762e-01 | 0.141 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.231762e-01 | 0.141 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.231762e-01 | 0.141 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.231762e-01 | 0.141 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.231762e-01 | 0.141 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.231762e-01 | 0.141 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.252947e-01 | 0.139 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.265775e-01 | 0.139 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.265775e-01 | 0.139 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.268067e-01 | 0.139 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.397097e-01 | 0.131 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.420100e-01 | 0.130 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.445401e-01 | 0.128 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.445401e-01 | 0.128 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.445401e-01 | 0.128 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.445401e-01 | 0.128 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.445401e-01 | 0.128 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.445401e-01 | 0.128 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.445401e-01 | 0.128 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.494336e-01 | 0.125 | 1 | 1 |
| Innate Immune System | R-HSA-168249 | 7.507084e-01 | 0.125 | 1 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.521240e-01 | 0.124 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.521240e-01 | 0.124 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.521240e-01 | 0.124 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.566903e-01 | 0.121 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.566903e-01 | 0.121 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.583809e-01 | 0.120 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.642564e-01 | 0.117 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.642564e-01 | 0.117 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.642564e-01 | 0.117 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.642564e-01 | 0.117 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.642564e-01 | 0.117 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.642564e-01 | 0.117 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.642564e-01 | 0.117 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.642564e-01 | 0.117 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.642564e-01 | 0.117 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.642564e-01 | 0.117 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.642564e-01 | 0.117 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.644656e-01 | 0.117 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.684400e-01 | 0.114 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.699622e-01 | 0.114 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.706427e-01 | 0.113 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.706427e-01 | 0.113 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.706427e-01 | 0.113 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 7.724697e-01 | 0.112 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.738660e-01 | 0.111 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.807840e-01 | 0.107 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.824522e-01 | 0.107 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.824522e-01 | 0.107 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.824522e-01 | 0.107 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.824522e-01 | 0.107 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.824522e-01 | 0.107 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.824522e-01 | 0.107 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.824522e-01 | 0.107 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.824522e-01 | 0.107 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.824522e-01 | 0.107 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.838920e-01 | 0.106 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.838920e-01 | 0.106 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.843996e-01 | 0.105 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.857580e-01 | 0.105 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.865218e-01 | 0.104 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.958035e-01 | 0.099 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.964636e-01 | 0.099 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.964636e-01 | 0.099 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.970722e-01 | 0.099 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.970722e-01 | 0.099 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.992444e-01 | 0.097 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.992444e-01 | 0.097 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 7.992444e-01 | 0.097 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 7.992444e-01 | 0.097 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.992444e-01 | 0.097 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.992444e-01 | 0.097 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.992444e-01 | 0.097 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 7.992444e-01 | 0.097 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 7.992444e-01 | 0.097 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.029662e-01 | 0.095 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.029662e-01 | 0.095 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.071829e-01 | 0.093 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.083832e-01 | 0.092 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.083832e-01 | 0.092 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.117518e-01 | 0.091 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.147415e-01 | 0.089 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.147415e-01 | 0.089 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.147415e-01 | 0.089 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.147415e-01 | 0.089 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.147415e-01 | 0.089 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.184350e-01 | 0.087 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.196765e-01 | 0.086 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.196765e-01 | 0.086 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.196765e-01 | 0.086 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.258911e-01 | 0.083 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.261316e-01 | 0.083 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.283604e-01 | 0.082 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.283604e-01 | 0.082 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.290431e-01 | 0.081 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.290431e-01 | 0.081 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.290431e-01 | 0.081 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.290431e-01 | 0.081 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.290431e-01 | 0.081 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.290431e-01 | 0.081 | 1 | 1 |
| Choline catabolism | R-HSA-6798163 | 8.290431e-01 | 0.081 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.290431e-01 | 0.081 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.303690e-01 | 0.081 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.303690e-01 | 0.081 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.361975e-01 | 0.078 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.391749e-01 | 0.076 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.404863e-01 | 0.075 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.404863e-01 | 0.075 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.422414e-01 | 0.075 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.422414e-01 | 0.075 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.422414e-01 | 0.075 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.422414e-01 | 0.075 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.422414e-01 | 0.075 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.422414e-01 | 0.075 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.422414e-01 | 0.075 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.434635e-01 | 0.074 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.455928e-01 | 0.073 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.500534e-01 | 0.071 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.500534e-01 | 0.071 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.500534e-01 | 0.071 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.500534e-01 | 0.071 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.509745e-01 | 0.070 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.515538e-01 | 0.070 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.535064e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.544216e-01 | 0.068 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.544216e-01 | 0.068 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.544216e-01 | 0.068 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.544216e-01 | 0.068 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.544216e-01 | 0.068 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.590948e-01 | 0.066 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.590948e-01 | 0.066 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.590948e-01 | 0.066 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.590948e-01 | 0.066 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.592771e-01 | 0.066 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.602880e-01 | 0.065 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.625119e-01 | 0.064 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.656620e-01 | 0.063 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.656620e-01 | 0.063 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.656620e-01 | 0.063 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.656620e-01 | 0.063 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.656620e-01 | 0.063 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.656620e-01 | 0.063 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.656620e-01 | 0.063 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.656620e-01 | 0.063 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.656620e-01 | 0.063 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.686469e-01 | 0.061 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.750638e-01 | 0.058 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.760351e-01 | 0.057 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.760351e-01 | 0.057 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.760351e-01 | 0.057 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.760351e-01 | 0.057 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 8.760351e-01 | 0.057 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.760351e-01 | 0.057 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.760351e-01 | 0.057 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.760351e-01 | 0.057 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.760351e-01 | 0.057 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.833037e-01 | 0.054 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.856078e-01 | 0.053 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.856078e-01 | 0.053 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.856078e-01 | 0.053 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.856078e-01 | 0.053 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.856078e-01 | 0.053 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.856078e-01 | 0.053 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.886821e-01 | 0.051 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.913890e-01 | 0.050 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 8.928199e-01 | 0.049 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.944419e-01 | 0.048 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.944419e-01 | 0.048 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.944419e-01 | 0.048 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.944419e-01 | 0.048 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.944419e-01 | 0.048 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.944419e-01 | 0.048 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.944419e-01 | 0.048 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 8.944419e-01 | 0.048 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.944419e-01 | 0.048 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.010564e-01 | 0.045 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.012908e-01 | 0.045 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.012908e-01 | 0.045 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.017949e-01 | 0.045 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.025942e-01 | 0.045 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.025942e-01 | 0.045 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.025942e-01 | 0.045 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.025942e-01 | 0.045 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.025942e-01 | 0.045 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.025942e-01 | 0.045 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.025942e-01 | 0.045 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.036120e-01 | 0.044 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.040958e-01 | 0.044 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.040958e-01 | 0.044 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.040958e-01 | 0.044 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.096131e-01 | 0.041 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.101173e-01 | 0.041 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.101173e-01 | 0.041 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.101173e-01 | 0.041 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.101173e-01 | 0.041 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.101173e-01 | 0.041 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.111109e-01 | 0.040 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.111109e-01 | 0.040 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.134499e-01 | 0.039 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.142881e-01 | 0.039 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.142881e-01 | 0.039 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.142881e-01 | 0.039 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.170598e-01 | 0.038 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.170598e-01 | 0.038 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.170598e-01 | 0.038 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.170598e-01 | 0.038 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.170598e-01 | 0.038 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 9.170598e-01 | 0.038 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.191287e-01 | 0.037 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.205793e-01 | 0.036 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.205793e-01 | 0.036 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.234665e-01 | 0.035 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.234665e-01 | 0.035 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.234665e-01 | 0.035 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.234665e-01 | 0.035 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.234665e-01 | 0.035 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.255806e-01 | 0.034 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.255806e-01 | 0.034 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.277360e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.293786e-01 | 0.032 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.293786e-01 | 0.032 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.293786e-01 | 0.032 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.293786e-01 | 0.032 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.316979e-01 | 0.031 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.348344e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.348344e-01 | 0.029 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.348344e-01 | 0.029 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.348344e-01 | 0.029 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.348344e-01 | 0.029 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.363918e-01 | 0.029 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.388587e-01 | 0.027 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.426571e-01 | 0.026 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.445148e-01 | 0.025 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.445148e-01 | 0.025 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.457325e-01 | 0.024 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.464259e-01 | 0.024 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.488020e-01 | 0.023 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.489954e-01 | 0.023 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.527582e-01 | 0.021 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.550367e-01 | 0.020 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.591254e-01 | 0.018 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.597777e-01 | 0.018 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.597777e-01 | 0.018 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.616313e-01 | 0.017 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.628863e-01 | 0.016 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.628863e-01 | 0.016 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.649918e-01 | 0.015 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.657548e-01 | 0.015 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.657548e-01 | 0.015 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.657548e-01 | 0.015 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.684018e-01 | 0.014 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.684018e-01 | 0.014 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.684018e-01 | 0.014 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.686649e-01 | 0.014 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.708443e-01 | 0.013 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.708443e-01 | 0.013 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.708443e-01 | 0.013 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.708443e-01 | 0.013 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.719781e-01 | 0.012 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.726452e-01 | 0.012 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.730982e-01 | 0.012 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.751779e-01 | 0.011 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.766847e-01 | 0.010 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.770970e-01 | 0.010 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.770970e-01 | 0.010 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.770970e-01 | 0.010 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.773937e-01 | 0.010 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.777145e-01 | 0.010 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.788678e-01 | 0.009 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.820096e-01 | 0.008 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.820096e-01 | 0.008 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.820096e-01 | 0.008 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.820096e-01 | 0.008 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.830783e-01 | 0.007 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.846845e-01 | 0.007 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.846845e-01 | 0.007 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.846845e-01 | 0.007 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.858263e-01 | 0.006 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.862552e-01 | 0.006 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.871790e-01 | 0.006 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.871790e-01 | 0.006 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.879705e-01 | 0.005 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.880421e-01 | 0.005 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.880421e-01 | 0.005 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.888485e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.889011e-01 | 0.005 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.897597e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.903053e-01 | 0.004 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.914716e-01 | 0.004 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.915756e-01 | 0.004 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.919127e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.921483e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.921483e-01 | 0.003 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.923937e-01 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.924997e-01 | 0.003 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.925797e-01 | 0.003 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.926828e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.929677e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.936837e-01 | 0.003 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.937637e-01 | 0.003 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.939085e-01 | 0.003 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.946236e-01 | 0.002 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.951873e-01 | 0.002 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.954237e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.957779e-01 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.957779e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.961048e-01 | 0.002 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.964044e-01 | 0.002 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.964064e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.966846e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.967863e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.974738e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.975983e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.975983e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.977843e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.981046e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.981142e-01 | 0.001 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.981175e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.982603e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.982603e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.983180e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.985034e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.985194e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.986341e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.987453e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.988685e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.990467e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.990874e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.990874e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.991657e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.992132e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.992234e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.992652e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.993904e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.995215e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.995935e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.996535e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.996866e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.996973e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.998326e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998368e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998412e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.998680e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.998846e-01 | 0.000 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.998881e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999095e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999502e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999722e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999836e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999839e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999883e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999888e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999939e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999959e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999970e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999976e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999990e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
